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Background: More evidence is needed on the potential role of ‘booster’ interventions in the maintenance
of increases in physical activity levels after a brief intervention in relatively sedentary populations.
Objectives: To determine whether objectively measured physical activity, 6 months after a brief
intervention, is increased in those receiving physical activity ‘booster’ consultations delivered in a
motivational interviewing (MI) style, either face to face or by telephone.
Design: Three-arm, parallel-group, pragmatic, superiority randomised controlled trial with nested
qualitative research ﬁdelity and geographical information systems and health economic substudies.
Treatment allocation was carried out using a web-based simple randomisation procedure with equal
allocation probabilities. Principal investigators and study statisticians were blinded to treatment allocation
until after the ﬁnal analysis only.
Setting: Deprived areas of Shefﬁeld, UK.
Participants: Previously sedentary people, aged 40–64 years, living in deprived areas of Shefﬁeld, UK, who
had increased their physical activity levels after receiving a brief intervention.
Interventions: Participants were randomised to the control group (no further intervention) or to two
sessions of MI, either face to face (‘full booster’) or by telephone (‘mini booster’). Sessions were delivered 1
and 2 months post-randomisation.
Main outcome measures: The primary outcome was total energy expenditure (TEE) per day in kcal from
7-day accelerometry, measured using an Actiheart device (CamNtech Ltd, Cambridge, UK). Independent
evaluation of practitioner competence was carried out using the Motivational Interviewing Treatment
Integrity assessment. An estimate of the per-participant intervention costs, resource use data collected
by questionnaire and health-related quality of life data were analysed to produce a range of economic
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models from a short-term NHS perspective. An additional series of models were developed that used TEE
values to estimate the long-term cost-effectiveness.
Results: In total, 282 people were randomised (control = 96; mini booster = 92, full booster = 94) of whom
160 had a minimum of 4 out of 7 days’ accelerometry data at 3 months (control = 61, mini booster = 47,
full booster = 52). The mean difference in TEE per day between baseline and 3 months favoured the
control arm over the combined booster arm but this was not statistically signiﬁcant (–39 kcal, 95%
conﬁdence interval −173 to 95, p = 0.57). The autonomy-enabled MI communication style was generally
acceptable, although some participants wanted a more paternalistic approach and most expressed
enthusiasm for monitoring and feedback components of the intervention and research. Full boosters were
more popular than mini boosters. Practitioners achieved and maintained a consistent level of MI
competence. Walking distance to the nearest municipal green space or leisure facilities was not associated
with physical activity levels. Two alternative modelling approaches both suggested that neither intervention
was likely to be cost-effective.
Conclusions: Although some individuals do ﬁnd a community-based, brief MI ‘booster’ intervention
supportive, the low levels of recruitment and retention and the lack of impact on objectively measured
physical activity levels in those with adequate outcome data suggest that it is unlikely to represent a
clinically effective or cost-effective intervention for the maintenance of recently acquired physical activity
increases in deprived middle-aged urban populations. Future research with middle-aged and relatively
deprived populations should explore interventions to promote physical activity that require less proactive
engagement from individuals, including environmental interventions.
Study registration: Current Controlled Trials ISRCTN56495859, ClinicalTrials.gov NCT00836459.
Funding: This project was funded by the NIHR Health Technology Assessment programme and will be
published in full in Health Technology Assessment; Vol. 18, No. 13. See the NIHR Journals Library website
for further project information.
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Glossary
Accelerometer Instrument for measuring physical activity (such as Actiheart – see below).
Actiheart Chest-worn device that records heart rate, interbeat interval and physical activity. It calculates and
measures activity energy expenditure.
Bootstrapping A simulation method for deriving non-parametric estimates of variables of interest
(e.g. the variance in the incremental cost-effectiveness ratio) from a data set.
Cost-effectiveness acceptability curve A graph that plots a range of possible cost-effectiveness
thresholds on the horizontal axis against the probability (chance) that the intervention will be cost-effective
on the vertical axis. In technology appraisals, cost-effectiveness acceptability curves are a means of
representing the uncertainty surrounding the cost-effectiveness estimates in relation to the decision.
‘Full booster’ Two 20- to 30-minute face-to-face physical activity consultations, delivered in a motivational
interviewing style, 1 month apart. This included an exploration of barriers and motives to change, decisional
balance, agenda setting, action planning and relapse prevention.
Incremental cost-effectiveness ratio The ratio of the difference between the mean cost of a technology
and the cost of the next best alternative technology to the difference in the mean outcomes.
‘Mini booster’ Two 20-minute telephone physical activity consultations, delivered in a motivational
interviewing style, 1 month apart. This aimed to promote and sustain increased physical activity levels,
focusing on exploration of relevant physical activity experience and action planning, and to discuss physical
activity and usage of the DVD.
Motivational interviewing A directive, client-centred counselling style for eliciting behaviour change by
helping clients to explore and resolve ambivalence.
Motivational Interviewing Treatment Integrity code The Motivational Interviewing Treatment Integrity
code is a behavioural coding system, the use of which produces a score on a global scale indicating how well
or poorly a practitioner is using motivational interviewing.
Probabilistic sensitivity analysis A way of representing uncertainty in the results of economic evaluations.
Uncertainty may arise from missing data, imprecise estimates or methodological controversy. A sensitivity
analysis repeats the main analysis using different assumptions to examine the effect on the results. In
probabilistic sensitivity analysis, probability distributions are assigned to the uncertain parameters and are
incorporated into evaluation models based on decision-analytical techniques (e.g. Monte Carlo simulation).
Research assistant In this study research assistants were employed to conduct research activities (screening
candidates for study eligibility, collecting baseline and follow-up data) and as interventionists (delivering the
motivational interviewing ‘booster’ interventions).
Self-determination theory A theory of motivation concerned with supporting supposedly intrinsic or
natural tendencies to behave in effective and healthy ways.
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Transtheoretical model Defines behaviour change as a process rather than a single event and offers
practical suggestions for how individuals can change behaviour. The transtheoretical model offers
practitioners a common, validated framework for guiding participants through periods of change and
proposes strategies for maintaining positive behaviours.
Utility score A measure of the strength of a person’s preference for a specific health state in relation to
alternative health states. The utility scale assigns numerical values on a scale from 0 (death) to 1 (optimal or
‘perfect’ health). Health states can be considered worse than death and thus have a negative value.
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Scientiﬁc summary
Background
The beneﬁts of increasing levels of physical activity for people with sedentary lifestyles and those at
increased risk of chronic disease are well established. Systematic reviews have identiﬁed a need for further
research on the clinical effectiveness and cost-effectiveness of interventions intended to increase and
maintain physical activity levels. In 2006, the National Institute for Health and Care Excellence
recommended brief interventions in primary care. They also called for more work to understand how
recent increases in physical activity could be sustained in formerly sedentary people, as studies with longer
follow-up times had suggested high levels of relapse. Systematic reviews also suggest that dependence on
self-reported measures of physical activity and the difﬁculty of blinding participants mean that treatment
effects may have been exaggerated in previous primary research studies of interventions that support
people to be more active.
Objectives
The Shefﬁeld physical activity booster trial aimed to recruit participants who had already received a brief
intervention to evaluate different intensities of booster intervention. The primary objective was to
determine whether objectively measured physical activity, 6 months after a brief intervention, is increased
in those receiving physical activity ‘booster’ consultations delivered in a motivational interviewing (MI) style,
either face to face or by telephone. Secondary objectives included comparisons after longer follow-up
(12 months after the brief intervention); physiological measures of ﬁtness and self-reported physical
activity; analyses of mediators (interventionist ﬁdelity) and moderators (demographics and access to
facilities) of treatment effect explored quantitatively and qualitatively; and a cost-effectiveness analysis.
Design
Three-arm, parallel-group, pragmatic, superiority randomised controlled trial with nested qualitative
research ﬁdelity and geographical information systems (GIS) and health economic substudies. Treatment
allocation was carried out using a web-based simple randomisation procedure with equal allocation
probabilities. The principal investigator and study statisticians were blinded to treatment allocation until
after the ﬁnal analysis only.
Setting
The 55 most deprived neighbourhoods in Shefﬁeld, UK.
Participants
Between May 2009 and June 2011 NHS Shefﬁeld sent letters with postage-paid reply cards to 70,388
people inviting them to enrol in a programme to help them become more physically active. A brief
intervention was targeted at people not already meeting the current recommendations of 30 minutes of
moderate activity, ﬁve times a week. Previously sedentary people aged 40–64 years, living in deprived
areas of Shefﬁeld, UK, who had increased their self-reported physical activity levels by 30 minutes per
week after receiving a brief intervention, were randomised.
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Interventions
1. A ‘full booster’ group receiving two face-to-face physical activity consultations, provided in a MI style,
1 and 2 months after randomisation.
2. A ‘mini booster’ group receiving two telephone-based physical activity consultations, provided in a
MI style, 1 and 2 months after randomisation.
3. A control group who received no intervention after randomisation.
Interventions were underpinned by self-determination theory and used the relational and technical aspects
of MI. Session content considered client background, typical day, readiness to change, decisional balance,
importance for change and action planning. Follow-up telephone calls explored progress to date and
reviewed agreed action plans with a view to modiﬁcation when necessary.
Main outcome measures
The primary outcome was total energy expenditure (TEE) in kcal per day from 7-day accelerometry,
measured using an Actiheart device (CamNtech Ltd, Cambridge, UK) at 3 months. The mean TEE in the
combined booster group and in the control group was compared using a two independent samples t-test
and 95% conﬁdence interval (CI), with the associated p-value for the estimated mean difference between
the groups calculated. Secondary outcome measures included self-reported moderate or strenuous physical
activity using the Scottish Physical Activity Questionnaire (SPAQ); health-related quality of life (HRQoL)
using the 16-item Short Form health survey instrument (SF-12v2 plus 4); self-determination using the
Behavioural Regulation in Exercise Questionnaire (BREQ-2); body weight and height and physiological
measures of ﬁtness (12-minute walk test).
An estimate of the per-participant intervention costs, resource use data collected by questionnaire
and HRQoL data were analysed to produce a range of economic models from a short-term NHS
perspective. An additional series of models were developed that used TEE values to estimate the
long-term cost-effectiveness.
Qualitative research elicited information on potential effect moderators at 3 months post randomisation.
The survey questionnaire asked participants about the type and location of physical activity they had
undertaken during the previous 3 months, reasons for staying physically active, factors that inﬂuenced
their physical activity behaviour and social support from signiﬁcant others. Booster recipients were asked
about intervention acceptability. Questionnaire completers who received a booster were invited to a
semistructured interview lasting about 20 minutes and conducted over the telephone or face to face. The
topic guide covered questions about participants’ physical activity views and habits as well as their opinions
of the intervention. Interviews were digitally recorded, transcribed verbatim and analysed using the
‘framework’ approach.
The GIS analysis used network distance analysis and univariable linear regression models to test the
association between mean TEE in kcal per day at 3 months and potential geographical moderators
(pedestrian access to municipal green space and leisure facilities).
In the ﬁdelity assessment, interventionists (n = 4) were assessed for their competence after training and at
9 and 18 months using the Motivational Interviewing Treatment Integrity (MITI) assessment to evaluate
global ratings of evocation, collaboration, autonomy/support, direction and empathy. Counts of MI
adherent and non-adherent behaviours were made. Sessions were independently coded by a qualiﬁed MITI
coder. We employed analysis of variance to test the null hypothesis that physical activity measured
by mean TEE at 3 months was the same across all of the interventionists who delivered the
MI intervention.
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Two types of cost-effectiveness model were developed, which used different approaches and sources of
data to estimate the health effect, in quality-adjusted life-years (QALYs), of the interventions. A short-term
cost-effectiveness model incorporated trial-based estimates of the effect of the study interventions – mini
booster and full booster – on participants’ use of NHS resources during the trial period. It also incorporated
trial-based estimates of the effect of the interventions on participant utility using responses from
participants who completed the SF-12v2 plus 4 HRQoL questionnaire at baseline and 9 months. Twelve
scenarios were evaluated to account for structural uncertainty. Approximate costs of the interventions
were incorporated in the model alongside the estimates of the effect of the interventions on resource use.
Another individual sampling model considered the effect of the interventions over a much longer time
horizon than the trial duration and assumed that any potential QALY beneﬁts of the interventions are
mediated through the clinically measurable health beneﬁts of increased physical activity. We populated a
hypothetical cohort of 500,000 individuals with the age and gender variability of the trial population at
baseline. Ofﬁce for National Statistics life tables were used to deﬁne and simulate the ongoing mortality
hazard in the simulated population. We used a regression equation to adjust QALYs by age and gender,
discounting QALY gains at a rate of 3.5% per annum. Three alternative scenarios used different
assumptions about the longevity of the effect of the interventions and about the causal relationship
between physical activity and mortality hazards. We estimated the mean incremental treatment effect on
patient utilities using a differences-in-differences and a simple differences approach.
Results
We randomised 282 participants (control = 96; mini booster = 92, full booster = 94) of whom 160
(control = 61, mini booster = 47, full booster = 52) had a minimum of 4 out of 7 days’ accelerometry data
at 3 months. There were no marked differences in baseline characteristics between arms or between those
followed up and those lost to follow-up. The mean difference in TEE per day between baseline and
3 months favoured the control group (2266 kcal) over the combined booster groups (2227 kcal), but was
not statistically signiﬁcant (−39 kcal, 95% CI −173 to 95 kcal, p = 0.57). There was also no signiﬁcant
difference in the primary outcome when the full booster and mini booster groups were compared. A
difference in TEE per day of 112 kcal, favouring the full (face-to-face) booster, was observed, but this result
was not statistically signiﬁcant and of borderline clinical signiﬁcance. There was no statistically signiﬁcant
difference between groups on any secondary outcome measure, at 3 or 9 months, apart from the
12-minute walk test (adjusted mean differences 90.8 m, 95% CI 14.5 to 167.1 m at 3 months and 115.9 m,
95% CI 1.1 to 230.7 m at 9 months). Results were consistent after adjusting for age, gender, body mass
index, SF-12v2 plus 4 scores and total minutes of physical activity at brief intervention and baseline.
Postal questionnaire respondents (n = 75) and interviewees (n = 26) reported physical activity that was
mainly private and individual in character, with a minority participating in structured exercise classes or
competitive sports. Under half reported exercising with others. Participants felt that social support was
important, exercising with others was encouraging and motivating oneself in isolation was difﬁcult.
Non-family members were sometimes seen as better support than family, who were often perceived as a
barrier. Musculoskeletal injuries were a frequently cited barrier to becoming more active whereas chronic
physical conditions were often a motivator. The autonomy-enabled MI communication style was generally
acceptable, although some participants wanted a more paternalistic approach and most expressed
enthusiasm for monitoring and feedback components of the intervention and research. The face-to-face
intervention was seen as preferable to the telephone booster. Self-reported moderate to vigorous physical
activity often appeared to be at odds with the objective data.
Global ratings were mostly characterised as proﬁcient for direction and competent for other global
MI measures. The use of technical aspects of MI, including the use of open questions, increased across
all interventionists from baseline. The global rating of ‘direction’ was consistently high across all
interventionists at phase 1 and phase 2. The reﬂection to question ratio increased across the
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four interventionists who completed delivery of the intervention from phase 1 to phase 2. The use of
directional and deeper complex reﬂections was rated moderate or below competence across all
interventionists. MI ﬁdelity was associated with physical activity as measured by mean TEE per day in kcal at
3 months (p = 0.027).
The GIS analysis found wide variations in pedestrian access to municipal green space and leisure facilities.
However, there was no statistical association observed between access and TEE at 3 months.
Two alternative modelling approaches, evaluating a large number of scenarios, both suggested that
neither intervention was likely to be cost-effective. The main economic evaluations indicated that neither
the mini booster intervention nor the full booster invention is cost-effective at any willingness-to-pay
threshold. An additional analysis based on the long-term model, however, which incorporated data on
physical activity differences in differences between arms in a different way from the main analysis,
suggested that the full booster intervention might be cost-effective, assuming a willingness-to-pay
threshold of £20,000 per QALY, if the cost of the intervention is less than approximately £300 per
participant. This additional analysis assumes that all participants who receive the intervention increase
their physical activity levels by equal amounts. This assumption may be unwarranted given that those
participants who are already comparatively physically active may increase their physical activity levels most.
Conclusions
Although some individuals ﬁnd a community-based, brief MI ‘booster’ intervention supportive, the low
levels of recruitment and retention and the lack of impact on objectively measured physical activity levels
in those with adequate outcome data suggest that it is unlikely to represent a clinically effective or
cost-effective intervention for the maintenance of recently acquired physical activity increases in deprived,
middle-aged urban populations. The lessons learnt in undertaking this trial should inform both the design of
future physical activity intervention trials and the development of more effective interventions that not only
are feasible and affordable but also have sufﬁcient reach to have an impact in the most deprived, and most
sedentary, populations who could beneﬁt most from sustained increases in their physical activity levels.
Future research with middle-aged and relatively deprived populations should explore interventions to
promote physical activity that require less proactive engagement from individuals, including environmental
interventions. The design of studies to evaluate interventions should include both objectively measured, and
self-reported, levels of physical activity as outcomes, given the lack of agreement between these measures.
Study registration
This trial is registered as ISRCTN56495859 and ClinicalTrials.gov NCT00836459.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Background
Regular physical activity is associated with reductions in all-cause mortality, risk of cardiovascular diseaseand some types of cancer.1–3 Frequent exercise has a role in both the prevention and the management
of hypertension, type 2 diabetes and obesity as well as a variety of mental health conditions.4–6 However,
most of the UK population do not attain levels of physical activity sufﬁcient to confer such beneﬁts.7 For
the last 10 years, a key Department of Health policy objective has been encouraging the population to
undertake a total of at least 30 minutes of at least moderate intensity physical activity on 5 or more days
of the week.8
Brief interventions delivered in primary care can increase physical activity levels and are recommended as
effective and cost-effective interventions by the National Institute for Health and Care Excellence (NICE).9,10
However, the evidence base largely consists of studies with short-term follow-up post intervention and that
use self-reported increases in physical activity by trial participants as a primary outcome. Maintenance of
recommended physical activity levels is understood to be essential to achieve the reported health beneﬁts.
As a result, NICE identiﬁed that further research was warranted on the long-term sustainability of such
treatment effects.10 At the time, the few studies that had followed participants over the long term
suggested that approximately half of those who initiate a physical activity programme relapse and return
to their previous sedentary lifestyle within 6 months.11
In the last 6 years, since the publication of the original NICE guidance in March 2006 recommending the
use of brief interventions in primary care to encourage physical activity,10 a number of additional primary
studies and relevant systematic reviews have been published. These recent reviews of effectiveness and
cost-effectiveness evidence are further discussed in Chapter 8 (see Other recent evidence for the
effectiveness and cost-effectiveness of ‘brief’ and ‘booster’ interventions for increasing and sustaining
physical activity). The availability of further evidence on the use of brief interventions has led to the
initiation of a programme to update the original NICE guidance and this new guidance was published in
May 2013.12
In the meantime, the Shefﬁeld physical activity booster trial was funded and undertaken to address one of
the major gaps in the evidence base identiﬁed by the original NICE guidance.10
The booster trial was designed to evaluate the effectiveness and cost-effectiveness of motivational
interviewing (MI) ‘booster’ interventions to help previously sedentary people maintain recently increased
physical activity levels acquired following a brief intervention. MI13 is one of the behaviour change
interventions recommended by NICE for health promotion.14
The brief intervention involved provision of an interactive DVD based on a MI approach that is directive, is
person centred and replicates the style of other successful behaviour change programmes and was
underpinned by the theoretical construct of self-determination theory.15,16 All interventions were delivered
by trained facilitators whose competence was independently assessed using a treatment ﬁdelity framework
to ensure consistent delivery.17,18
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Chapter 2 Methods
Methods for the main trial
This report is concordant with the extension of the Consolidated Standards of Reporting Trials (CONSORT)
statement to improve the reporting of pragmatic trials.19 An internal pilot trial, conducted between May
2009 and March 2010 and focusing on feasibility outcomes, is reported elsewhere.20 The ﬁnal protocol
can be found in Appendix 1 and a table of changes made to the protocol over the course of the project is
presented in Appendix 2.
Participants
To identify potentially eligible study candidates we worked with NHS Shefﬁeld (Shefﬁeld Primary Care
Trust), the health service organisation responsible for commissioning health services for the local population
(until April 2013). Between May 2009 and June 2011 NHS Shefﬁeld sent letters with postage-paid reply
cards to 70,388 people inviting them to enrol in a programme to help them become more physically active.
Six general practices were also given a total of 305 marked recruitment packs to distribute. These packs
were identical to those sent from NHS Shefﬁeld with the exception that the covering letter was not
personalised. An unknown number of packs were also given to four community centres to be distributed by
health trainers and health champions. Mail-outs and responses were allocated to output areas (OAs)
according to the National Statistics Postcode Look-up table [November 2010 version; see http://geoconvert.
mimas.ac.uk/help/documentation/10nov/nspd-version-notes-november-2010.pdf (accessed 21 November
2013)]. The response rate for each OA was calculated as the total number of allocated responses divided by
the total number of allocated mail-outs. We performed a post hoc analysis to investigate whether response
rate was related to population transience. Transience rate was calculated using information obtained from
the 2001 census (small area statistics, Table CAS008), speciﬁcally the outgoing population divided by the
outgoing population plus the static population.21 An unweighted Spearman’s rank correlation test between
response rate and transience was performed in R version 2.15.0. (R Foundation for Statistical Computing,
Vienna, Austria; see www.R-project.org/).
The physical activity programme involved a ‘brief intervention’ combining an interactive DVD and
area-speciﬁc written information about local facilities and opportunities for physical activity. The DVD was
developed by a team at Shefﬁeld Hallam University using MI principles, which are consistent with NHS
guidance on physical activity and behaviour change interventions.10,14 The content and development of this
DVD are provided more fully in Appendix 1.
Research assistants (RAs) telephoned respondents and administered the Scottish Physical Activity
Questionnaire (SPAQ).22 Those eligible to receive the brief intervention (DVD and information sheet) were
(1) residents of the 55 most economically deprived neighbourhoods in the city of Shefﬁeld (out of 100),
(2) those aged 40–64 years and (3) those not achieving the recommended activity level (30 minutes of
moderate activity on at least 5 days) assessed using the SPAQ and wishing to have support to become
more active. RAs telephoned those sent a DVD 3 months later to assess their eligibility for participation in
the trial. Eligible candidates (4) had increased their physical activity level by at least 30 minutes of
moderate or vigorous activity per week (assessed using the SPAQ) over the 3-month brief intervention
(DVD) period and (5) were capable of giving written informed consent for trial participation. Individuals
with chronic conditions who could beneﬁt from physical activity were not excluded unless their condition
signiﬁcantly impaired their ability to exercise.
The validated SPAQ contains a series of questions assessing physical activity behaviour over the previous
7 days and also asks whether or not this level of weekly activity is typical. When observed weekly activity
was reported as atypical, SPAQ asks participants to clarify what constitutes a more typical week in terms of
DOI: 10.3310/hta18130 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 13
3
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Goyder et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
an increased or reduced number of minutes of physical activity. Before and after the brief intervention
period the RAs were asked to interpret the observed minutes of physical activity (as assessed using SPAQ)
and to include any additional minutes of activity that were felt to be typical for study candidates who
reported that the previous week had been atypical.
Interventions
Candidates who were assessed as eligible during the telephone assessment described in the previous
section were invited to attend a baseline assessment at a community venue. Those who consented were
randomly allocated (see Randomisation and blinding) to one of three groups:
1. a ‘full booster’ group receiving two face-to-face physical activity consultations provided in a MI style,
1 and 2 months after randomisation
2. a ‘mini booster’ group receiving two telephone-based physical activity consultations provided in a
MI style, 1 and 2 months after randomisation
3. a control group who received no intervention after randomisation.
Both booster interventions are fully described in the study protocol, which can be found in Appendix 1.
The full booster involved two face-to-face consultations, intended to last between 20 and 30 minutes,
which took place in community venues. The consultations replicated a brief MI method designed for
time-limited consultations in medical settings and which had already been successfully employed to
change health-related behaviours.23,24 During the full booster consultations, strategies were worked
through at a pace dictated by the participant and the menu used to structure information exchange
without being prescriptive.
The mini booster involved two physical activity MI consultations delivered by telephone, each intended to
last approximately 20 minutes. The telephone consultations followed a script of known efﬁcacy that has
been implemented in previous physical activity promotion studies delivered by members of this research
team.25,26 It is thought that telephone counselling can provide an alternative to face-to-face contact that is
relatively inexpensive in time and ﬁnancial terms.14 In previous studies in adult populations, telephone-based
approaches have increased physical activity participation at 6 months compared with no telephone support
and to a greater extent than standard reading materials.27,28
Objectives
The primary objective of the main study, a parallel-group randomised controlled trial (RCT), was to
determine if physical activity assessed using an Actiheart device (CamNtech Ltd, Cambridge, UK) 3 months
after randomisation (6 months after a brief intervention) increases in participants allocated to two
intervention groups (receiving two booster physical activity consultations, delivered in a MI style, either by
telephone or face to face) compared with participants allocated to a control group (receiving no further
contact after the baseline assessment). Secondary objectives were to:
1. determine whether physical activity 9 months after randomisation (12 months after the brief
intervention) is signiﬁcantly increased in participants allocated to the two intervention groups compared
with participants allocated to the control group
2. compare physiological measures of ﬁtness (12-minute walk test29) and self-reported physical activity
(SPAQ instrument) between allocated groups
3. compare health-related quality of life (HRQoL), resource use (including health and social care contacts)
and economic costs between allocated groups
4. investigate whether the impact of the intervention may be modiﬁed by gender, ethnicity or the types
of physical activity undertaken (including use of community facilities for physical activity)
5. undertake a process evaluation to identify, using both quantitative and qualitative methods,
psychosocial and environmental factors that may mediate or modify the effectiveness of
the intervention.
METHODS
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Outcomes
Table 1 shows the timing of assessments and interventions, all made at community venues. The primary end
point was the level of physical activity measured at 3 months post randomisation using Actiheart [speciﬁcally,
the mean total energy expenditure (TEE) in kcal per day over a 1-week period]. Secondary end points were:
1. objective measures of physical activity including:
i. TEE in kcal per day from 7-day accelerometry and heart rate monitoring using Actiheart
(at 9 months)
ii. physical activity counts (PACs) per week
iii. minutes of moderate/vigorous physical activity per day
iv. meeting the current physical activity recommendation of at least 30 minutes per day (continuous or
in bouts of at least 10 minutes of at least moderate intensity) for at least 5 days a week (yes or no)
2. self-reported moderate or strenuous physical activity using the SPAQ, which records type and duration
of activities in the previous week
3. HRQoL using the Shefﬁeld version of the 16-item Short Form health survey instrument
(SF-12v2 plus 4)
4. self-reported use of community facilities for physical activity
5. self-reported health and social care contacts (see Methods for the health economic analysis for the
analysis plan)
6. self-determination using the Behavioural Regulation in Exercise Questionnaire (BREQ-2)30
7. body weight and height [to allow calculation of body mass index (BMI)]
8. physiological measure of ﬁtness (12-minute walk test).
The primary outcome was measured at 3 months post randomisation whereas the secondary outcomes
were measured at 3 and 9 months post randomisation.
A decision was made to abandon the analysis of self-reported physical activity based on a questionnaire
adopted from the HTA-funded Exercise Evaluation Randomised Trial (EXERT) trial.31 This was because
completion errors remained high even after repeat training of those administering it. The decision to
abandon the use of this form was made in consultation with the trial steering committee and the HTA
programme manager and the EXERT team and is fully documented elsewhere.32
Sample size
The sample size was originally based on a primary outcome that was subsequently superseded by the use
of Actiheart, that is, a physical activity measure based on the mean physical activity levels from the 7-day
accelerometric assessment (recorded as counts per week) at 3 months post randomisation (6 months after
initial contact). Before progression to the main trial, an internal pilot was undertaken to estimate the
variability of the outcomes and the minimum clinically important difference (MCID) based on one-third of
the standard deviation (SD) of the primary outcome from the observed data and power estimation
(conditional on the initial proposed sample size of 600 subjects). From the feasibility phase, the estimated
effect size based on one-third of the SD was 34,464.7 PACs per week and 101.5 kcal per day TEE.32 When
re-estimating the sample size using data from an internal pilot study the revised sample size estimate either
stays the same or increases (it cannot be less than the original estimate).33,34
Assuming a mean difference in TEE of 101.5 kcal per day between the intervention group and the control
group as the smallest difference of clinical and practical importance that is worth detecting, then with 450
subjects (300 intervention, 150 control) the trial was originally determined to have 92% power to detect
this mean difference or greater between the ‘booster’ arm and the control arm (assuming a SD of
304.6 kcal per day) as statistically signiﬁcant at the 5% (two-sided) signiﬁcance level using a two
independent samples t-test. With 300 subjects in the booster intervention (150 mini booster, 150 full
booster) the trial would also have had approximately 82% power to detect a similar mean difference in
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TABLE 1 Timing of assessments and interventions
Assessment/intervention Minus 3 months Minus 2 months Minus 1 month ∼ Minus 1 week Baseline 1 month 2 months 3 months 9 months
Brief intervention
screening checklist
✓
SPAQ ✓ ✓ ✓ ✓
Brief intervention
questionnaire 1
✓
DVD (if eligible) ✓
DVD usage
assessment/advice
✓ ✓
Booster trial
screening checklist
✓
Participant information
sheet
✓ ✓
Participant consent form ✓
BREQ-2 ✓ ✓ ✓
Booster trial
questionnaire 2
✓ ✓ ✓
Questionnaire 3
(SF-12v2 plus 4)
✓ ✓ ✓
Height and weight ✓ ✓ ✓
Randomisation ✓
Booster intervention
(booster groups only)
✓ ✓
12-minute walk test ✓ ✓
7-day accelerometry ✓ ✓
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TEE of 101.5 kcal per day between the two booster arms as statistically signiﬁcant at the 5% (two-sided)
signiﬁcance level using a two independent samples t-test. Assuming an approximate 25–35% loss to
follow-up by 3 months post randomisation, we proposed to recruit and randomise 200 subjects per
intervention group to give a total sample size of 600 participants, giving the study power of between 87%
and 92% to detect a mean difference in TEE of 101.5 kcal per day.
Randomisation and blinding
A Shefﬁeld Clinical Trials Research Unit (CTRU) statistician, not on the trial team, used a simple
randomisation procedure to generate the randomisation sequence, with each participant having a one-third
probability of being allocated to one of the three intervention arms. We used a block size of 200 with no
stratiﬁcation. Eligible participants were randomised to one of the three arms using a central web-based
randomisation service delivered by Shefﬁeld CTRU after patient eligibility and informed consent were
conﬁrmed by a RA. Participants and outcome assessors were not blind to treatment allocation because of
the practical nature of the intervention. However, the primary outcome was objectively assessed using the
Actiheart device. Most other outcomes were self-reported. Study statisticians and the principal investigator
were blinded to the treatment allocation codes until after the ﬁnal analysis.
Statistical methods
Analysis population
The intention-to-treat (ITT) data set included all participants who were randomised according to randomised
treatment assignment (ignoring anything that happened after randomisation, including non-compliance,
protocol deviations and withdrawals); participants also had to have a valid 3-month post-randomisation
Actiheart accelerometry measurement of physical activity.
A valid Actiheart accelerometry measurement was deﬁned as having at least 4 complete days (of the 7 days)
of measurements of physical activity. We used the ‘auto-ﬁll’ option on the Actiheart to minimise the
amount of missing data. The ‘auto-ﬁll’ option ﬁlls the gaps, of up to 2 hours, with the average value
calculated from the recorded portion of the same day.35 If the device identiﬁed > 2 continuous hours of
missing data then, even using the ‘auto-ﬁll’ option, this was classiﬁed as an incomplete day. When data
were obviously missing because the participant had taken the accelerometer off to sleep, imputation of
‘sleeping’ values was employed by using the mean values during sleeping times. The decision about which
data were missing as a result of ‘sleeping’ was made by study team members blind to the treatment
allocation. After discussion with the trial management group and steering committee, incomplete days
were classiﬁed as having > 1000 minutes (16.7 hours) of lost or missing activity per day as measured by the
Actiheart. Although the manufacturers assert that there should be no issue with missing data, few studies
report the majority of participants returning complete data sets. A brief review of published studies shows
that a ‘complete day’ of Actiheart data is typically considered to be 500–600 minutes of recording.36,37
Although many studies do not report the thresholds used, in the absence of advice from the manufacturers
or deﬁnitive studies to determine the optimal threshold, researchers must determine an appropriate cut
point to maximise both data validity and participant inclusion.
In addition to the ITT set, two other data sets were analysed as part of the sensitivity analysis. A complete
cases data set was a subset of the ITT data set that included randomised participants with all 7 complete
days of physical activity measurements at 3 months post randomisation. A per-protocol data set was
deﬁned as including those who received the intended two booster sessions (either face to face or by
telephone) among participants in the booster intervention arm. Participants who did not receive the
booster sessions as intended were excluded from this data set. Additional data sets were also analysed for
the primary outcome as part of the sensitivity analysis assuming different missing mechanisms using
regression and multiple imputation approaches.
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Handling incomplete days or missing daily counts measurements
Exploratory analysis of potential risk factors associated with not having evaluable data (at least 4 complete
days of Actiheart data) was undertaken using logistic regression. Spaghetti plots stratiﬁed by intervention
arm were also used to explore the missing pattern of the primary end point with respect to the
measurements during days of the week. To achieve 80% reliability with respect to activity counts and time
spent in moderate to vigorous activity in adults, at least 3–4 days (of the 7 days) of activity monitoring are
required.38,39 In this regard, the primary outcome measure (mean TEE in kcal per day) was calculated as the
mean TEE over 7 days among those with at least 4 complete days of evaluable Actiheart data.
The primary method to deal with missing data on the secondary outcome, activity counts per week, was to
scale up complete observed daily measurements to 7 days using the following formula:
PAC7i ¼
Total Physical Activity counts per day ðcomplete daysÞ
Number of observed complete days
 7 days ð1Þ
where PAC7i is the new standardised physical activity measurement for 7 days for participant i. The
number of PACs per day was calculated by multiplying PACs per minute by 1440 (24 hours in a day
multiplied by 60 minutes in an hour). This approach was used for patients who have at least 4 complete
days measured after imputation using ‘auto-ﬁll’ and ‘sleeping’ time as described earlier.
Statistical analysis
Multiple logistic and linear regression was used to compare the baseline characteristics [i.e. gender,
ethnicity, employment status, age, BMI, weight, height, SF-12v2 plus 4 physical component summary score
(PCS), SF-12v2 plus 4 mental component summary score (MCS), Relative Autonomy Index (RAI) of the
BREQ-2, and SPAQ change scores] of the completers (≥ 4 days of valid Actiheart data at 3 months post
randomisation) and non-completers (< 4 days). An interaction term was included in the regression model
to see whether the characteristics of the completers and non-completers were different between the
booster and the control groups. The purpose was to explore whether the missing data mechanism was
related to the intervention or whether there are observed characteristics that might predict whether or not
a randomised participant would have valid and complete Actiheart data at 3 months post randomisation.
For sensitivity analysis, multiple imputation was used to obtain a complete data set for the primary
outcome by ﬁlling incomplete daily measurements. Twenty multiple imputation data sets were created and
we imputed, at most, 3 incomplete days of the week per participant (among those with at least 4
complete days). The multiple imputation model took into account participants’ baseline characteristics
(such as age, gender, weight, height, HRQoL and BMI) and longitudinal time sequence as well as total
physical activity at baseline and 3 months before randomisation. In addition, for participants with at least 1
complete day of the outcome measure, multiple imputation was also used to impute the missing daily
measurements as part of further sensitivity analysis using the same multiple imputation model as described
above but imputing at most 6 incomplete days of the week per participant.
Baseline characteristics
The baseline demographic characteristics and physical measurements were summarised and assessed for
comparability between the booster and the control arms.40–42 Age, weight (mass), height (stature), BMI,
SPAQ change score, BREQ-2 RAI dimension score and SF-12v2 plus 4 PCS and MCS scores were presented
on a continuous scale. For these continuous variables, summary statistics such as the minimum, maximum,
mean, SD, median and interquartile range (IQR) were presented. Numbers of observations used with
number and percentages in each category are presented for categorical variables (e.g. gender, marital
status, ethnicity and stage of change). Summary statistics are presented by treatment group and assessed
for comparability. No statistical signiﬁcance testing has been carried out to test baseline imbalances
between the intervention arms but any noted differences are descriptively reported.43,44
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Data completeness
Reporting of data completeness is an integral part of clinical trial reporting. Hence, summaries of data
completeness are shown on a CONSORT ﬂow chart from participants’ enrolment, during follow-up and at
the end of the trial. Data completeness is based on the primary outcome (mean TEE in kcal per day) and
having a valid measurement at 3 and 9 months post randomisation.
Effectiveness analyses
The primary aim was to compare the intervention group (full or mini booster) with the control group (no
booster). The primary comparison was between the mean physical activity levels from the accelerometer
(mean TEE in kcal per day) in the two ‘booster’ arms combined compared with the mean physical activity
levels in the control arm at 3 months post randomisation. This difference in means between the
intervention group and the control group was compared using a two independent samples t-test; a 95%
conﬁdence interval (CI) for estimated mean difference between the groups was also calculated and
reported with its associated p-value. The research hypothesis was that the booster intervention groups will
have greater levels of physical activity than the control group. In all of the analyses the control group was
treated as the reference for comparisons.
An adjusted analysis using multiple regression was also conducted to estimate the effect of the
intervention adjusted for baseline covariates (such as age, gender, HRQoL, BMI and SPAQ at baseline and
3 months before randomisation). The ordinary least squares adjusted regression coefﬁcient for the
intervention effect was presented and reported with its associated 95% CI and p-value.
A secondary objective of the study was to compare the effect of the two interventions (full booster vs. mini
booster) at 3 months post randomisation using the primary outcome, mean TEE per day. Therefore, we
repeated the above analysis to compare the effects of the full and mini booster interventions.
The analysis outlined above for the primary outcome was also repeated for the main secondary outcome,
PACs per week at 3 months post randomisation, and for the TEE and PAC outcomes at 9 months
post randomisation.
Analysis of secondary outcomes
The following continuous secondary outcome measures were assessed at 3 and 9 months
post randomisation:
l PCS, MCS and Short Form questionnaire-6 Dimensions (SF-6D) scores from the SF-12v2 plus 4
l average minutes per day spent on moderate activity [3–6 metabolic equivalents of task (METs)]
l average minutes per day spent on vigorous activity (> 6 METs)
l average minutes per day spent on moderate and vigorous activity (≥ 3 METS)
l BREQ-2 dimensions (amotivation, external regulation, introjected regulation, identiﬁed regulation,
intrinsic regulation, RAI)
l BMI
l distance walked (in minutes) during a 12-minute walk test.
Mean outcomes were compared between the combined booster groups and the control group using two
analysis of covariance (ANCOVA) multiple regression models: a simple model that adjusted for the baseline
value of the outcome only and a more complex model that adjusted for several covariates including age,
gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation and the
baseline outcome measurement. The mean differences in outcomes between the groups and their
associated 95% CI and p-value from the two models were reported.
Secondary binary categorical outcomes were the number and proportion maintaining (or increasing) their
weekly duration of physical activity (based on the self-reported SPAQ) and the number and proportion
meeting the current recommendations of at least 30 minutes of moderate physical activity (MET level ≥ 3)
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on at least 5 days of the week. We compared these outcomes between the booster groups and the
control group at 3 and 9 months post randomisation using a continuity-corrected chi-squared test; 95%
CIs for the estimated differences in proportions between the booster groups and the control group were
also calculated.45
Gender, ethnicity and access to community facilities (self-reported use of community facilities vs. no use of
community facilities) were predeﬁned as subgroups that we wished to test for evidence of effectiveness in
an exploratory analysis. An additional post hoc exploratory subgroup evaluation was undertaken to assess
the impact of the timing of the initial mail-out (summer/spring vs. winter/autumn). The exploratory
subgroup analysis used multiple linear regression with the primary outcome, the mean TEE (per day) levels
from the Actiheart at 3 months post randomisation, as the response. We used an statistical test for
interaction between the randomised intervention group and the subgroup to directly examine the evidence
for the treatment effect of the combined booster groups varying between subgroups.43,46,47 Subgroup
analyses were performed regardless of the statistical signiﬁcance of the overall intervention effect
(booster vs. control). The model below was used to assess the interaction:
Outcome ¼ randomised groupþ subgroupþ randomised group subgroup interaction ð2Þ
A graphical plot of mean proﬁle subgroups with intervention group was used to display the
interaction effect.48
Methods for the process evaluation
The aim of the process evaluation was to (1) assess how acceptable and appropriate participants found the
intervention and (2) identify psychosocial and environmental factors that may modify the effectiveness of
the intervention. The study contained two components: (1) a survey by postal questionnaire, incorporating
closed and open questions, and (2) a semistructured interview conducted individually face to face or over
the telephone, depending on the preference of each participant.
Our methodological and theoretical approach is that adopted by Snape and Spencer,49 characterised by a
subtle realism, interpretivism and pragmatism: we understand our subject matter through participants’
contextually situated perspectives; we strive for neutrality and objectivity during data collection and
analysis and we attempt to be as transparent as possible as we move beyond the data during
interpretation to serve the needs of policy-makers.
Survey
Survey questionnaires were sent to participants before their 3-month research assessment and they were
asked to completed the questionnaire before the assessment and return it in a sealed envelope. If the
survey was not completed participants were asked if they would be willing to complete it at the 3-month
research assessment, after which the participant sealed it in an envelope and handed it back to the RA.
Because of delays in regulatory approvals, questionnaires were sent out from April 2010 only and the ﬁrst
47 randomised participants were not invited to complete it.
The survey questionnaire asked participants about the type and location of physical activity that they had
undertaken during the previous 3 months, reasons for staying physically active, factors that inﬂuenced
their physical activity behaviour and social support from signiﬁcant others. The versions of the
questionnaire sent to participants in the full and mini booster arms of the trial also contained questions on
the intervention received. Participants were asked why they chose to participate; their preferred format for
such an intervention; their expectations of the intervention and the extent to which these were met and
whether they found the intervention easy, convenient, non-judgemental and non-confrontational.
Participants were also asked their opinion about the amount of contact time with the project worker, the
extent to which they felt encouraged to set their own goals for physical activity and the extent to which
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they felt that the intervention had helped them to resolve their barriers to physical activity, expand their
knowledge of physical activity, increase their awareness of local facilities and opportunities and increase
their conﬁdence to stay active. Finally, participants were asked whether they had become more physically
active than they were before participating and what had helped them achieve this. The questionnaire sent
to those in the full booster arm of the trial can be found in Appendix 4. The questionnaires distributed to
the mini booster and control arms are available from the team on request.
In-depth interviews
Those receiving a booster intervention who also responded to the survey questionnaire (see Survey) were
given the option of participating in an in-depth interview. Because of the poor response there was no
scope for purposive sampling; as a result, we interviewed a sample comprising all of the 26 people who
volunteered. We did not elicit reasons for declining a research interview. Three RAs performed the
interviews: Andrew Hutchison PhD (male) and Kimberly Horspool MSc and Sue Kesterton MSc
(both female). KH and SK had both studied qualitative research techniques as part of their MSc but were
novice interviewers. AH was more experienced having conducted a number of qualitative research
interviews as part of his doctoral research. None of the interviewers delivered the intervention to the
interviewees but interviewers may have been involved in collecting baseline data for the RCT component
from some interviewees. Interviewees would have known that interviewers were on the research team and
were from Shefﬁeld Hallam University and may have associated them with exercise science and delivery of
the intervention. The interviewers were asked to withhold their own opinions and to make it clear that this
interview was separate from the intervention motivational interviews. No ﬁeld notes were taken and no
repeat interviews were undertaken.
Semistructured interviews lasted between 9 and 32 minutes (median 21 minutes) and were conducted
over the telephone or face to face in a quiet room at a community venue, according to each participant’s
choice. For most interviews no one was present except for the participant and the researcher. In one case
a participant chose to conduct the interview on a mobile phone and, for part of the time, in a public place.
A topic guide was provided to interviewers (see Appendix 5); this was not pilot tested. This guide included
questions on participants’ levels, choice and prioritisation of physical activity as well as the beneﬁts and
costs associated with staying physically active. It also included questions on participants’ experiences of the
booster sessions and why they had or had not helped them to stay active and why participants felt that
the booster sessions were or were not a good way to give them the support that they needed.
Interviews were digitally recorded and transcribed verbatim. Transcripts were not returned to participants
for comment or correction. Daniel Hind conducted the initial data analysis in NVivo version 10 (QSR
International, Southport, UK) using a constant comparative method to identify themes. We used a
‘framework’ approach to analysis in which a priori and emergent themes were identiﬁed using the
following stages: familiarisation, identifying a thematic framework, indexing, mapping and interpretation
(charting was not undertaken).50 For instance, a theme of a priori interest was the perceived effectiveness
of the booster sessions; subthemes within this category were derived inductively from familiarisation with
the transcripts.50,51 The results were used to explore insights into the mechanisms that may have
contributed towards the quantitative ﬁndings and to identify any other emerging issues or factors that may
have inﬂuenced the uptake of the boosters and which had not previously been documented.52 Data
saturation was achieved53 with no substantively new themes emerging in the last 10 interview transcripts.
Participants were not asked to provide feedback on the themes.
Having indexed transcripts using our own thematic framework, we undertook a rapid review of the
literature to ﬁnd existing frameworks to evaluate dimensions of (1) prior conditions experienced by
the participants; (2) barriers to and facilitators of adoption of new behaviours or technologies; and (3) the
acceptability/appropriateness of the interventions. For prior conditions (see Chapter 4, Prior conditions) we
used dimensions described by Rogers (p. 172).54 We adopted, with modiﬁcations, the dimensions of the
Motivators of and Barriers to Health-Smart Behaviors Inventory, developed by Tucker and colleagues55
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(see Chapter 4, Barriers to physical activity and Physical activity: motivators). Our dimensions of
intervention acceptability are based on those described by Nastasi and Hitchcock56 (see Chapter 4,
Motivational interviewing: perceived effectiveness, Motivational interviewing: consistency with
perspectives or world views, Motivational interviewing: perceived feasibility and Motivational interviewing:
perceived importance).
Methods for the ﬁdelity study
Background
Although a small number of studies assessing the efﬁcacy of physical activity counselling have reported the
content, frequency and duration of training of those delivering the physical activity counselling
intervention, the majority do not, and it is not uncommon for most clinical trials to fail to even report the
content of the counselling intervention.57,58
Although physical activity counselling based on MI has been rolled out across the UK through the Let’s Get
Moving education programme,59 it remains unclear whether those delivering the training and those
delivering the intervention to patients are doing so according to the approach intended. This failure to
embed assessments of competence has raised questions over the value of short-term workshops with little
or no ongoing supervision and professional practice reﬂection. It is clear that programmes such as this
offer a potentially valuable additional education framework but few studies are currently being published
that have clearly assessed the ﬁdelity of those delivering the intervention.
It has therefore been suggested that behavioural interventions should clearly report (1) the content of or
elements of the intervention, (2) the characteristics of those delivering the intervention, (3) the
characteristics of the recipients, (4) the setting [e.g. Physical Activity Referral Scheme (PARS)], (5) the mode
of delivery (e.g. face to face or by telephone), (6) the intensity and contact time (e.g. number of sessions)
and (7) participant adherence to delivery protocols.60 The booster trial embedded these principles into its
design along with treatment ﬁdelity frameworks intended to provide standardisation of the behavioural
intervention without losing innovation and ﬂexibility within the two intervention arms.17,18 Furthermore, the
action planning and maintenance phases in both experimental arms used behaviour change techniques, as
recommended by Michie and colleagues,60 which are thought to enhance self-regulation towards change.
The assessment of the existing competence and subsequent training of those delivering the MI
interventions was evidence based and built on recent reviews of training in MI.61
Motivational interviewing content and delivery
The MI component was delivered by RAs trained by a member of the Motivational Interviewing Network of
Trainers and followed existing frameworks for MI in physical activity contexts.62,63 The key phases and
content of the intervention are provided in Table 2 and follow the phases of MI.64 The relational aspect
(or ‘spirit’) of MI is pivotal to the approach and emphasises participant ‘autonomy’ as opposed to
TABLE 2 Motivational interviewing content and session structure
MI content MI phase
Opening exchange/agenda setting Engagement
Decisional balance Focusing
Importance of change (agreed target behaviour) Evoking
Readiness to change (agreed target behaviour)
Action planning Planning
Maintenance phase Maintenance
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‘imposing authority’; ‘evocation’ rather than ‘education’; and ‘collaboration’ instead of ‘confrontation’.
Once underpinned with the relational approach, the technical skills of MI were delivered, which included
open-ended questions, afﬁrmations, reﬂective listening and summarising.13 Those delivering the
intervention received 6 days of formal training over the ﬁrst 12 months of the study in addition to
follow-up supervision for the remainder of the study using audio recordings for reﬂective feedback.
Treatment fidelity assessment and methods
To ensure that the criteria for treatment ﬁdelity were met, those delivering the MI physical activity booster
interventions (RAs) were assessed for their competence in delivering MI before and throughout the
intervention period. The assessment of practitioner competence used was the Motivational Interviewing
Treatment Integrity (MITI) assessment.65 Minimum practitioner levels will be based on the levels of
‘competence’ as stated in the MITI coding system. To account for practitioner competence ‘drift’ (post
training), follow-up reviews of practitioner MI competence were carried out at appropriate intervals
(approximately every 9 months).
The MITI assessment was used to measure the interventionist application of key facets of MI, which
included ‘global ratings’ of evocation, collaboration, autonomy/support, direction and empathy. In
addition, ‘behaviour counts’ were recorded, which included giving information, MI adherent behaviours
(e.g. asking permission, afﬁrming, emphasising personal control), MI non-adherent behaviours
(e.g. advising, confronting, directing), open compared with closed questions and simple and complex
reﬂections. The calculations for MITI were based on existing standards,65 as seen in Table 3.
The relationship between motivational interviewing fidelity and levels
of physical activity: statistical methods
We employed analysis of variance (ANOVA) to test the null hypothesis that physical activity measured by
mean TEE at 3 months was the same across all of the RAs who delivered the MI intervention. We plotted
the means of mean TEE with their associated 95% CIs stratiﬁed by the RA who delivered the MI
intervention to show how physical activity varies across RAs ranked by their global proﬁciency ratings. A
further ANOVA model was ﬁtted with RAs with the same global proﬁciency rating grouped together. We
dropped from the analysis RAs who delivered very few sessions. In addition, for the few sessions in which
MI was delivered by two RAs, we allocated the session to the RA who delivered more sessions.
Methods for the geographical information systems study
Aim
The aim of this substudy was to explore whether access to green space and leisure facilities inﬂuenced the
effectiveness of the intervention. We used network distance analysis to produce a set of variables for each
of the 282 trial participants, which represents his or her pedestrian access to municipal green space and
any relevant leisure facilities.
TABLE 3 Motivational Interviewing Treatment Integrity treatment ﬁdelity results
Clinician behaviour count or summary score thresholds Beginner proﬁciency Competency
Global clinician ratings (average) 3.5 4.0
Reﬂection to question ratio (R : Q) 1 2
Per cent open questions (% OQ) 50 70
Per cent complex reﬂections (% CR) 40 50
Per cent MI adherent (% MIA) 90 100
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Network distance analysis
Euclidean (straight line) distance is the simplest measure of distance between two points. However, in a
city it is rarely possible to follow a straight line between two points. Moreover, rivers, railway lines and
sometimes roads force pedestrians to take routes that may deviate considerably from a straight line. To
gauge the realistic walking distance between two points in a city, it is necessary to build a network
representation of the pedestrian-accessible routes within the city and surrounding area. The shortest route
between any two points on the network can then be calculated mathematically.
The most labour-intensive step is creating the network. The Integrated Transport Network™ (ITN) in OS
MasterMap® [Ordnance Survey, Southampton, UK; see www.ordnancesurvey.co.uk/oswebsite/products/
os-mastermap/itn-layer/index.html (accessed 10 October 2012)], can be used for this purpose, but
unfortunately it is not possible to download a single portion of the ITN covering all of Shefﬁeld and the
surrounding area. Instead, we downloaded the data for this area from OpenStreetMap (see www.
openstreetmap.org). In a certain respect, OpenStreetMap is actually more useful to us than the ITN; it is
created (in part) by local volunteers, walking on foot and recording data with global positioning system
(GPS) devices, and therefore provides information on pedestrian access that is more detailed than a typical
OS map.
Roads and footpaths, etc. in OpenStreetMap are stored in a simple vector format that makes it relatively
easy to extract the information required to build a network. The only problem is that the labelling of
pedestrian accessibility for roads (especially trunk roads) is not consistent and is occasionally inaccurate.
It was therefore necessary to manually exclude the following sections of road:
l A61 Dronﬁeld bypass
l Shefﬁeld Parkway
l Mosborough Parkway
l A57 (section linking Mosborough Parkway to the M1)
l A616 Stocksbridge bypass
l Park Square roundabout
l Tinsley roundabout and Tinsley viaduct.
Crossing points for non-pedestrian roads, for example bridges and underpasses, are well detailed in
OpenStreetMap.
Although the shortest distance between points within the network can be calculated very accurately, there
is the potential for error when calculating the network distance between features that do not lie within
the network. Unfortunately, the centroids of postcode areas, and the polygons representing municipal
green space boundaries, do not lie within the network. Here it is necessary to spatially ‘join’ these features
to an appropriate point on the network. This is best done manually; however, because of the large
amount of work that this would require it was necessary to automate the joining process, as follows.
Each postcode centroid was linked to the closest point on the network and the Euclidean distance
between the centroid and the network point added to the network distance.
Each green space polygon was linked to all network points falling inside it, with the minimum network
distance to any of these points deemed to be the minimum network distance to the polygon itself. As
pedestrian entry points to green space are well detailed in OpenStreetMap, this means that the network
distance mostly takes the entry points into account.
The major limitation of the automated joining process is that sometimes the network point that the
feature is linked to is not always the most appropriate. For example, a postcode area may include adjacent
houses that face onto different streets so that an address may be attributed to a network point on a street
from which there is actually no access to the property. Similarly, for green space, points on the network
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outside the green space polygon may sometimes be closer to the actual entry points than those inside the
polygon. This can result in network distance errors of ≥ 100 m, in some cases substantially more if the
difference in network distance between the automated choice of point and the optimum choice of point is
large. Fortunately, very large anomalies appear only in rural areas where the road network is sparse and
therefore were not a signiﬁcant concern in this analysis.
Green space measures
All municipal green spaces in Shefﬁeld were considered, excluding certain types of land use inappropriate
for exercise. Shefﬁeld City Council classiﬁes these spaces as ‘city’, ‘district’ or ‘local’ according to their
catchment areas. We used ‘city’ as a proxy for high-quality space and ‘district’ as a proxy for medium-quality
space in terms of attractiveness. Local spaces were too ubiquitous for a meaningful spatial analysis. Of
municipal green spaces belonging to other authorities, only Rother Valley Country Park was included
(designated high quality).
Digitised boundary data for municipal green spaces in Shefﬁeld were provided by the Shefﬁeld City
Council Parks and Countryside team. As well as boundary information, these data included a classiﬁcation
of the usage and catchment area categorisation of each space. These are explained fully in a Shefﬁeld City
Council Parks and Countryside report66 but are summarised here as follows:
l Usage type:
¢ parks
¢ gardens
¢ sports sites (e.g. tennis courts)
¢ playing ﬁelds
¢ playgrounds
¢ playground/open space
¢ woodlands
¢ moorland/heathland
¢ open spaces
¢ allotments
¢ churchyards/cemeteries
¢ other site types – speciﬁed:
¢ golf courses
¢ farms
¢ show grounds
¢ depots
¢ ancillary sites to other leisure facilities (e.g. car parks).
l Catchment area categorisation:
¢ city wide
¢ district (up to 1.3 km)
¢ local (up to 0.4 km).
We decided to disregard the following usage types: playgrounds (because our participants are middle-aged),
allotments (as nearby allotments are relevant only to the minority of local residents who rent them),
churchyards/cemeteries (less likely to be appropriate places for exercise), farms, depots and ancillary sites.
Inclusion of the catchment area categorisation information is more problematic than inclusion of usage
type as it is not clear on what research, if any, it is based. However, disregarding the categorisation is
equally problematic as ‘local’ municipal green space is ubiquitous. For example, our preliminary study
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considered all municipal green spaces in Shefﬁeld of the appropriate usage type and the size of a football
pitch or greater and found very few postcodes in the city that were further than 1 km from such a space,
with roughly 50% falling within 500 m and roughly 30% falling within 300 m. This tallies with the
ﬁndings of Barbosa and colleagues.67 Also, most distances > 500 m fell in the most afﬂuent parts of the
city, which were not included in the booster trial (this also tallies with the ﬁndings of Barbosa and
collegaues67). Because of random errors inherent in our network distance measurements (see Network
distance analysis), such small network distances would contain an unacceptable amount of uncertainty.
It was also felt that it was important for us to take some account of the attractiveness of municipal
green spaces.
Therefore, we decided to make use of the catchment area categorisation as a proxy for the quality/
attractiveness of the space, using an ordinal scale in which citywide represents the highest quality, district
represents medium quality and local represents the lowest quality. Disregarding all green spaces with
unsuitable usage types (see earlier) we measured the shortest network distance to:
(a) high-quality municipal green spaces of appropriate types
(b) high- or medium-quality municipal green spaces of appropriate types.
We excluded Shefﬁeld’s three municipal golf courses; these have citywide catchment areas but this is
clearly based on their attraction as a leisure facility (as deﬁned in leisure facility measures) offering golf,
rather than as a green space, and the booster participant questionnaire responses indicated that very few
participants played golf.
One potential problem with using the green space data for Shefﬁeld is that many of the booster
participants live on the edge of the city and could be using municipal green spaces belonging to
surrounding authorities (Barnsley Metropolitan Borough Council, Rotherham Metropolitan Borough
Council, Derbyshire County Council or North East Derbyshire District Council). This was a matter of
sufﬁcient concern for us to request green space boundary data from these authorities. However, because
of the green belt around Shefﬁeld, there are actually few important municipal green spaces belonging to
these authorities that are close to the borders of Shefﬁeld. The exception to this is Rotherham, with the
two conurbations forming a continuous urban area. However, this area is heavily industrialised and there
are few important municipal green spaces. One very important exception is Rother Valley Country Park,
which borders south-east Shefﬁeld; a boundary polygon for this park was added manually to the set of
green spaces having a citywide catchment area.
All green space measures in this study are shortest distance measures. So far we have decided not to use a
gravity model for green space as the need to include an arbitrary distance decay parameter would be a
potential source of bias. However, this remains an option for future work. Regarding the more
sophisticated ﬂoating catchment area gravity model, this may actually be inappropriate for green space:
unlike a capacity-constrained service such as a health practitioner, a green space that is heavily used (and
thus full of people) may be more attractive and more likely to be perceived as appropriate for recreational
exercise or as a walking route than one that is less well used.
Leisure facility measures
Leisure facilities, as distinct from green spaces, are deﬁned here as places where a physical activity is
facilitated by some kind of organisation, usually in return for payment. For example, we deﬁne a tennis
club as a leisure facility but an unsupervised tennis court within a park as part of a green space. Similarly, a
publicly accessible playing ﬁeld is considered a green space rather than a leisure facility, unless it is part of
a sports club. Data on leisure facilities are easier to collect than data on green spaces because leisure
facilities can be treated as point locations. Even though these facilities may cover a large area, there is
usually an ofﬁce where people must go to pay, and this is typically also the building to which the address
of the facility relates. Therefore, noting the limitations of geocoding accuracy explained in Network
distance analysis, it is credible to use the postcode centroid of the facility’s address as a point location.
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The chief problems in collecting data on leisure facilities were twofold:
l deciding which types of leisure facility were relevant to the booster participants
l ensuring that all leisure facilities of these types, located within a reasonable distance of the study area,
were included.
To address the ﬁrst point we had the beneﬁt of the questionnaires completed by the booster participants
(see Outcomes and Survey). These data suggest that the main physical activities relevant to the participants
were walking, gardening, swimming and gym-based activities. Walking relates to municipal green space
rather than leisure facilities and gardening relates to neither, so we considered only leisure facilities
offering a gym and/or swimming.
To address the second point we used the Sport England online ‘active places’ database,68 which provides
an authoritative list of sports facilities, with each facility listed as offering one or more types of activity.
Two of these types of facilities, ‘health and ﬁtness suite’ and ‘swimming pool’, correspond directly to gyms
and swimming respectively. The postcode of each facility is also included on the database, as is an
indicator of how the public can access the facility (those open only to sports clubs or community
associations, rather than individuals, were excluded). For each facility postcode we calculated the network
distance to every other postcode within Shefﬁeld, and for each Shefﬁeld postcode we recorded the
shortest network distance to:
l a unisex gym
l a female-only gym
l a swimming pool.
As with green space, we did not implement any of the more sophisticated ‘gravity’ models for leisure
facilities. The basic gravity model is additive, meaning that having three gyms a 500-m network distance
from one’s home would be scored three times better than having one gym 500 m away. This is clearly
inappropriate as gyms are often paid for on a membership basis, and it is unlikely that a participant would
join several gyms. Although swimming may be offered on a pay-per-session basis more frequently than
gym facilities, it is still questionable whether having three local pools is exactly three times better than
having one local pool.
Here, the ﬂoating catchment area gravity model is potentially more useful than the basic gravity model as
it links the usefulness of local facilities to local demand.69 A gym may be less desirable if it is frequently
crowded and one has to wait to use particular exercise machines, and the same may also apply to lane
swimming in pools. In this context having multiple local facilities can be beneﬁcial, as greater provision of
facilities means that they are less likely to be crowded. Unfortunately, the problem with interpreting this
model is determining local demand; although the size of the local population can be easily obtained from
census data, people often choose leisure facilities close to where they work rather than where they live, so
using population data could be misleading, particularly in the city centre.
Given these issues, and for consistency in the analysis methods, we have used straightforward minimum
distance analysis.
With leisure facilities there is also the issue of affordability. Some facilities are expensive and may not be
realistically accessible to the more deprived communities targeted by the booster recruitment strategy.
However, pricing information is not included in the Sport England database and it was not possible within
the timescale of this project to obtain pricing information separately for each facility. Restricting the
analysis to municipal facilities was considered but in Shefﬁeld some privately run leisure facilities are less
expensive than municipal ones. It is therefore important to recognise that affordability may be an
additional barrier to accessing local leisure facilities, even when they are geographically close, which this
analysis does not address.
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Statistical methods
We constructed crude scatter plots of mean TEE per day (kcal) at 3 months against potential moderators
generated from the geographical information systems (GIS) analysis and other continuous baseline
potential moderators to explore any univariable linear relationships. In addition, we stratiﬁed these
plots by intervention arm to explore whether the univariable linear relationships were consistent within
the intervention arms. Univariable linear regression models were ﬁtted with amount of physical activity
measured by mean TEE per day (kcal) as the response and potential moderator as an explanatory variable
to explore whether a potential moderator was a predictor of physical activity at 3 months.
To explore the moderation effect, we ﬁtted multivariable linear regression models on the same response
variable with intervention group, potential moderator and interaction between treatment group and
potential moderator as explanatory variables (as given by Equation 3). Plots of the ﬁtted regression line
stratiﬁed by booster treatment group were constructed to explore any potential interactions. In addition,
hypothesis testing on the interaction term was also undertaken using Equation 3 to test the moderation
effect of GIS variables on physical activity. Variables were classiﬁed as being moderators of physical activity
if they had a signiﬁcant interaction effect with treatment at 3 months.
Mean TEE per day ðkcalÞ ¼ potential moderatorþ treatment group
þ potential moderator treatment group ð3Þ
Methods for the health economic analysis
Introduction
As part of the trial data collection, participants answered questions on their use of NHS facilities at
3 months and 9 months post randomisation. Participants also completed the SF-12v2 plus 4 HRQoL
questionnaire, allowing SF-6D HRQoL scores at 3 and 9 months to be produced.70 Together with an
estimate of the intervention cost, such data allow a simple estimate of the effect of the intervention on
mean HRQoL and average cost to be produced by comparing costs and utility scores at the end of the
intervention with those before the intervention.
A potential problem with using this approach in the case of the booster intervention is illustrated in
Figure 1. Figure 1a illustrates a typical pharmaceutical RCT. The patient population is recruited on the basis
of suffering from a particular disease, which has a progressive effect on their HRQoL. The intervention
reduces disease progression and so a difference in HRQoL emerges between the intervention arm (dashed
line) and the control arm (solid line) by the end of the trial. Figure 1b indicates the potential effect on
HRQoL of a lifestyle intervention. Both the control arm and the intervention arm are generally in good
health initially but because of low levels of physical activity both are at an increased risk of developing a
range of diseases and conditions related to sedentary behaviour. As the intervention is not intended to
modify a disease but instead modify a lifestyle factor that predisposes people over the long term to
increased morbidity and mortality risks, a straightforward comparison of before-and-after levels of resource
use and HRQoL may be misleading as it may have been too soon for the mediating effect of physical
activity on health to have become apparent.
For this reason, the cost-effectiveness of the interventions was assessed using two distinct modelling
approaches. Alongside a short-term model comparing participants’ self-reported HRQoL and NHS resource
use at 3 and 9 months, a long-term epidemiological model was also developed in which differences in the
primary physical activity measure recorded in the trial, TEE, were mapped onto effects on mortality
reported in epidemiological literature. This approach better allows the complex mediating effects of
physical activity on health to be formally represented but also increases the dependence of the modelling
results on strong assumptions about this physical activity–health relationship.
In the rest of this section overviews of the methods used to produce the two models are provided.
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Cost-effectiveness modelling overview
Two types of cost-effectiveness model were developed, which used different approaches and sources of
data to estimate the health effect, in quality-adjusted life-years (QALYs), of the interventions. Both types of
model are described in more detail below.
Short-term questionnaire-based model
A short-term cost-effectiveness model has been constructed that incorporates trial-based estimates of the
effect of the two interventions – mini booster and full booster – on participants’ use of NHS resources
during the trial period. It also uses trial-based estimates of the effect of the interventions on participant
utility using responses from participants who completed the SF-12v2 plus 4 HRQoL questionnaire at
baseline and 9 months.70 Approximate costs of the interventions are also incorporated in the model
alongside the estimates of the effect of the interventions on resource use.
Resource use data collected and used
Data were collected at randomisation and at the end of the trial on participant use of NHS facilities. This
included all face-to-face and telephone consultations with general practitioners (GPs) and other primary
care staff, attendance at hospital accident and emergency (A&E) facilities, use of hospital outpatient
facilities, number of hospital day cases and number and duration of hospital stays. With these data it is
possible to produce an estimate of the effect of the intervention on resource use from an NHS perspective.
Uncertainty in the true frequency with which each type of NHS resource was accessed was represented
using a Dirichlet distribution with a non-informative prior of 0.5 added to each cell count.
For each trial arm – control, mini booster and full booster – the number of times that each participant had
been to A&E, used hospital outpatient facilities, been a hospital day case and stayed overnight in hospital
was recorded at both randomisation and up to 9 months later. Along with the reason for each resource
use event, the number of times that type of resource was accessed for that reason was also recorded.
For example, some participants may stay 2 nights in a hospital for a particular reason, others may have
three hospital day appointments for another reason. What is of interest from a resource use perspective
is the number of resource use units – such as nights in hospitals, day appointments, A&E admissions –
rather than number of events. For this reason the number of resource use units of each resource use type
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FIGURE 1 Timing of HRQoL benefits. (a) Curative intervention; and (b) preventative public health intervention.
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was calculated by multiplying the number of resource units represented by an event by the frequency of
each event. Costs for each type of resource use unit were estimated from a standard source71 to
produce estimates of the cost of each type of resource use at the start and end of the trial and in each
trial arm. These were divided by the number of participants in each arm to produce an estimated cost
per participant.
Estimating costs from a societal perspective
These data were also used to provide estimates of the effect of different health conditions from a broader,
societal perspective, which are presented as separate analyses. From this broader perspective, each use of
a NHS facility was assumed to incur an additional cost. This additional cost was calculated as the national
minimum wage for older people of working age multiplied by an assumed amount of time that it would
take a patient to make use of each particular service type. The number of working hours foregone in
making use of each type of NHS resource is shown in Table 4.
Although a signiﬁcant proportion of the patient population was close to, or older than, retirement age and
so may not be expected to be in full-time employment, the same opportunity costs were applied to all
patients. This is to account for the societal value of services that people who are not in employment can
be assumed to provide to friends and family, such as looking after children, home maintenance, looking
after pets and so on. Each of these services can be bought and so has a market value at or above
minimum wage. These simplifying assumptions are more likely to overestimate than underestimate the
true societal costs and so could be considered an upper range of the cost-effectiveness of the
interventions from a societal perspective.
Estimating health-related quality of life
Responses from participants who completed the SF-12v2 plus 4 questionnaire were used to derive an SF-6D
utility score.70 Differences in differences between an intervention arm and the control arm are used to
produce an estimate of the incremental effect of each intervention on participant utility over this period.
Deterministic results
A version of the model is presented that provides a single best estimate of the mean incremental cost and
mean incremental QALY gain for both the mini booster and full booster interventions. These best
estimates combine resource use and utility values estimated from trial data with approximate intervention
costs elicited from report authors involved in conducting the interventions. These estimates are somewhat
approximate and are intended more to be illustrative than authoritative. The effect of the high level of
uncertainty in these estimates on decision uncertainty is explored through probabilistic sensitivity
analysis (PSA).
Probabilistic sensitivity analysis
Within PSA, instead of a single best estimate of the incremental cost and QALY gain of each intervention
being used, the effect of uncertainty around these values was assessed by drawing 1000 plausible values
TABLE 4 Assumed number of hours of labour or equivalent foregone from each use of a NHS facility
Resource type Assumed working hours foregone
Visit to A&E 15 (2 days)
Hospital day case 7.5 (1 day)
Hospital outpatient 7.5 (1 day)
Hospital overnight stay 7.5 (1 day)
GP telephone consultation 1
Visit to GP surgery 3.75 (half a day)
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from joint distributions of the mean costs and mean QALYs of each intervention. These are shown on
scatterplots, with different plotting symbols representing estimates from different arms.
Cost-effectiveness acceptability frontiers
Cost-effectiveness acceptability frontiers (CEAFs) were used to translate the joint incremental cost and
incremental QALY estimates (‘scatter’) produced from the PSA into an indication of decision uncertainty.
This involved calculating the incremental cost-effectiveness ratio (ICER) implied by each joint estimate of
incremental cost and incremental QALYs and identifying the proportion of ICERs that are below a given
willingness-to-pay threshold (λ). The horizontal axis of a CEAF indicates how the proportion of ICER
estimates below the threshold varies across different values of λ. Within this analysis, the range of λ values
considered was between £0 and £50,000 per QALY. CEAFs differ from cost-effectiveness acceptability
curves in that only the option estimated to be optimal, that is, with the greatest net mean beneﬁt,
is plotted.
Long-term epidemiological model
As stated previously, interpretation of the short-term cost-effectiveness model can be problematic as the
intervention is preventative rather than curative and the participants are not selected from a population
characterised by a particular disease. Because of this, it may be more valid to consider the effect of the
intervention over a much longer time horizon than the trial duration and to assume that any potential
QALY beneﬁts of the intervention are mediated through the clinically measurable health beneﬁts of
increased physical activity. This is the rationale for presenting a long-term epidemiologically based model
alongside the short-term questionnaire-based model described in the previous section. Unfortunately,
adopting this approach requires making a number of strong assumptions about how the physical activity
measures recorded within the trial translate into an impact on population health. The long-term model
was an individual sampling model constructed in the R statistical programming language (version 2.14.2).
The approach taken to develop this model, together with the assumptions made, are described in the
following section.
Populating a hypothetical cohort of individuals
As the population who participated and were eligible for the intervention were drawn from a fairly general
working age population, an individual sampling model was constructed to represent variability in terms of
age and gender of the population at baseline. After discussion amongst project members, it was decided
that the age distribution of the hypothetical population considered in the long-term model should be
drawn from the age distribution of the booster trial participants rather than the population eligible for the
trial. This is because trial participants did not appear to be uniformly drawn from the population eligible to
participate but were disproportionately drawn from the upper end of the age range eligible to participate.
For simplicity, it was assumed that trial participants were drawn equally from both genders.
Hypothetical population size
Within these analyses, the size of the simulated cohort was selected to be 500,000 individuals. Increasing
the number of individuals sampled in the simulation will lead to greater stability in estimates of mean
effect but will substantially increase the computing time that models need to run.
Defining and simulating the ongoing mortality hazard in the
simulated population
Once the hypothetical cohort of individuals was constructed, the aim was to simulate their clinical
experiences over their lifetime. Beginning at their initial age, the probability that they die in the following
year was estimated using Ofﬁce for National Statistics (ONS) life table data.72 If they survive the following
year, their age is increased by 1 year and the probability of them dying in the following year is updated to
reﬂect their new age. The mathematical model involves applying this process iteratively for each of the
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individuals in the cohort until death, producing a series of simulated initial ages and ages at death.
Table 5 provides a simple illustration of this:
Calculating quality-adjusted life-years
The purpose of simulating each individual 1 year at a time is to estimate the accrual of QALYs over the life
course. Recent work by the School of Health and Related Research (ScHARR) at the University of Shefﬁeld has
indicated that the QALYs associated with living another year differ according to the age and gender of the
patient and to reﬂect this it has produced a regression equation that allows age- and gender-adjusted QALYs
to be calculated.73 This equation has been used within the mathematical model to produce more accurate
estimates. Each additional year lived by a simulated individual therefore results in an increment to the number
of QALYs accrued by that individual but this amount differs each year according to this equation.
In adjusting QALYs according to the age and gender of an individual, the different levels of morbidity that
typically affect people at different ages and which differentially affect men compared with women are
implicitly accounted for and so the model incorporates morbidity effects alongside mortality effects.
For simplicity, however, it was assumed that different levels of physical activity do not have a mediating
effect on the degree of morbidity that an individual experiences relative to other people of the same age
and gender.
Discounting
As is standard practice in UK-based health-care economic modelling, QALYs gained are discounted at a
rate of 3.5% per annum.74
Assumptions about the longevity of the effect of the intervention
An intention of the long-term model was to represent a plausible decline in physical activity levels in the
years following the trial, returning to baseline levels for participants in each of the three trial arms after
2 years. As baseline levels of physical activity were not recorded using Actiheart, three alternative scenarios
using the long-term model were used. One scenario used the 9-month activity levels relative to the
3-month activity levels and two other scenarios compared differences between arms at 3 months and
9 months post randomisation. The implications of these different assumptions about the appropriate
comparators are discussed below, see Problems with inferring causal effects from the data.
Assumptions about the causal relationship between physical activity and
mortality hazards
A number of sources of epidemiological research exist which suggest that a monotone relationship exists
between how physically active people of working age are and their all-cause mortality rates.75–80 However,
no source could be identiﬁed that related directly to the population eligible for the intervention (those
aged between 40 and 64 years inclusive), those who participated in the intervention (who tended to be
drawn disproportionately from the older ages within the pool of those eligible) or the particular physical
activity measures recorded by the Actiheart system.
TABLE 5 Illustration of results from a simple patient natural history simulation
Person number Initial age (years) Gender Age at death (years)
1 51 Male 82
2 45 Male 75
3 59 Female 84
4 48 Female 90
5 52 Male 86
Column 2 is drawn from trial participants’ ages. Column 4 is estimated from life tables.
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Because of this a number of assumptions had to be made to relate the epidemiological results to the
outcomes reported in the booster trial. The main epidemiological source used to inform the assumed
relationship between physical activity measures and adjusted mortality risks was a US-based study
published in the New England Journal of Medicine (NEJM) in 2002.81 In this study the peak exercise
capacity, as measured in METs, for older men of working age (mean age 59 years) was assessed through
standardised treadmill-based testing. The paper presents a ﬁgure showing the relationship between
relative risk (RR) of death and quintile of exercise capacity. The risk ratio for the highest exercise capacity
quintile was chosen as the reference category. These data are presented in Table 6, as well as values
adjusted to have the third quintile as the reference category.
Although initially it was assumed that the risk ratio to MET relationship could be mapped directly from the
NEJM results to the Actiheart data, as both the data in the NEJM article and the booster trial data were
categorised according to METs, it was recognised that this was not appropriate. This is because the
contexts in which these METs were recorded were not equivalent. In the case of the NEJM article, METs
were of physical exercise capacity and involved trying to identify an upper physical limit to patients’
physical performance over a short period of time. In the case of the Actiheart data the METs were of
typical activity over a period of 1 week. Instead, an indirect approach to mapping the relationship was
used. This involved making the additional assumption that the relationship between quintiles held, even if
the unit of measurement was different.
The outcome measure used from the booster trial to estimate the relationship between exercise quintile
and RR was mean daily TEE, which was recorded using the Actiheart device at both 3 months and
9 months. The median TEE score from both time periods combined was identiﬁed and all scores recorded
were converted to a proportion of this median score. The central proportional TEE score within each of the
ﬁve quintiles was calculated by sorting all values from lowest to highest and identifying the values 10%,
30%, 50%, 70% and 90% of the way across this distribution, to identify proportional TEE values
associated with each quintile. The relationship between TEE (as a proportion of the median TEE) and
exercise quintile is presented in Table 7. This shows that someone whose TEE was approximately 80% of
TABLE 7 Mapping between quintile and TEE as a proportion of the median
Quintile Mean TEE per day (kcal) TEE as proportion of the median
1 (lowest) 1703 0.77
2 1998 0.90
3 2224 1.00
4 2434 1.09
5 (highest) 2839 1.28
TABLE 6 Reported relationship between exercise capacity quintile and RR of death
Quintile Risk ratio
a
Centralised risk ratiob
1 (lowest) 4.5 2.5
2 2.5 1.4
3 1.8 1.0
4 1.4 0.8
5 (highest) 1.0 0.6
a Quintile 5 was the reference category.
b Quintil 3 was the reference category.
Source: Myers and colleagues.81
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the median is in the lowest physical activity quintile and someone whose TTE was approximately 30%
more than the median was in the highest quintile. Participants’ TEE levels at 3 months and 9 months are
also presented graphically in Figure 2.
Data from Tables 6 and 7 were combined to produce a regression equation mapping proportional TEE
against RR of death. A good ﬁt was found by assuming a power law relationship between these variables.
The data and mapping equation identiﬁed are shown in Figure 3. The best ﬁt equation identiﬁed was
y = 1.056x−2.951, where y is RR and x is TEE as a proportion of the median.
Using Actiheart data to adjust mortality risks in the simulated cohort
By using the power law mapping equation shown in Figure 3, an estimated RR for each proportional TEE
value determined from the Actiheart data can be produced. The procedure for this within the
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FIGURE 2 Relationship between mean daily TEE at 3 months and mean daily TEE at 9 months by intervention group.
Grey lines indicate the centre of each quintile.
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FIGURE 3 Mapping equation between assumed RR of death and TEE as a proportion of the median.
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mathematical model involved ﬁrst duplicating the initial simulated cohort of individuals produced using the
ONS population data and then applying TEE scores drawn from the ﬁnal observations in treatment arms
combined to one of these cohorts and TEE scores drawn from the ﬁnal observations in the control arm to
the other of these cohorts. TEE scores were sampled with replacement from each respective arm. The RR
associated with the particular proportional TEE assigned to that individual was then assumed to apply to
him or her. An illustration of this is provided in Table 8.
The risk of death in the following year for each individual is then calculated by ﬁnding the estimated
probability of death in the following year using life table data adjusted for age and gender and then
multiplying that risk by that individual’s estimated RR. Within the mathematical model the positive effect of
the treatment can operate only through this life table adjustment, although as described above other
positive clinical relationships between physical activity and mortality risk could also be incorporated in later
additions of the model.
Problems with inferring causal effects from the data
There are two fundamental challenges to the validity of the long-term model: ﬁrst, the main physical
activity outcome recorded in the booster trial, TEE, is a surrogate or proxy from the perspective of the
long-term model, in which the outcome is QALYs; second, it is difﬁcult to judge what is the counterfactual
or baseline, that is, what would have happened to those participants who were assigned to the
intervention arms of the trial if they were assigned to the control arm.
The previous section has shown the degree of potential model dependence on a number of assumptions
that had to be made to link TEE with mortality. Some of these assumptions are strong, such as the
assumption that quintiles of exercise capacity in one population correspond directly to quintiles of physical
activity in another population. The validity of such assumptions therefore has a knock-on effect on the
validity of the model outputs.
The issue of estimating the counterfactual is a fundamental challenge in the case of the booster trial for a
number of reasons:
1. Actiheart measurements including TEE and PACs were not recorded at the start of the trial (‘baseline’).
Instead, the ﬁrst measures were recorded at 3 months post intervention. Additionally, subjective
measures of physical activity such as the SPAQ were known to have only very slight correlation with the
objective measures so cannot be reliably used to impute the objective scores at baseline.82
2. The level of attrition within the trial was high, meaning that the sample of participants who completed
the trial may not be representative of those who started the trial, and so there is a signiﬁcant potential
bias issue.
3. The number of participants who had valid and complete Actiheart measures at 3 months and 9 months
post randomisation is signiﬁcantly smaller than the number who completed the booster trial.
TABLE 8 Illustration of how proportional TEE (pTEE) and RRs are linked to simulated individuals in the
mathematical model
‘Control’ cohort ‘Treatment’ cohort
Person
number
Initial age
(years) Gender pTEE RR
Person
number
Initial age
(years) Gender pTEE RR
1 51 Male 1.1 0.80 1 51 Male 0.9 1.45
2 45 Male 0.9 1.45 2 45 Male 1.1 0.80
3 59 Female 0.9 1.45 3 59 Female 1.3 0.49
4 48 Female 0.8 2.05 4 48 Female 1.0 1.06
5 52 Male 1.0 1.06 5 52 Male 1.7 0.22
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Because of the high level of attrition and low number of participants with complete Actiheart data, it may
be wrong to assume that the population mix in each arm is similar at 3 months and 9 months after the
start of the trial, because of patterns of selective attrition. This means that it may be problematic to
assume that differences in the outcome measures between the control arm and the treatment arm
observed at 3 months and 9 months are due to the treatment effect.
For this reason, a differences-in-differences approach was used. This involves comparing change over time
in the outcome in the treatment group with change over time in the outcome in the control group. As no
TEE measurements were recorded at baseline, the 3-month scores were used as proxies for the baseline
levels and the 9-month scores were assumed to be the longer-term post-intervention levels.
It may be argued that using the 3-month post-intervention scores as the baseline scores is a very strong
assumption because a signiﬁcant treatment effect may be present at 3 months post intervention. In theory,
a highly effective intervention could appear to be less effective than a less effective option because the
more effective intervention is most effective at 3 months whereas the less effective option is more effective
at 9 months than at 3 months. This is illustrated in Figure 4, in which the more effective intervention is
indicated by the solid line and the less effective intervention by the dashed line. Because of this potential
problem with using the 3-month scores as the baseline scores in the differences-in-differences approach,
separate analyses using a simple differences approach were also carried out. These analyses involved
comparing the TEE levels at 3 months in the intervention arms with the TEE levels at 3 months in the
control group, and the 9-month TEE levels in the intervention arms with the 9-month TEE levels in
the control group.
The fundamental problem with the simple differences approach is that differences between groups at
either 3 months or 9 months could be due to differences between the groups that were present at
randomisation, rather than differences as a result of the intervention. This is illustrated in Figure 5 in which
the intervention had no effect on the physical activity levels of either arm (the solid or dashed lines), but
comparing scores in arms at either 3 months or 9 months would suggest a treatment effect. In this study,
although the participants were randomly assigned to each of the three arms and so on average can be
assumed to have similar baseline characteristics at randomisation, because of the degree of attrition in the
study the composition of the three arms cannot be assumed to be the same at 3 months or 9 months
because the attrition may have been selective. For example, participants who were least inclined towards
additional physical activity may be more likely to leave the treatment arms but may stay in the control arm.
3
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FIGURE 4 Illustration of a scenario in which it would be wrong to attribute differences in differences (9 months vs.
3 months) between the treatment arm and the control arm to a treatment effect.
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Estimating the mean incremental treatment effect on patient utilities using
a differences-in-differences approach
In the differences-in-differences approach, four out of six hypothetical groups with the same initial age
and gender proﬁles were compared. The six groups are:
l FT – the ‘treated’ full booster arm. All individuals’ scores were sampled with replacement from the
scores of participants who were assigned to the full booster group and provided valid Actiheart data at
9 months and 3 months. The RRs associated with the individuals’ 9-month scores were used for the
ﬁrst 2 years, then the RRs associated with individuals’ scores at 3 months were used thereafter. This
represents the assumption that any treatment effect of the intervention is unlikely to last much longer
than the duration of the trial.
l FU – the ‘untreated’ full booster arm. The same as for FT but with the 3-month RRs used throughout.
l MT – the ‘treated’ mini booster arm. The same as FT but drawing from participants in the mini booster
arm rather than the full booster arm.
l MU – the ‘untreated’ mini booster arm. The same as FU but drawing from participants in the mini
booster arm rather than the full booster arm.
l CT – the ‘treated’ control arm. As with FT and MT but using 9-month control group scores for 2 years
instead. Using scores from this group helps to control for trends over time and any effect on physical
activity of being part of the trial even if not assigned to one of the treatment arms.
l CU – the ‘untreated’ control arm. As with FU and MU.
The utility effect of the intervention was therefore estimated as (MT –MU) – (CT – CU) for the mini booster
group and (FT – FU) – (CT – CU) for the full booster group.
Estimating the mean incremental treatment effect on patient utilities using
a simple differences approach
Using notation similar to that presented above, the six groups are:
l F3 – scores at 3 months in the full booster arm
l F9 – scores at 9 months in the full booster arm
l M3 – scores at 3 months in the mini booster arm
l M9 – scores at 9 months in the mini booster arm
l C3 – scores at 3 months in the control arm
l C9 – scores at 9 months in the control arm.
The utility effects of the interventions were therefore estimated as F9 – C9 (full booster) and M9 – C9 (mini
booster) using 9-month data and F3 – C3 (full booster) and M3 – C3 (mini booster) using 3-month data.
3
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FIGURE 5 Illustration of a scenario in which it would be wrong to attribute differences between the treatment arm
and the control arm at 3 months or 9 months to a treatment effect.
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Primary and secondary models
Because both the simple differences approach and the differences-in-differences approach require that
problematic assumptions be made, neither the simple difference models nor the differences-in-differences
models should be considered preferable to each other. Instead, they should all be considered equal
primary models.
In addition to these primary analyses, a secondary model was also produced. This model involved assuming
that the changes in physical activity levels recorded between 3 months and 9 months in each arm were
equally distributed. This means that a mean increase in physical activity between 3 and 9 months will
translate into a mean increase in survival and longevity. Because the primary long-term models are
individual-level models and make use of a separate single observation from the trial and involve mapping
changes in physical activity to changes in annual risks, this does not necessarily occur in these models.
The approach used in this ‘value-added’ model is described in more detail in the following section.
The ‘value-added’ model
If F9i deﬁnes the level of activity recorded in the individual in the full booster arm at 9 months and F3i
deﬁnes the level of activity recorded in that same individual at 3 months, then in the differences-in-
differences model the physical activity level change in each individual at the end of 9 months is calculated
as F9i – F3i and so is different for each individual. In the ‘value-added’ model, however, an equal increase is
assumed for all participants in each arm. This increase, ΔF, is the mean difference between 9-month and
3-month scores observed in individuals in the full booster group. The increases in the control group, ΔC,
and the mini booster group, ΔM, are calculated similarly.
‘Value added’ means that the direction of effect in terms of estimated effect on mean utility should always
be in the same direction as the estimated effect on mean activity level and so may appear to produce
more plausible estimates when trial results indicate a mean increase in physical activity but the economic
model indicates a mean decrease in estimated utility. The cost of doing this, however, is to not make use
of some available individual-level data relating level of physical activity at 3 months to level of physical
activity at 9 months.
Additional assumptions about the physical activity–mortality relationship
As assuming that RRs related to physical activity levels applied indeﬁnitely produces implausible estimates
of the mortality effects of the intervention (such as indicating that a substantial proportion of those in the
highest exercise quintile will live to > 140 years), and as the available results are for middle-aged
individuals, it was additionally assumed that the relationship between physical activity and mortality rate
stopped when participants reached 70 years of age and that uniform risks applied from that age onwards.
For simplicity, and because of a paucity of data in those above this age, it was also assumed that no
individual would live longer than 99 years.
Additional scenario analyses
Assessing the effect of baseline physical activity on additional benefits of
additional physical activity
As the relationship between exercise quintile and mortality RR appears to follow a power law, it seems
important to consider how estimates of cost-effectiveness vary as a function of baseline levels of physical
activity. This is because a given increase in physical activity for people already relatively active is likely to
provide less additional health beneﬁt than the same increase in physical activity in a very sedentary
population. As a supplementary analysis, the long-term model was therefore used to estimate the effect of
an intervention that increased people’s physical activity from the ﬁrst to the second quintile, the second to
the third quintile, and so on.
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Chapter 3 Results of the main trial
All tables relating to results from the main trial can be found in Appendix 6.
Recruitment of trial participants
Figure 6 provides a detailed ﬂow chart showing participant recruitment and follow-up during the study.
Between May 2009 and June 2011 a total of 70,388 postal invitation letters with prepaid reply cards were
sent to residents aged 40–64 years in our study neighbourhoods inviting them to enrol in a programme to
help them become more physically active. Response and randomisation rates from the six mail-outs are
detailed in Appendix 6, Table 16. Mail-out 6 was sent in June 2011 in a ﬁnal attempt to boost recruitment
but with the expectation that 9-month follow-up results would not be available. The trial was closed to
recruitment in November 2011, the last opportunity within the funding envelope to recruit and follow
participants up for 3 months (the primary outcome assessment). No marked reply cards distributed by GPs
were returned; the team have no information on whether those distributed through community sources
were returned but it is assumed that most if not all respondents were approached through the primary
care trust mail-out (see Chapter 2, Methods for the main trial).
Of the invitation letters sent, only 4964 (7.1%) replies were received indicating an interest in taking part in
the trial. Of these potential participants, 2502 (50.4%) were contactable and were screened for eligibility
for the brief intervention. A total of 568 (22.7%) of those screened for the brief intervention were ineligible
to take part for various reasons (three were too young, 16 were too old, 470 were too active and already
achieving the current recommended activity levels of at least 30 minutes of at least moderate activity on at
least 5 days a week, 21 did not wish to be more active and 58 were ineligible for other reasons).
A total of 1934 participants wishing to have support to become more active and meeting the inclusion
criteria and eligible for the brief intervention were sent a DVD focused on increasing physical activity in
general. Three months after receiving the brief intervention, 1094 (56.6%) were contactable and their
physical activity levels were reassessed.
Of these, 556 (50.8%) successfully increased their physical activity levels and were eligible to be
randomised into the booster intervention trial, of whom 282 consented and were randomised into the
three arms of the trial in a ratio of 1 : 1 : 1 (control = 96, mini booster = 92 and full booster = 94).
Retention of participants during follow-up and evaluable data
Participants were followed up between August 2009 and February 2012. Of the 282 participants who
were randomised, 201 (71%) were followed up and assessed at 3 months after baseline (control = 76,
mini booster = 63 and full booster = 62). However, evaluable data on the primary outcome, mean
daily TEE, which was deﬁned as data from those with at least 4 complete days (lost not more than
1000 minutes in a day) of Actiheart measurements, were available for only 160 (57%) of the randomised
participants, which translated to an attrition rate of 43%. Therefore, 160 participants were available for
the ITT analysis on the primary outcome.
At 9 months post randomisation 50% (140/282) of the participants had an assessment, of whom 91 had
evaluable primary outcome data at 9 months of follow-up [a 9-month response rate of 32% (91/282)];
80 had evaluable data at both 3 and 9 months and the remaining 11 had evaluable data only at
9 months.
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Postal invitation to use brief intervention
(n = 70,388)
ITT set (n = 160)
ITT set (n = 91)
(n = 80) and additional 11
without 3 months data
Non-responders
(n = 65,424) (92.9%)
Not contactable
(n = 2462) (3.5%)
Ineligible
(n = 568) (0.8%)
Reasons:
• Too young (n = 3)
• Too old (n = 16)
• Too active (n = 470)
• Do not wish to be more active (n = 21)
• Other (n = 58)
Not contactable after 3 months
(n = 840) (1.2%)
Not randomised
(n = 274) (0.4%)
Reasons:
• Unable to contact (n = 20)
• Cancelled (n = 59)
• Repeated no shows (n = 54)
• Not interested taking part (n = 139)
• Unknown (n = 2)
Responders
(n = 4964) (7.1%)
Eligible; sent brief intervention
(n = 1934) (2.8%)
Eligible and contactable
(n = 1094) (1.6%)
Consented and randomised
(n = 282) (0.4%)
Allocated to control
(n = 96)
Allocated to ‘mini booster’
(n = 92)
Allocated to ‘full booster’
(n = 94)
3-month follow-up
(n = 76)
3-month follow-up
(n = 63)
3-month follow-up
(n = 62)
9-month follow-up
(n = 55)
Not followed up (n = 21)d
   4 complete days (n = 61)
< 4 complete days (n = 12)
Missing (n = 3)
   4 complete days (n = 47)
< 4 complete days (n = 10)
Missing (n = 6)
   4 complete days (n = 52)
< 4 complete days (n = 7)
Missing (n = 3)
      4 complete days (n = 36)
< 4 complete days (n = 6)
Missing (n = 13)
Not followed up
(n = 20)a
Not followed up
(n = 29)b
Not followed up
(n = 32)c
9-month follow-up
(n = 43)
Not followed up (n = 20)e
9-month follow-up
(n = 42)
Not followed up (n = 20)f
Contactable; screened for brief
intervention eligibility
(n = 2502) (3.6%)
Successfully increased physical 
activity levels
(n = 556) (0.8%)
Ineligible
(did not increase physical activity)
(n = 538) (0.8%)
>–>–>–
>–       4 complete days (n = 25)
< 4 complete days (n = 2)
Missing (n = 16)
>–        4 complete days (n = 30)
< 4 complete days (n = 5)
Missing (n = 7)
>–
FIGURE 6 Participant flow. a, 10 withdrew consent (one disappointed at allocation, two found it too time intensive,
two because of ill health, five for other reasons), one did not attend assessment, nine were lost to follow-up
(uncontactable); b, nine withdrew consent (three found it too time intensive, one because of ill health, five for other
reasons), four did not attend assessment, 16 were lost to follow-up (uncontactable); c, 14 withdrew consent (10 found
it too time intensive, one because of ill health, three for other reasons), one died, three did not attend assessment,
14 were lost to follow-up (uncontactable); d, one withdrew consent (because of ill health), three did not attend
assessment, five were lost to follow-up, 12 were randomised with insufficient time for 9-month follow-up; e, two
withdrew consent (too time intensive), one did not attend assessment, six were lost to follow-up, 11 were
randomised with insufficient time for 9-month follow-up; and f, two withdrew consent (one found it too time
intensive, one for other reasons), two did not attend assessment, three were lost to follow-up, 13 were randomised
with insufficient time for 9-month follow-up.
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Figures 7 and 8 show the crude distributions of evaluable primary outcome data at 3 and 9 months of
follow-up respectively.
Intervention received per protocol
Of the 186 participants who were randomised to the mini booster and full booster interventions, 73%
(136/186) received the intervention as per protocol [77% (71/92) in the mini booster arm and 69% (65/94)
in the full booster arm].
Baseline characteristics of participants
The baseline characteristics of the randomised and ITT participants are shown in Appendix 6, Tables 17
and 18, respectively. The distributions of participants’ characteristics were fairly similar between the control
and intervention arms in both sets of data. There were 28 participants among those randomised who did
not show an increase of at least 30 minutes of physical activity based on the SPAQ at brief intervention
screening and pretrial screening. Of these, 23 reported atypical activity at either brief intervention
screening or pretrial screening (see Chapter 2, Participants). However, the remaining ﬁve reported typical
activity on both assessments and reported an increase of less than the required amount of at least
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30 minutes but were randomised into the study in violation of the protocol (see Chapter 8, Recruitment
and retention). Four of these participants contributed 3-month Actiheart data and were retained in the ITT
analysis but excluded from a post hoc sensitivity analysis to assess their likely impact on the treatment
effect (see Effectiveness of the booster intervention at 3 months).
Figures 9 and 10 show Index of Multiple Deprivation (IMD) 201083 overall scores and income scores,
respectively, for booster participants based on the lower super output area (LSOA) corresponding to their
postcode. High scores indicate high levels of deprivation.
FIGURE 9 Index of Multiple Deprivation 2010 overall scores for randomised participants.
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Figure 11 shows the results of a preliminary geospatial cluster analysis using SaTScan™ version 9.1
[see www.satscan.org/ (accessed December 2013)]. Clusters of high response rates were present in High
Green and the Longley area of the city. Clusters of low response rates were present in the north and
central-south parts of the city. In a post hoc analysis we aggregated the number of mail-outs and the
number of response rates at LSOA level. A negative Spearman rank correlation of −0.22 was found
between the two factors. This indicates that people living in LSOAs with higher levels of deprivation were
less likely to respond to the initial mail-out (see Chapter 8, Recruitment and retention, for discussion).
Response rate was not found to be related to population transience, with the Spearman rank correlation
test between response rate and transience reporting a very weak correlation. The unweighted correlation
was −0.005 and the weighted correlation was 0.030. With n = 687, the correlation must have a
magnitude > 0.075 to be signiﬁcant at the 5% level.
FIGURE 10 Index of Multiple Deprivation 2010 income scores for randomised participants.
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Factors associated with having evaluable data at 3 months
of follow-up
The descriptive statistics of completers (with evaluable data) and non-completers (for any other reason) are
shown in detail stratiﬁed by intervention group in Appendix 6, Table 19. Non-completers had higher values
than completers for BMI (mean 31.5 kg/m2 and 29.4 kg/m2 respectively; mean difference −2.0 kg/m2, 95%
CI −3.4 to −0.6 kg/m2; p = 0.005; see Appendix 6, Table 21) and weight (mean 89.4 kg and 82.0 kg
respectively; mean difference −7.4 kg, 95% CI −11.7 to −3.1 kg; p = 0.001; see Appendix 6, Table 21).
FIGURE 11 Map showing response rate by neighbourhood to booster mail-outs. Mail-outs from April 2009 to
November 2010 together with clusters of high/low response rates identified by SaTScan.
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However, there was no evidence of an interaction between the intervention and the completers group. This
means that, even though the overall distribution of completers and non-completers was slightly different with
respect to weight, BMI, PCS scores and RAI between the booster group and the control group, their within-
group distributions were similar and in the same direction across these treatment groups (see Appendix 6,
Tables 19 and 21). There was some evidence to suggest an interaction between gender and the completers
group with a high proportion of male non-completers in the booster group [51 (58.6%)] compared with
completers [42 (42.4%)] (interaction p = 0.034; see Appendix 6, Table 20). In addition, the odds of having
evaluable data were slightly lower in the mini and full booster intervention arms although this was not
statistically signiﬁcant at the 5% signiﬁcance level. There was no sufﬁcient evidence to indicate an association
between having complete evaluable data at 3 months and other variables (see Appendix 6, Tables 19–21).
Appendix 6, Table 18 shows that the baseline characteristics of the ITT sample (n = 160) were broadly
similar despite the 43% (122/282) attrition rate from the original randomised sample.
Distribution of the primary outcome at 3 months of follow-up
Figures 12 and 13 show the distribution of mean TEE per day (kcal) stratiﬁed by intervention arm, which
was fairly normally distributed. The pooled SD of the mean TEE per day at 3 months was 417.4 kcal.
Effectiveness of the booster intervention at 3 months
At 3 months the observed mean TEE per day was 2266 kcal and 2227 kcal in the control and booster
intervention arms respectively (see Appendix 6, Table 22), which translated to a mean difference of
−39 kcal (95% CI −173 to 95 kcal; p = 0.6) in favour of the control arm and less than the expected MCID
of 102 kcal in favour of the booster intervention. After adjusting for age, gender, BMI, total minutes of
physical activity at brief intervention and pretrial screening and HRQoL based on SF-12v2 plus 4 total
scores (see Appendix 6, Table 22), the adjusted mean difference in mean TEE per day was similar (–40 kcal,
95% CI −117 to 37 kcal; p = 0.3) and still in favour of the control group. The wide CIs around the observed
treatment effect indicate the uncertainty in the effectiveness estimates but the results are not statistically
signiﬁcant, potentially of some clinical or practical importance as the CIs include the MCID of 102 kcal but
the point estimates clearly show that the control group had the better outcomes.
A forest plot (Figure 14) summarises the treatment effect and its direction, which is in favour of the control
arm in ﬁve analysis sets (including the primary analysis) under different assumptions except using
imputations including all participants with at least 1 complete day of evaluable data, which was slightly in
favour of the intervention. However, this observed effect was very small, only 20% of the expected MCID
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FIGURE 12 Box plot of mean TEE per day (kcal) at 3 months stratified by intervention arm (n = 160).
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of 102 kcals, and diminishes after adjusting for age, gender, BMI, total minutes of physical activity at brief
intervention and pretrial screening and SF-12v2 plus 4 total scores (see Appendix 6, Table 21). Details of
sensitivity analysis on the primary analysis in Appendix 6, Table 22 are shown in Appendix 6, Table 21 and
graphically displayed in Figure 14.
Figure 15 shows the distribution of mean daily TEE for the cohort of participants at 3 and 9 months. The
treatment effect (mean difference) excluding the four protocol violators, described in Baseline characteristics
of participants, was −51.2 kcal (95% CI −185.7 to 83.3 kcal; p = 0.453) in favour of the control group.
Effectiveness of the mini booster intervention compared
with the full booster intervention at 3 months
At 3 months post randomisation we observed a mean TEE per day of 2168 kcal and 2280 kcal in the mini
booster (n = 47) and full booster (n = 52) intervention groups, respectively, which translated to a mean
difference of 112 kcal (95% CI −57 to 280 kcal; p = 0.2) in favour of the full booster group. After
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adjusting for age, gender, BMI, total minutes of physical activity at brief intervention and pretrial screening
and HRQoL based on SF-12v2 plus 4 total scores, the mean difference was 56 kcal (95% CI −38 to
149 kcal; p = 0.4). Again, the wide CIs around the observed treatment effect indicate the uncertainty in
the effectiveness estimates and the results are not statistically signiﬁcant. However, as the CIs do include
the MCID of 102 kcal, and the point estimates clearly show that the full booster group had the better
outcomes at 3 months, we cannot rule out a signiﬁcant difference between the mini booster group and
the full booster group.
Secondary outcomes at 3 and 9 months
Appendix 6, Table 24 shows the effectiveness of the full booster (face-to-face) intervention compared with
the control. We observed a small increase in physical activity of 14 kcal in favour of the full booster
intervention at 3 months although this is not statistically signiﬁcant and far from being clinically important.
The wide CI around this estimated effect indicates huge uncertainty and is compatible with no difference
in effectiveness between the control and the full booster intervention. The direction of the effect changed
in favour of the control group after adjusting for potential confounders (see Appendix 6, Table 24).
As shown in Appendix 6, Table 25, we observed a decrease in physical activity of approximately 98 kcal in
the mini booster intervention group compared with the control group at 3 months, although this was
not statistically signiﬁcant and the uncertainty around the estimated effect was also large. The direction of
the effect was consistent even after adjusting for age, gender, BMI, total minutes of physical activity at 3
months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total scores). Similarly, the
differences at 9 months in TEE are not statistically or clinically signiﬁcant, as illustrated by Figures 15 and 16.
For the other continuous secondary outcomes – PACs (see Appendix 6, Tables 30 and 32), PCS, MCS and
SF-6D scores from the SF-12v2 plus 4 (see Appendix 6, Tables 34 and 35), average minutes per day spent
on moderate activity (3–6 METs), average minutes per day spent on vigorous activity (> 6 METs) and average
minutes per day spent on moderate and vigorous activity (≥ 3 METS) (see Appendix 6, Tables 36 and 37)
and BMI (see Appendix 6, Tables 44 and 45) – we found no reliable statistical evidence of a difference in
outcomes between the booster group and the control group at 3 and 9 months post randomisation. There
was insufﬁcient evidence to support differences in self-reported levels of physical activity between the
booster group and the control group at 3 and 9 months. However, based on the ITT set (see Appendix 6,
Table 46), participants in the booster group reported increased physical activity of around 49 minutes and
74 minutes over a 1-week period at 3 and 9 months, respectively, although this was not statistically
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signiﬁcant at the 5% signiﬁcance level. In addition, there was a very weak correlation to support a positive
linear association between the objective measure (based on accelerometry) and the self-reported measure
of physical activity (based on the SPAQ) at 3 months of follow-up (Pearson correlation coefﬁcient = 0.03,
95% CI −0.13 to 0.19; p = 0.686), as shown in Figure 17. Some studies elsewhere reported similar results of
a weak association between objective and subjective measures of physical activity.82 In light of the very weak
association between the objective and the self-reported measures of physical activity, we urge that results
based on the self-reported SPAQ measure are interpreted with caution (see Figure 17).
Similarly, for the following binary categorical outcomes, we found no reliable statistical evidence
of a difference in outcomes between the booster group and the control group at 3 and 9 months post
randomisation: the number and proportion maintaining (or increasing) their weekly duration of physical
activity (based on the self-reported SPAQ; see Appendix 6, Tables 38 and 39) and the number and
proportion meeting the current recommendations of at least 30 minutes of at least moderate physical activity
(MET level ≥ 3) on at least 5 days of the week (see Appendix 6, Table 50). Figure 18 shows a clustered bar
chart of the distribution of the number of days with at least 30 minutes of at least moderate physical activity.
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Only for the distance walked (in metres) during a 12-minute walk test (see Appendix 6, Tables 48 and 49)
and the BREQ-2 dimensions (introjected regulation, identiﬁed regulation and intrinsic regulation; see
Appendix 6, Table 40) did we ﬁnd any reliable or borderline statistical evidence of a difference in outcomes
between the booster group and the control group at 3 and 9 months post randomisation at the 5%
signiﬁcance level.
Subgroup analyses
Gender, ethnicity and access to community facilities (self-reported use vs. no use of community facilities) were
predeﬁned as subgroups that we wished to test for evidence of effectiveness in an exploratory analysis. As the
majority of participants with valid 3-month primary outcome data were white British [89% (143/160)], we could
not test for an ethnicity subgroup effect. We found no reliable statistical evidence of any (gender or access to
community facilities) subgroup effects or interactions between the booster group and control group at 3 and
9 months post randomisation (Figures 19–24 and see Appendix 6, Tables 51–54). In addition, there was no
reliable statistical evidence to suggest that the timing of the initial mail-out had an impact on the response of
participants at 3 months (see Appendix 6, Tables 55 and 56). However, there was some indication (with respect
to direction of the effect) that participants who were approached to take part in the summer or the spring were
performing slightly better in the full booster arm than their counterparts who were approached in the winter or
the autumn, although there was huge uncertainty in the estimated effect (see Appendix 6, Table 55).
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FIGURE 19 Subgroup evaluation for the primary outcome at 3 months stratified by gender (n = 160).
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224.3; p = 0.882).
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FIGURE 21 Interaction effect of the intervention and gender at 9 months. Interaction = 49.2 (95% CI −262.6 to
361.0; p = 0.755).
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FIGURE 22 Forest plot of the effect of the intervention stratified by use of community facilities in the last month
at 3 months.
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FIGURE 23 Interaction plot of the intervention and use of community facilities in the last month at 3 months.
Interaction = −160.2 (95% CI −469.1 to 148.7; p = 0.307).
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Interaction = 100.3 (95% CI −264.8 to 465.3; p = 0.586).
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Chapter 4 Results of the process evaluation
All tables relating to the process evaluation can be found in Appendix 7.
Results of the survey
The sample
In total, 239 people were sent and 75 returned the survey questionnaire. The baseline characteristics of the
survey population are compared with the baseline characteristics of trial participants who did not take part in the
survey in Appendix 7, Table 57. The only variable that shows a difference between groups worth highlighting
was the change in SPAQ score between −3 months and baseline, with non-responders reporting larger changes
than survey responders. Formal signiﬁcance testing for baseline comparability was not performed.
Closed questions
The responses to the process evaluation closed questions are presented in Appendix 7, Table 58. Over the
3 months before they were surveyed, 64 respondents (84.2%) reported taking part in recreational/leisure
activities (e.g. gardening, cycling), 10 (13.2%) in competitive sports/exercise, 26 (34.2%) in structured
exercise (e.g. an exercise class) and 54 (71.1%) in active commuting (e.g. walking/cycling to work). In total,
37 (48.7%) respondents reported undertaking physical activity at home, 41 (53.9%) in a local open space
(e.g. a park), 34 (44.7%) in a facility (e.g. a gym, pool, community centre or track), 52 (68.4%) as part of
their daily activities (e.g. in work, shopping, walking the dog or commuting) and 11 (14.5%) in other
places. The most common reasons given for staying physically active were to improve health and get ﬁtter
or to stay ﬁt, with 59 respondents (77.6%) reporting that this was very much the case. The most commonly
reported inﬂuence on being able to perform their chosen activity was a respondent’s own health (n = 56,
73.7%). In total, 34 respondents (44.7%) reported that they did physical activity with other people, of
whom most (n = 29, 38.2%) said that they found this fairly or very useful. The most commonly reported
partners for physical activity were a spouse (n = 19, 25.0%), friend (n = 15, 19.7%) or other family member
(n = 10, 13.2%). If further physical activity ‘booster’ advice had been available in the future, more people
would have preferred it to be delivered face to face (n = 29, 58.0%) than over the telephone (n = 13,
26.0%) or by written advice (n = 12, 24.0%).
Overall, 43 (86.0%) of those who received physical activity ‘booster’ advice said that it met their
expectations, with more in the face-to-face full booster group reporting so (n = 24, 96.0%) than in the
telephone mini booster group (n = 19, 76.0%). The majority (n = 38, 76.0%) agreed or strongly agreed
that the ‘booster’ counselling/advice sessions ﬁtted easily into their daily schedule, with no obvious
difference between the mini booster (n = 19, 76%) and full booster (n = 19, 76%) participants. The
majority of respondents who were full booster recipients (n = 21, 84.0%) agreed or strongly agreed that
the ‘booster’ counselling/advice sessions had been conducted at a convenient location.
In total, 41 respondents (82.0%) who received booster interventions agreed or strongly agreed that the
project worker was non-judgemental and 39 (78.0%) agreed or strongly agreed that the booster
counselling/advice sessions were non-confrontational in nature. A total of 44 participants (88.0%) agreed
or strongly agreed that, throughout the ‘booster’ counselling/advice sessions, the project worker
understood what they were saying. Overall, 22 respondents (44.0%) said that they spoke more than
the project worker and 21 (42.0%) spoke roughly the same amount as the project worker. In total,
45 respondents (90.0% of those receiving the intervention) said that the amount of contact time with the
project worker was about right. The majority (n = 42, 84.0%) agreed or strongly agreed that they were
encouraged to set their own goals for physical activity and 31 (62.0%) agreed or strongly agreed that,
as a result of the ‘booster’ counselling/advice sessions, they had been able to resolve their barriers
towards physical activity. Overall, 33 (66.0%) agreed or strongly agreed that, as a result of the ‘booster’
counselling/advice sessions, they now knew more about the beneﬁts of physical activity. The same number
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agreed or strongly agreed that, as a result of the ‘booster’ counselling/advice sessions, they now knew
more about the risks associated with living an inactive lifestyle. In total, 32 (64.0%) agreed that, as a result
of the ‘booster’ counselling/advice sessions, they were now more aware of available physical activity
facilities and opportunities and 41 (82.0%) agreed or strongly agreed that, as a result of the ‘booster’
counselling/advice sessions, their conﬁdence to stay active had increased.
Open questions
Recreational/leisure activities over the previous 3 months
Common recreational/leisure activities reported were gardening (n = 38), walking (including walking the
dog) (n = 24) and swimming (n = 10). Housework/DIY (n = 7), gym-based activities (n = 5), cycling (n = 5),
rambling/hillwalking (n = 4), running (n = 3), football (n = 2), badminton (n = 2), Wii/Wii Fit (n = 2) and yoga
(n = 2) were also reported. The following activities were listed by one respondent each: Zumba, tai chi,
diving, camping, bowling, snooker and golf. Some people reported more than one activity. Few people
reported activities relating to competitive sports and there was signiﬁcant overlap with activities classiﬁed
as recreational/leisure activities. Football, walking/rambling, gym-based activity, badminton and golf were
all included in both categories.
Common forms of structured exercise reported were gym-based exercise (n = 8), dance-based exercise
(including at home) (n = 7), low-impact exercise classes (n = 6), cardiovascular exercise classes (n = 5),
home-based exercise (not including dance/dance videos) (n = 4) and swimming (n = 2). Some people
reported more than one activity in this category.
The most commonly reported form of active commuting was walking (n = 33). Walking activities that did
not involve commuting (n = 9) or in which it was unclear whether or not they formed part of a commute
(n = 10) were also reported. One participant reported cycling and one responded ‘yes’ without any further
details. Some people reported more than one activity in this category.
Location of activities
Commonly reported facilities used included a leisure centre (including a gym and/or pool) (n = 28), a rural
location (n = 6), a community centre (n = 2), a football facility (n = 2), a physiotherapy centre (n = 2) and
shops (n = 2). The following locations were listed by one respondent: dancing, local area, school lessons,
tennis courts, local neighbourhood, friend’s home and allotment. Some people reported the use of more
than one location.
Reasons for staying physically active
Several people stated that a reason for staying physically active was that a health professional
recommended that they should do so. This included a doctor (n = 4), consultant (n = 2), nurse (n = 1),
dietitian (n = 1) and the booster research team (n = 1). Under ‘other’, one person reported that the decision
to stay physically active was prompted by a wellness advisor at work.
Reasons for taking part in the project
Using thematic analysis, we grouped the reasons that people gave for participating in the project into
the following categories: self-improvement, altruism and curiosity. Responses concerning the wish for
self-improvement were the most numerous and thematically diverse: respondents wished to improve or
maintain their health or well-being, weight level, medical prognosis, ﬁtness level, motivation to do physical
activity, performance or practice in particular physical activities or their knowledge about what activities
and levels of activities were best for them as individuals. A minority of respondents also discussed their
wish to challenge or better understand themselves. Responses that we categorised as ‘curious’ included
comments to the effect that the project sounded interesting, respondents wanted to know more or to see
what was ‘on offer’ and respondents were looking for new ideas or wanted to try something new.
Responses classiﬁed as ‘altruistic’ conveyed a desire to help with the research, to advance science and to
help other people in the future.
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Prior expectations of the ‘booster’ physical activity sessions
Participant reports of prior expectations of the booster sessions overlapped considerably with reports of the
reasons for participating in the study, perhaps indicating that they were not making a clear distinction
between the contacts made by RAs for the purposes of research study data collection and the contacts
made by RAs as part of the intervention (see The importance of monitoring and feedback). Although
many of the answers categorised in the previous section under self-improvement, altruism and curiosity
were reiterated, there were responses that were conceptually distinct. For instance, respondents reported
hoping that the intervention would increase their conﬁdence. A number of respondents reﬂected on
needing encouragement to set, achieve and maintain goals, targets or standards. Respondents also
wanted information about their own ﬁtness levels (see The importance of monitoring and feedback) and
this included advice on physical activity that would meet or suit their existing medical needs (see Previous
conditions, Barriers to physical activity and Physical activity: motivators on medical health issues).
What helped people become more physically active than they were before
the study?
Participants from all three groups listed similar factors contributing to an increase in their physical activity
levels since the onset of the study. The largest number of reasons given related to the booster intervention.
Some respondents felt that the booster intervention had given them help, advice and support and conﬁdence.
A number of respondents reported the role played by their newly increased awareness of the health beneﬁts
of physical activity, including weight loss, and the dangers of being inactive. A number mentioned the
motivation or encouragement provided by the RAs, including that provided by a desire to achieve goals and
targets set with the counsellor. Participants reported responding to prompts to think about an active daily
routine, discussing the need and different ways to keep ﬁt, as well as an increased awareness about their own
activity levels. Aside from the engagement with the RAs, respondents reported other, wide-ranging, extrinsic
factors affecting changes in physical activity levels including the adoption of ﬂexible working hours, having
appropriate footwear, the receipt of a medical diagnosis and support from family or friends. A few reported
more intrinsic reasons, with some crediting themselves for becoming more proactive. These individuals talked
about their self-motivation, their own desire to improve their ﬁtness or reduce their weight.
Results of the in-depth interviews
The sample
In total, 26 people participated in the in-depth interviews between December 2010 and February 2012.
The baseline characteristics of the interview population are compared with the baseline characteristics of
the trial participants who did not take part in the interviews in Appendix 7, Table 59. Participants in full-time
employment were under-represented (15% in the interview population compared with 35% of those not
interviewed). As with the survey population, increases in self-reported physical activity in the 3 months
before baseline were lower for those interviewed than for those not interviewed.
Actiheart data were not available for six interviewees. Of the remaining 20, 17 contributed 7 days of data,
one contributed 4 days of data and two contributed 3 days of data (see Appendix 7, Table 60). We have no
evidence that any of the participants met the national guidance of at least 30 minutes of moderate/vigorous
exercise on at least 5 days per week, although it is highly likely that one participant would have done so as
he did > 5 hours of at least moderate activity on each of the 3 days over which he contributed data. Two
people met the target of 30 minutes of moderate/vigorous exercise on 3 days; two people met the target
on 2 days; three people met the target on 1 day; and the remaining 13 people did not meet the target on
any day for which they provided accelerometry data.
Participants noted that they preferred the following physical activities: walking, swimming, cycling,
gardening, walking the school run, football, running, yoga, gym, badminton, physical jobs, playing on the
Wii and dancing. Some participants also declared a strong dislike for the gym and one declared a strong
dislike for jogging.
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Previous conditions
Previous practice
Two distinct groups of people seemed to emerge as salient in the sample. First were people with positive
past experiences of physical activity whose commitment to an active lifestyle had been disrupted by the
time that they were contacted by the trial team. This disruption frequently involved medical conditions,
environmental factors, such as a change in working patterns, or a change in priorities, such as new
commitments brought on by family (see also Barriers to physical activity and Physical activity: motivators):
Yeah, but I did do quite a bit of walking in my working life. I’ve cut back on the work and eventually
retired . . . and suddenly it hits you that yes, all you’re doing is sitting round all day.
Co-habiting male, 65 years
Because I suffer from vertigo and I kept going dizzy – it’s the Raynaud’s [syndrome] – I’d stopped
cycling for five years.
Married male, 65 years
I’d more or less retired from running because I’ve been doing sport all my life and I just thought,
coming up to 50, I thought, ‘Give it up’ because I wasn’t, because we’ve got twins and . . . we were
up early in the morning and you were breaking your sleep pattern . . . So I just thought, I’ll give up
the running and just look after the kids.
Divorced male, 49 years
Second were those who did not discuss previous positive experiences and for whom the uptake of physical
activity was related to morbid introspection brought on by the birth of children, grandchildren or ageing
(see also Physical activity: motivators):
Well I’ve been going to the gym for 10 years and I can’t say I really enjoyed any of that time. I’ve
never been a particularly sporty person all through my life but I got to about 52 and I thought well
if you don’t get you know . . . I was doing a lot of driving and a lot of sitting behind a desk, so I
thought if you don’t do something now, it’s never going to happen because it’s all downhill
from 60 so . . .
Married male, 64 years
My main motivation is the fact I’ve stopped smoking and well, my girls . . . At the end of the day it is
as much for me as it is for them . . . I’m sure they don’t want to lose their dad when they’ve just
turned 20 do they?
Married male, 48 years
Many people in the sample, but especially those with previous positive experiences of physical activity,
were revising their expectations of what they were capable of after injury, the onset of a chronic physical
condition or just the ageing process more generally. This was clearly difﬁcult for many and the subject of
intense rumination:
I did used to be a very, very good squash player, played up at [. . .] many times against the masters . . .
the first operation stopped me playing squash . . . the same surgeon, promised me that it would get
me back doing everything . . . and it didn’t, you know. I could have done with [the motivational
interviewing] then, you know, saying, ‘Don’t do this; move onto something else’.
Co-habiting male, 65 years
I’m not doing what I did some 12 months before . . . I know now I’m not going to be able to return
to that level.
Divorced male, 55 years
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Yes. Yes. I realise I can’t be what I was, so I’ll never be doing a marathon again, but at least . . . every
five miles is a marathon to me now, between start and finished.
Married male, 65 years
Felt needs or problems
Many participants simply wanted ‘to feel ﬁtter’. Of these, a number were looking for advice on tailoring a
physical activity regimen to their lifestyle: ‘I didn’t want to join any gyms or anything . . . I wanted some
other options and something that if I didn’t fancy going one week I didn’t have to’ (married female,
52 years).
Many were motivated by goals or perceived beneﬁts which they hoped that increased physical activity
levels would deliver (see Physical activity: motivators). For some, these anticipated beneﬁts were urgent
because of changing life circumstances:
I wanted to build my strength up, My husband became ill and I was having to do a lot of . . . physical
work and I was finding it very difficult because I suffer with arthritis myself. So I needed to lose
weight . . . to build my muscle up as well.
Married female, 64 years
Long-term conditions
At least half of those interviewed had a chronic condition that affected their attitude to physical activity in
one way or another (see Barriers to physical activity and Physical activity: motivators), including traumatic
stress; high blood pressure and high cholesterol; arthritis and depression; obesity, stress and depression;
depression; asthma plus a family history of diabetes, mental illness and obesity; breast cancer, high
cholesterol and pre-diabetes; a history of total knee surgery; arthritis and knee problems; chronic lung
disease; chemotherapy-related neuropathy; shoulder injury; hypertension, diabetes and a history of heavy
drinking; Raynaud syndrome and a history of transient ischaemic attacks.
Social norms
Although not prevalent, there were at least three instances of participants reporting that physical activity
was not socially normative in their community:
I think so yeah. I think some of it is being on your own, if you know what I mean? If you are on your
own and your friends don’t do exercise it doesn’t encourage you much.
Married female, 52 years
And that’s the thing; a lot of pressures get put on people that they can’t, because their peers will say:
‘Oh you don’t want to be doing that, you want to be coming down the pub and having a few beers
like we normally do’ . . . then they feel pressurised to actually say, ‘Well I’d better not do that because
I’ll upset them’.
Divorced male, 55 years
People have said to me, ‘Oh . . . you’ve done Sheffield round walk – which is about 16 mile – you
must be daft!’
Married male, 65 years
Barriers to physical activity
Preferred alternatives
At least 10 people explicitly mentioned that they had preferred alternatives to physical activity, including
college classes and work; watching television; looking after their children and going to work and running
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their own business. A number of people also mentioned ‘personal’ or ‘family situations’ that had disrupted
or prevented the uptake of physical activity routines:
I find it more difficult to keep motivated, cos I don’t really like exercise. I could . . . I’m one of these
people that could just sit and watch telly all day and enjoy it.
Divorced female, 65 years
Yeah . . . my personal life has been a bit different in these last 12 months or so, I think that’s, you
know, made more of an impact on my fitness . . . I can’t get down to the gym, I won’t have time, coz
I run my own business, you see, I have my own shop.
Widowed male, 60 years
Cos I do still do some part time work – I look after a lady with dementia – so I’m not free every day
by any means. So the main thing is, sort of fitting it in around . . . Once a week is fine. Fitting in twice
or three times can be difficult sometimes to find that bit of free time.
Single female, 62 years
Medical health issues
At least 10 interviewees had chronic health issues (see Physical activity: motivators) and a number of other
more acute episodes were also declared, including muscle strains and trauma leading to sepsis; knee
injury; muscle pain – non-speciﬁc; back pain; foot pain; severe depression and pain in the side and leg.
Those with acute injuries often described difﬁculty maintaining their existing programme of exercise: ‘I was
doing an hour’s session with a personal trainer. She gave me a programme to do. But the trouble is I was
ﬁnding with these injuries . . . I couldn’t do all of it’ (married male, 64 years).
Those who have had surgical treatment or aggressive treatment for a chronic disease often reported
constraints placed on them by caregivers so as not to aggravate their condition:
I’m not allowed to . . . as much as I hated running on me own, it always had to be done for stamina,
didn’t it? . . . After you’ve had total knee surgery . . . you can’t go pounding on the road and you’ve
got to be careful, she says to me, cos I had it done at such a young age, they said, you know, 50,
you’ve got to look after it cos it’ll last 25 years if you want, but they just said to me, ‘you know if
there’s any problems, you’ll have to have remedial surgery’.
Married male, 58 years
Oh yeah, I was always active . . . Well, I was working as well before I went off on the sick, so
everything fell – because of the illness [cancer] and whatnot, everything sort of stopped for a while.
Married male, 57 years
Psychosocial conditions such as depression and heavy drinking presented participants with barriers to
starting physical activity that were more related to apathy, lethargy or procrastination:
Yeah, because my doctor recommended the exercise for severe depression, it’s the depression . . .
vicious circle . . . it’s the depression that stops the motivation, you know, I can sort of very easily think,
‘Can’t be bothered’ or ‘Let’s not bother’.
Single female, 62 years
Environmental support
Earlier we introduced the idea that maintaining physical activity levels might be difﬁcult when it was not
socially normative (see Previous conditions, Social norms). Some people also found their family to be a
barrier. Societal and personal budgetary constraints were mentioned by a number of people. Some had
experienced cherished physical activity programmes being cancelled because of local authority cuts:
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‘They’ve got a group, a dad’s group, and I do the 5-a-side, but that’s kind of stopped due to lack of
funding’ (married male, 48 years).
Others saw their own ﬁnancial situation as constraining their options:
Well, I do want . . . I’d like a lifestyle that is more active, but . . . until I earn more money [laughs] . . .
But at the moment, I’ve got very little coming in and very little being spent . . . membership for gyms
costs a fortune, I can’t even entertain the idea really.
Divorced male, 50 years
I mean, this is the other thing about my lifestyle, because of the severe restrictions on income, I have
to spend most of my time at home so I’m not wearing down my shoes too often . . . And that’s the
thing: it’s very easy, you know, when you’re on your own, on a low income, it’s very easy to get
depressed and get down. You can spend a lot of time wasting a lot of time just not doing anything,
you can just sit down, feel absolutely miserable.
Single male, 51 years
Those who did work often found that a constraint, especially when shift work prevented access to facilities
and establishment of a routine (see also Barriers to physical activity, Preferred alternatives). Threats to
personal safety were not a common concern, except among those who had aspired to cycle:
I thought, ‘God, to ride a bike on these streets is going to be terrifying’.
Single female, 47 years
I don’t feel confident riding on the roads . . . so I’ve decided I’m not doing cycling.
Divorced female, 65 years
Roads are a nightmare in the morning on a bike, you know, when there’s lots of cars on the road.
Married male, 58 years
A number of people cited bad weather as a barrier to physical activity. For some, this was speciﬁcally
related to chronic conditions or the side effects of aggressive medical treatment. For most, it was simply a
self-evident fact that cold, wet weather was not appropriate for exercise:
Yeah, so, what I need is one of those cycle machines in my flat during the winter time, during the
grotty weather, then I’ll have no excuse at all!
Single male, 51 years
I am a summer cyclist because, when it’s cold and wet and you’re on a bike . . . we havn’t got the
weather, have we?
Married male, 58 years
The problem I have, in England of course we have the weather in the winter . . . come spring, like
now, I’m increasing my energy and my exercise regime.
Co-habiting male, 61 years
Self-consciousness
Self-consciousness was not a widely cited problem; the following two instances were noted:
There’s a gym outside, I think she called it a green gym, it’s the one at Millhouses Park . . . I think my
problem is, I’m not really a great fan of gyms . . . I suppose I’m just too self-conscious about
these things.
Single male, 51 years
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The fact that I am getting older and I feel more embarrassed about going to the swimming baths
and things, or a gym, [deterred me] whereas it never used to bother me in the past.
Single female, 56 years
Physical activity: motivators
General commitment and priorities
As many as 15 interviewees expressed views that could be characterised as commitment to physical
activity. For about one-third of these, the commitment seemed intrinsic or part of their identity:
To anybody that doesn’t walk and they’re quite capable . . . I find that as alien as what they find
me doing them sort of things, not doing anything when you‘re quite capable that you could
do something.
Married male, 65 years
Everybody should be involved in sport.
Divorced male, 49 years
Yeah, like I say I’ve always either gone to a gym . . . for, god knows how long . . . I’ve never been idle
about it.
Widowed male, 60 years
For the majority, especially those without previous positive experiences of physical activity, it seemed
extrinsic – a response to received understandings about the need to ward off inﬁrmity, to stay in a
condition to live independently or to discharge one’s responsibilities and to be a role model to
one’s family:
Staying alive [is my main goal]. I’ve got two babies. Two and a half and three and a half, you know, it
would be nice to see them have kids. You know, so pretty much that singularly would be my main
goal I would say.
Married male, 48 years
It would be nice if [my children] could enjoy sport the way I enjoyed sport growing up.
Divorced male, 49 years
I have to be as self-reliant as I can.
Single male, 51 years
I lied to [my children] as much as I wasn’t involved in any sports activities with them when they were
young, and they’ve taken it up themselves and enjoying it, I have now found in sport activities
something that’s helping me to stay healthy and I’m getting more benefits out of it now at this age.
Single female, 47 years
I have experience of people in the family who’ve not been active and how quickly they’ve
deteriorated, health wise and they just couldn’t get about any more, because they weren’t prepared
to push their selves and that sort of scared me into thinking, ‘I’m not going to get like that’.
Married female, 62 years
Goals or benefits
Most interviewees (at least 20) described their motivation to maintain physical activity levels in terms of
anticipated beneﬁts or goals, including wanting to feel ﬁtter and not so lethargic in the long term;
knowing that exercise will make you feel good during and afterwards; for social contact; being a role
model; warding off illness, disease or inﬁrmity and living longer; dealing with stress or depression; gaining
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in self-conﬁdence; wanting to lose weight for ‘vanity’, a holiday, a wedding outﬁt or health purposes;
wanting to remain independent and wanting to try other activities previously thought too taxing:
It’s like if you’re a runner you never feel like going out for a run do you? But then when you’re out
there, as soon as you’ve even got your trainers on, you’re feeling better, do you know what I mean? . . .
Yeah you feel better when you have done it, you feel a bit sluggish when you go and when you come
back you feel more energetic. I mean you feel a bit tired, but it’s a nice feeling.
Married female, 52 years
The thing is that, it’s a way I’ve had to deal with stresses throughout my life, if I had a particularly
stressful time, I usually get out for a nice brisk walk up a hill or two. I’ve been on benefits for a very,
very long time so I’ve, the only way to handle such stress is actually to do lots of exercise.
Single male, 51 years
The cycling has a sort of almost immediate effect, when I’ve done sort of 20 minutes/half an hour on
the bike. You can actually sort of feel a bit of mood lift. It’s strange.
Single female, 62 years
You live longer and I think you just feel better if you do even if you don’t want to do it, you just feel
better, look better.
Divorced female, 65 years
I’ve got to build the body up, you know. My wife laughs at me . . . when she sees the bingo wings
and whatnot.
Married male, 57 years
Personal preference
Only two people explicitly made the point that they actively preferred physical activity to other activities
and embraced it as part of their identity:
Your body is made to work, not just to sit and watch television like my brother . . . There is other
things to do than watch television all day.
Married male, 65 years
To anybody that doesn’t walk and they’re quite capable . . . if they’ve got an injury or disabled etc.,
I find that as alien as what they find me doing them sort of things.
Married male, 65 years
Medical health issues
Although illness and injury could often be a barrier to uptake or maintenance of physical activity, it was
also cited in response to questions about motivation by at least 20 interviewees. Those with mental health
problems were driven by their perception that physical activity could alleviate symptoms of stress, anxiety or
depression, either somatically (‘I really do ﬁnd that there’s an immediate lift’) or psychologically (‘it takes
your mind off it’). In at least one case a person with depression had been prescribed exercise for the
management of depression. Prescribed exercise was much more common among those with chronic
physical conditions. Most of those with a long-term physical condition (see Previous conditions) talked
about clinic visits when asked about what motivated them to become or stay active. However, nobody
explicitly claimed that doctors had recommended exercise to them, although conversations such as
the following often suggested that this was the case:
[My cholesterol] went up to 5.7 and the doctor said we do prevention now . . . and she’s put me on
to 10mg of Eprinel now . . . because she said my blood pressure were a bit higher than it had been so
that’s a big motivation to keep fit.
Single male, 54 years
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Environmental and social support
For some, having support and advice from someone who was not a friend or family member, such as a
supportive personal trainer, was critical (see also Motivational interviewing: perceived importance). Some
people reported getting support from their families, particularly children or grandchildren, or neighbours.
For others, the experience of exercising with other people, with whom one could talk, was motivating,
with buddying up for swimming, joining classes and cycling, walking or running in groups or clubs all
being mentioned:
I suppose if you get somebody who motivates you as well, that goes with you or join a group or
something, that’s when it’s enjoyable more I think.
Married female, 52 years
[You] buddy up with someone . . . So that you get a bit of talk. I’ve made friends I’ve had from
walking and it’s made a difference.
Single female, 56 years
Sociable sentiments were not ubiquitous with some people reporting choosing physical activities or times
and locations to avoid their family and friends. Ready access to facilities was also important for some. One
person reported being encouraged to make regular use of the exercise bike and step machine in their GP’s
summerhouse. Easy access to countryside where it was pleasurable to walk was encouraging for a number
of people.
Motivational interviewing: perceived effectiveness
Only three people said that they thought that the booster sessions had no impact on them. All expressed
the sentiment that they continued to do what they would have done anyway. Two of these achieved 0
and 5 minutes of moderate levels of activity during 7 Actiheart days. The other did not contribute
Actiheart data.
nothing that was said over the phone or through interview made the slightest bit of difference.
Married male, 48 years
Seven people expressed ambivalence about whether the booster sessions were effective, through
convoluted, contradictory, evasive or indirect answers:
Well it’s ticking boxes, yes . . . there’s things I mentioned to [motivational interviewer] which I haven’t
quite got round to doing yet . . . I don’t know if I can get down to it. I think my problem is, I’m not
really a great fan of gyms.
Single male, 51 years
Of these seven, three contributed no Actiheart data and three achieved 0, 3 and 9 minutes of moderate/
vigorous activity over 7 Actiheart days. The last had 3 days where they met (43 minutes) or almost met
(27 and 28 minutes) the national target of 30 minutes of moderate/vigorous activity a day.
In total, 15 people said that they thought that the booster sessions had been effective. Of these, 11 met
the national target of 30 minutes of moderate/vigorous activity on at least 1 day. Three exhibited fairly
sedentary activity levels on all days.
Motivational interviewing: consistency with perspectives or world views
At least four people, were, at best, ambivalent about MI. At least two explicitly said that they had hoped
for an exercise programme or some kind of physical activity provision:
I would have expected more of a, shall we say, physical challenge? . . . I thought there would have
been more physical activity to be measured and said, ‘Well, yeah, you did this when you came on the
programme, you were able to do this by the time you’d got to the end of the programme’.
Co-habiting male, 65 years
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Two disliked the autonomy-supported communication style used in MI (see Chapter 8, Views on physical
activity and motivational interviewing ‘boosters’, for discussion):
Just two people chatting really, you know, I’m trying to give her some answers and she’s doing the
best to give me some advice . . . it’s just like same old same old.
Married male, 48 years
I wanted to be told what the opinion was of my state of fitness. I want some results, you know, and
being told off or being told that, ‘Well, it’s what you actually do in your day to day work keeps you
reasonably fit, if necessary, or . . .’ . . . I wanted somebody to say, ‘Well, we’ve done your blood
pressure’ or ‘We’ve measured you, we’ve weighed you and so we think’, blah blah blah.
Divorced male, 50 years
However, at least 10 people expressed enthusiasm for the autonomy-supported communication style.
Common themes that emerged were that people liked the question-and-answer format and the
informality. They found it businesslike and characterised the approach as encouraging, supportive and to
do with fact ﬁnding rather than being ‘pushy’ or judgemental:
Well I was encouraged, but not pushed . . . So it’s obviously a lot better than virtually being told, what
about this or no sorry, do this or this or this. So it was open and it enabled me to do it at the pace I
wanted it to.
Widowed female, 65 years
At least 10 people made comments to the effect that they found the advice appropriate and ﬂexible to
their context. Clients frequently made statements to the effect that MI was thought-provoking or that it
helped them focus on the importance of and barriers to physical activity. It gave them ideas that they
could not have come up with themselves and pushed them to think about how much exercise they
actually did. For many, the assistance in setting realistic goals was critical:
We set little goals for me to achieve . . . sort of saying, build your exercise up from 15 minutes to 30,
40 and I managed to get up to an hour a day on some days . . . he sort of set me targets for me to
achieve, not too big, and goals and I found that because I knew that I was meeting him again . . . I
made myself do them. I enjoyed the exercise once I got into it . . . I didn’t want to go and say, oh I
didn’t achieve what we’d set out because the goals weren’t big goals and I think that’s the key, not
to set a goal too big that it’s impossible to reach, so you think well I’m never going to do it, so I’ll not
bother. You know, you can give up if the goal is too far ahead . . . I knew that I could achieve it. If I
thought it was impossible to do, then human nature being as it is, I thought well I’m never going to
do that, so I’m not even going to try.
Married female, 52 years, achieving recommended activity levels on 3/7 Actiheart days
It’s gradually making the changes . . . it’s about not drastic changes, it’s about taking one step at a
time and gradually make the changes towards setting the goals that you want . . . make the changes
to achieve the goals that you want to set yourself. So it’s helping people to achieve realistic goals.
Single female, 47 years
Motivational interviewing: perceived feasibility
For the vast majority of participants, the timing, duration and periodicity of booster sessions was highly
convenient. Complaints were infrequent but focused on continuity of care (‘I don’t think I’ve seen the
same person twice have I?’) and the need for more sessions. Suspecting that lack of funding might explain
the limited provision (two sessions), one participant suggested that introducing clients into a peer-support
(‘self-help’) group would be better than the current ‘abrupt’ end to the programme.
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Seven out of 13 people interviewed who received MI by telephone believed that face-to-face booster
sessions would have been preferable. One man with his own business and children found it difﬁcult to
protect time either at work or at home:
because I work for myself, you know, if someone walks in, you know, I’ve got to see to them straight
away . . . so it’s easier for me to make a time [for a face-to-face meeting] and, you know, I’ll be there . . .
at 6 o’clock, when I get home, it’s like ‘Daddy, Daddy’ and . . . I’m being followed into every room,
can’t go anywhere!
Divorced male, 49 years
Those receiving face-to-face MI often said that they thought that the physical presence of the person
made the MI more effective (see Motivational interviewing: perceived importance and The importance of
monitoring and feedback):
Actually seeing the individuals who come and talk to you, so it’s like a one-to-one communication,
the physical contact I think is very important . . . What difference would it make to me – somebody
just over the telephone, ticking a box? Why can’t they just meet me?
Single female, 47 years
Motivational interviewing: perceived importance
A majority of people expressed the view that they felt that MI was important in some way, for instance
because it met some acknowledged need. Sixteen people used language to the effect that the MI gave
them encouragement, motivation, ‘a push’, impetus, a boost to their conﬁdence or similar. For some, it
helped them keep motivated in a situation of social isolation or disliking exercise or preferring alternatives:
Because I live on my own, I find it more difficult to keep motivated, cos I don’t really like exercise.
I could . . . I’m one of these people that could just sit and watch telly all day and enjoy it.
Divorced female, 65 years
Many people said that they needed help with ideas for alternative physical activity strategies or help with
overcoming barriers or thinking through life changes, especially retirement. People frequently claimed that
the sessions helped them ‘focus’ or reinforced knowledge or goals:
I did start to try and look for ways and means of filing my time in, after I’d retired. Most of my
immediate family were worried that I wasn’t going to survive this winter with not being able to go to
work, so I was looking to broaden my horizons.
Co-habiting male, 65 years
At least four people mentioned that they enjoyed the social contact of the booster session. Sometimes this
was because they were able to engage in a depth of conversation about an issue that was important to
them that they did not feel able to do (or would not be productive) with a friend or family member:
Well it’s good to have a chat with someone. I don’t get much opportunity at home . . . I mean, it’s a
welcome break to my day, having a conversation along those lines. It’s a sort of a change . . . having
to think about something different.
Single male, 51 years
Because your family and your friends know you too well and they have got a preconceived idea of
you, whereas [the motivational interviewer] hadn’t, ya know, it was just me.
Married female, 62 years
In summary, participants claimed that the MI met a number of needs, including providing encouragement
and the opportunity to think laterally about problems and solutions with a professional removed from their
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normal social context. However, as the next section discusses, interviewees often framed these views in
terms of altering their behaviour because of an awareness that they were being observed:
It’s little things that you can talk through which you probably wouldn’t have thought of and it seems
to be important, but who would you talk to about it? Like, how do I fit in the jobs that I’ve got and
fit in what I want to do, and is the diet I’ve got important and should I be doing this, and things like,
‘Oh for goodness sake, I can’t be bothered with it’, but because I’ve had to think about it, because
I’m going to talk to someone about it and then . . . It appears to have worked very well.
Married female, 65 years; our emphasis
The importance of monitoring and feedback
Around half (n = 13) of the participants expressed enthusiasm not for the motivational interview per se but
for the opportunity to be monitored and have feedback on their performance. For some, this involved the
expected pleasure of receiving objective feedback from the researcher or the Actiheart on their level of
activity over a week or during particular activities, as well as how that compared with national guidance or
other people:
to be honest, one of the reasons I participated in this is because I did want some feedback. I wanted
to be told what the opinion was of my state of fitness.
Divorced male, 50 years
I just wish I’d been able to carry on with the monitor, just to see what the heart monitor showed
through my normal week . . . I was quite disappointed I couldn’t just keep it on.
Single female, 62 years
I wanted to be able to see that result, to see what kind of exercise I did over that time, how much
calorie did I burn, you know, things like that. I would love to have something like that. I think that
generate a greater interest to go out and do something.
Single female, 47 years
Others reported that arranging to meet a researcher in 3 months’ time, for the research study primary
outcome follow-up, motivated them to increase their physical activity. This may indicate possible confusion
between research and intervention procedures and possible contamination of the intervention by the
research procedures (see Strength and weaknesses of the study). Some thought that they would feel
ashamed to admit it if they had not achieved their goals. Others actively looked forward to reporting
achievements that they had made:
the fact that you know you’re going to a session . . . you think I’ve got to do something because she’s
going to say, ‘what have you done since last time?’ If you sit there and say, ‘well, actually, nothing’ . . .
[it] increases the guilt value [laughs].
Married male, 64 years
It’s sort of saying, I realise that I remember you saying I’d do this and I haven’t done that yet, sort of
thing, and I’m always disappointed with myself when I say things and I don’t do them.
Single male, 51 years
The very fact that I actually told [the motivational interviewer] I was going to go swimming meant I
had to do it. There was no pressure on me to do it from her but the very fact that I actually told
somebody I was going to do it meant I had to do it . . . because I’d actually told her I was going to do
it, it made me want to do it.
Married female, 56 years
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in the nicest possible way, I was having to report to somebody and . . . I know me: that is what I
need. I don’t mean that I was being told off or anything like that . . . Just to have to report that, yes
I’m doing this, or I’ve started doing that and getting a bit of praise. I think we all like praise don’t we,
deep down, and that helped.
Widowed female, 65 years
you keep that pressure on by saying, ‘Right, you’ve got an appointment in 4 weeks’ time and we’re
going to put this on, and blah-di-blah’, so you know, people think, ‘Ah, I must do it, I must do it’.
Widowed female, 65 years
Of these, a number of people expressed how important it was that the person holding them to account
was a relative stranger rather than a friend:
It could’ve been a friend, but it’s not as easy with a friend to do it . . . And it kept my mind focused,
just the fact that I was talking to someone, someone who obviously knew what they were talking
about as opposed to, I mentioned a friend before, where a friend wouldn’t know the same, wouldn’t
have the same knowledge.
Widowed female, 65 years
Yeah, yes, cos day-to-day people, they’re with you all day, they’re either bored of it or they can see it
for themselves, or you know, you might catch them when they’re not particularly interested. You
know, so it’s not quite so easy, whereas with somebody else who is a stranger as well, I quite liked
that, rather than, sort of, if it hadn’t gone well, it’s not, you know, somebody judgemental.
Married female, 53 years
The prevalence of optimistic self-assessment
We have already noted earlier that self-reported physical activity from the SPAQ correlated poorly with
objective physical activity (see Figure 17) and the low numbers of people meeting physical activity targets
of 30 minutes of moderate to vigorous physical activity on any particular day (see Appendix 6, Table 50).
However, some interviewees made very explicit and detailed claims to the effect that they were very
physically active when the Actiheart data suggested otherwise:
Well don’t forget, my work involves me running around after a tower crane up buildings that were
anything from 6 to 18 floors up that had no lifts in them, and you know so that’s kind of pretty
physical all by itself.
Married male, 48 years, who met physical activity guidance on 1/7
Actiheart days; median (range) minutes per day
of moderate activity = 0 (0–40)
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Chapter 5 Results of the ﬁdelity assessment
Assessment of interventionist motivational interviewing
experience and competence
Those delivering the intervention (RAs) typically had approximately 3 years’ experience of delivering
physical activity interventions; in addition, two had formal psychological or counselling workshop training
prior to this trial. However, all RAs had experience of physical activity programming training in a range of
settings. This was predominantly in local authority, gym, health or university contexts and did not focus on
health behaviour change. All of the RAs had an educational background in sport and exercise science,
psychology, physical activity and wellness at undergraduate and postgraduate level.
At the initial MI training sessions an evaluation was made of the competence of the RAs in delivering the
technical and relational components of MI. All of the RAs were able to competently describe and
demonstrate the level 1 skills of MI, which focused on a higher ratio of open to closed questions,
increased client talk time, simple reﬂections and summarising. In addition, the RAs were able to identify
the components and characteristics of the ‘spirit’ of MI. By the end of the ﬁrst training block (2 days
equivalent) the group could identify the use of afﬁrmation compared with praise although found
it more difﬁcult to apply this consistently in practice and still tended to fall into a ‘righting reﬂex’ of
problem-solving rather than eliciting opportunities and resources from the client.
At the ﬁrst formal assessment, independently coded using MITI (see Appendix 7, Table 61; ﬁrst
assessment), the RAs were consistently using level 2 MI skills, which included reﬂective listening, directional
open questions (e.g. optimism for change, intention to change, advantages and disadvantages of change)
and tools such as decisional balance, readiness and conﬁdence rulers and action planning. This level of
proﬁciency was in line with the clinician behaviour scores reported in Table 3.
The global rating scores (evocation, collaboration, autonomy/support, direction and empathy) across both
assessment period 1 (9 months from ﬁrst training) and assessment period 2 (18 months from ﬁrst training)
were consistent and the mean scores reﬂected a level of competence in all RAs with respect to ‘direction’
and a level of proﬁciency/competence in respect to ‘evocation’ and ‘empathy’. The per cent MI adherent
clinician behaviours were all at 100% at phase 1 and/or 2.
With regard to behaviour counts (e.g. per cent complex reﬂections, per cent open questions and reﬂection
to question ratio), the per cent open questions increased across all RAs from baseline, the reﬂection to
question ratio increased from phase 1 to phase 2 across all RAs and the open questions to complex
reﬂections ratio was higher than anticipated across all RAs.
Independent assessment of interventionist delivery
(Motivational Interviewing Treatment Integrity assessment)
The MITI coded sessions were independently assessed by a qualiﬁed MI coder and a number of aspects
were highlighted as positive and effective in addition to there being areas for enhancement. Although
‘direction’ scored as proﬁcient on the global ratings scale, feedback indicated a need for greater
recognition of individual participants’ level of readiness, values and the strength of change talk.84 This was
highlighted as requiring a greater use of more challenging complex reﬂections and a greater use of
strategies to elicit and strengthen change talk. The RAs scored highly for levels of empathy, however, and
similarly demonstrated a high level of client engagement, which is a common aspect of MI ‘spirit’.
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Although the use of ‘direction’ across all RAs was consistently high, most RAs did not sufﬁciently
demonstrate empathy and autonomy support, which are global MI measures.
The relationship between motivational interviewing fidelity and levels of
physical activity
There is moderate evidence to suggest that MI ﬁdelity is associated with physical activity as measured by
mean TEE per day (kcal) at 3 months (p = 0.027), that is, the level of physical activity of participants at
follow-up was associated with the overall ﬁdelity of delivery of the RA who delivered their MI intervention.
Figure 25 shows the means of mean TEE per day at 3 months with their associated 95% CIs stratiﬁed by
RA ranked by their global ﬁdelity rating. It should be noted that RA1, RA2 and RA3 had a similar global
proﬁciency rating of 3.5. Grouping these RAs together showed a stronger association between MI ﬁdelity
and mean TEE per day at 3 months (p = 0.003). As observed from Figure 25, RAs with a higher global
proﬁciency rating are associated with higher physical activity levels at 3 months. These results should be
interpreted with caution, however, given that some RAs delivered a lower number of sessions, as observed
by huge uncertainty around their estimated means. Moreover, the sessions were brief and it was not
possible to demonstrate all MI processes in some RA sessions that were coded. RA6 does not appear in
Figure 25 because she delivered very few sessions and was subject to MITI recording only over a short
period after initial training.
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FIGURE 25 Means of mean TEE per day (kcal) stratified by RA who delivered the MI sessions.
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Chapter 6 Results of the geographical information
systems analysis
Distance from municipal green spaces
Chapter 2 (see Green space measures) described the subdivision of municipal green spaces based on their
catchment area classiﬁcation (as determined by Shefﬁeld City Council) and certain other criteria. This led to
two sets of polygons, one representing the highest-quality green spaces and the other representing
medium- and high-quality green spaces. We calculated the shortest network distance from the home
postcode centroid of each participant to the nearest polygon in both sets. This resulted in two variables for
each participant, which are shown in Figures 26 and 27, respectively, using quantile colour-coded circles
placed at each of the randomised participants’ home postcode centroids.
The most striking feature of Figures 26 and 27 is that participants in High Green (the cluster of points in
the upper part of the map) live much further from these municipal green spaces than other participants
located more centrally within Shefﬁeld, despite being surrounded by open countryside. This is an issue that
has been encountered in other studies linking green space and exercise.85,86
Although there is a case for including all forms of green space in an analysis of access to spaces for
physical activity, it is also likely that municipal green space is, or is perceived to be, more accessible than
the green space that is available in the countryside. More speciﬁcally, municipal spaces typically offer a
‘tame’ version of nature that may be more attractive to those unused to active outdoor pursuits, with
better-marked paths and routes and not requiring any speciﬁc clothing or footwear such as walking boots.
Regarding the differences between Figure 26 and Figure 27, it is noticeable that, aside from Rother Valley
Country Park (the large park in the south-east corner of both maps), there are no high-quality green
spaces in the east or south-east of the city, despite these areas being well provided with medium-quality
green space. This aside, the two sets of data do not differ strongly.
Regarding the measuring of green space, it is worth noting that the greenery comes in many forms, not all
of which can be measured by land usage. For instance, many public roads in the Victorian areas of
Shefﬁeld are lined with mature deciduous trees, lending these areas a ‘green’ feel, even though these do
not count as municipal green spaces. However, it is beyond the scope of this study to address this issue.
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FIGURE 26 Shortest pedestrian network distance to high-quality green space (randomised participants only), as
determined using a citywide catchment area.
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FIGURE 27 Shortest pedestrian network distance to medium or high-quality green space (randomised participants
only), as determined using a district or citywide catchment area.
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Distance from leisure facilities
Chapter 4 (see Leisure facility measures) described the identiﬁcation of gyms and swimming pools
in the local area. Based on survey and interview data from the booster participants, these facilities were
felt to be the most relevant to the study. Figures 28 and 29 show the location of gyms and swimming
pools, respectively, in Shefﬁeld and the surrounding area, together with the network distance to the
nearest facility for each of the randomised participants. Note that as some gyms are female only,
the set of locations used for calculating network distance was different for male and female participants.
In Figure 28, female-only gyms are represented by a black star, with a white star for unisex gyms.
Regarding Figure 28, as with Figures 26 and 27, there is a noticeable difference in the results for
participants in High Green (the cluster of points in the upper part of the map). This is especially true of the
northern-most part of High Green, despite a gym being present at Tankersley Manor (the star just above
High Green on the map). This is because there is a high-speed trunk road (the A616 Stocksbridge bypass)
between the two, which is not suitable for pedestrians; the relatively high network distances here reﬂect a
detour across ﬁelds to reach a footbridge over the road.
The presence of female-only gyms does not have a large effect on the results, as these are mostly in areas
where other gyms are present.
In contrast to Figure 28, Figure 29 shows a marked absence of swimming pools in the east and south-east
of the city, except for the far south-east. Figure 29 also shows an apparent ‘corridor’ of mid-grey points
(indicating a relatively high network distance to the nearest swimming pool) in the north-west of the city;
however, this is an artefact resulting from the participant locations happening to fall in a line.
Association between trial outcomes and proximity to green
space and leisure facilities
The main purpose of mapping proximity to both green spaces and leisure facilities was to explore whether
geographical access to opportunities for physical activity was a predictor of activity levels in trial
participants. However, there was no statistical association observed between TEE at 3 months and
proximity to the above variables in trial participants and we found no evidence therefore to support the
hypothesis that geographical access to either municipal green space or swimming pools and gyms was an
independent predictor or moderator of physical activity. As the booster intervention was not shown to be
effective (a necessary condition for mediation analysis) and use of community facilities by participants
(a planned subgroup analysis) was not a moderator of intervention effect, we did not further explore
the hypothesis that geographical access or any other variables could be mediators of the impact of a
booster intervention.
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FIGURE 28 Shortest pedestrian network distance to a gym (randomised participants only). This was dependent on the
gender of the participant as some gyms are female only.
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FIGURE 29 Shortest pedestrian network distance to a swimming pool (randomised participants only).
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Chapter 7 Results of the health economic analysis
Scenarios modelled
As discussed in Chapter 2, a range of sources of structural uncertainty exist when attempting to infer the
long-term clinical and cost-effectiveness implications of the booster trial results, based largely on the
Actiheart data (as the primary outcome assessing differences in physical activity between trial groups). For
this reason it was decided to consider two different types of model and a number of scenarios within each
model type:
1. short-term model [see Short-term (directly elicited) model]:
l perspective: NHS, societal
l comparison: baseline compared with 3 months; baseline compared with 9 months; 3 months
compared with 9 months
l data: all available data; completers only
2. long-term model [see Long-term (epidemiological) model]
l primary
¢ individual-level differences-in-differences approach
¢ 3-month differences only
¢ 9-month differences only
l secondary
¢ ‘value-added’ differences-in-differences approach
¢ quintile effects.
A total of 12 separate short-term model scenarios are considered, involving all combinations of the three
variables listed above. Each of these scenarios is numbered as shown in Table 9.
Short-term (directly elicited) model
Resource use analysis
An analysis of the NHS resources consumed by participants in each of the trial arms indicated that
participants in the intervention arms had greater increases in NHS resource consumption at 9 months
compared with baseline than participants in the control arm, as indicated in Table 10.
Cost of the intervention
Estimates of the cost of the intervention were arrived at taking into account a range of factors including
number of sessions per completer; number of completer sessions per RA; numbers of completers at 3 and
9 months in the mini and full booster intervention arms; numbers of participants in the mini and full
booster arms; estimates of the duration of sessions in the mini and full booster arms; RA training and
monitoring costs; venue hire (full booster) and telephone call (mini booster) costs; and the ratio of
participants who completed a full or mini booster course to those assigned to the course.
Following discussion with RAs, the average duration of a mini booster session was estimated to be
20 minutes and the average duration of a full booster session was estimated to be 30 minutes.
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The cost per minute of a mini booster session was estimated to be lower than the cost per minute of a
full booster session as the latter required venue hire and RA travel time. Rates of attrition were similar in
both intervention arms at 3 months but were higher in the mini booster arm at 9 months. Because of this
the average total cost per completer (someone who attended two booster sessions and provided valid
Actiheart data) was estimated to be slightly higher in the mini booster arm at 9 months than in the full
booster arm at 9 months. Because of the high level of uncertainty in estimating the cost of the
intervention, eight different intervention cost estimates were produced for both the mini booster arm
and the full booster arm using different plausible assumptions. The assumptions made to produce these
estimates are shown in Appendix 7, Table 62; 2011 prices were assumed.
The range of estimates appeared to follow a log-normal distribution with a mean (SD) cost per completer
of £216 (£88) for the mini booster and £205 (£76) for the full booster. Because of the similarity of these
numbers the booster intervention was assumed to cost approximately the same irrespective of whether it
was the full booster or the mini booster. The two pairs of eight estimates were combined to produce a
mean (SD) cost per completer of £211 (£91), also assuming a log-normal distribution. Within the
deterministic analyses the mean estimate of £211 was used. Within PSA 1000 values were drawn from an
appropriately parameterised log-normal distribution.
Health-related quality of life data used
The trial outcome data used to populate the short-term model are patient-estimated utilities based on
SF-12v2 plus 4 questionnaire data recorded at baseline and at the end of the trial. These data are
presented in Figure 30 for participants who provided valid 9-month Actiheart data (‘completers’).
TABLE 9 Key to economic modelling scenarios
Scenario no. Perspective Time comparison Data used
1 NHS Baseline to 3 months All
2 Societal Baseline to 3 months All
3 NHS Baseline to 9 months All
4 Societal Baseline to 9 months All
5 NHS 3 months to 9 months All
6 Societal 3 months to 9 months All
7 NHS Baseline to 3 months Completers
8 Societal Baseline to 3 months Completers
9 NHS Baseline to 9 months Completers
10 Societal Baseline to 9 months Completers
11 NHS 3 months to 9 months Completers
12 Societal 3 months to 9 months Completers
TABLE 10 Differences-in-differences NHS resource use estimates
Differences in differences between
control arm and . . . Mean value (per participant) (bootstrapped 95% CI) (£)
Mini booster arm 26.68 (26.59 to 27.12)
Full booster arm 190.91 (190.56 to 191.25)
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Within scatter plots of this form, an overall trend over time would be indicated by the scatter deviating
from the diagonal line: above the line in the case of an upwards trend and below the line in the case of a
downwards trend. A difference between groups would be apparent if the three sets of scatter, indicated
by the three plotting symbols, tended to cluster in different places. It is seen from this plot that there does
not appear to be either a trend over time or a difference between groups.
Table 11 shows the mean (SD) change in HRQoL from baseline to 9 months by allocation group.
Differences-in-differences estimates, comparing the control group with either the mini booster group or
the full booster group, are also presented. These differences are very close to zero in all cases but very
slightly favour the control group over either of the intervention groups.
This approach was adopted for each of the analyses.
Simple threshold analysis
Given an estimated cost of the intervention of £211 per participant, and assuming a willingness-to-pay
threshold of £20,000 per QALY, the intervention would have to provide an additional 0.01055 QALYs to
be considered cost-effective.
Short-term scenarios
Figures 31–42 present scatter plots, CEAFs and tables summarising mean scores and ICERs for each of the
12 scenarios described in Table 9.
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FIGURE 30 Estimated utility scores reported at 3 and 9 months by allocation group (trial completers only).
TABLE 11 Mean (SD) change in HRQoL scores from 3 to 9 months
Group Mean (SD) change in HRQoL from 3 to 9 months
Differences in differences compared
with the control group
Mean Bootstrapped mean 95% CIs
Control 0.018 (0.010)
Mini booster 0.001 (0.015) −0.016 −0.018 to −0.016
Full booster 0.016 (0.014) −0.002 −0.002 to −0.000
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FIGURE 31 Scenario 1. (a) Scatter plot of difference in costs (£) against differences in QALYs; (b) CEAF; and (c) mean
costs, QALYs (to two decimal places) and ICERs.
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FIGURE 32 Scenario 2. (a) Scatter plot of difference in costs (£) against differences in QALYs; (b) CEAF; and (c) mean
costs, QALYs (to two decimal places) and ICERs.
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FIGURE 33 Scenario 3. (a) Scatter plot of difference in costs (£) against differences in QALYs; (b) CEAF; and (c) mean
costs, QALYs (to two decimal places) and ICERs.
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FIGURE 34 Scenario 4. (a) Scatter plot of difference in costs (£) against differences in QALYs; (b) CEAF; and (c) mean
costs, QALYs (to two decimal places) and ICERs.
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FIGURE 35 Scenario 5. (a) Scatter plot of difference in costs (£) against differences in QALYs; (b) CEAF; and (c) mean
costs, QALYs (to two decimal places) and ICERs.
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FIGURE 36 Scenario 6. (a) Scatter plot of difference in costs (£) against differences in QALYs; (b) CEAF; and (c) mean
costs, QALYs (to two decimal places) and ICERs.
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FIGURE 37 Scenario 7. (a) Scatter plot of difference in costs (£) against differences in QALYs; (b) CEAF; and (c) mean
costs, QALYs (to two decimal places) and ICERs.
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FIGURE 38 Scenario 8. (a) Scatter plot of difference in costs (£) against differences in QALYs; (b) CEAF; and (c) mean
costs, QALYs (to two decimal places) and ICERs.
DOI: 10.3310/hta18130 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 13
75
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Goyder et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
– 0.04
– 1000
– 500
0
500
1000
– 0.02 0.00 0.02
Utility (QALYs)
C
o
st
 (
£
)
0.04
Control
Mini booster
Full booster
(a)
0
0.0
0.2
0.4
0.6
0.8
1.0
10 20 30
Threshold (£000/QALY)
P
ro
b
a
b
il
it
y
 c
o
st
-e
ff
e
ct
iv
e
40 50
Control
Mini booster
Full booster
(b)
Scenario 9 Mean cost (£)
(c)
Mean QALY
ICER
(£/QALY) Mean Jackknifed 95% credible intervals
Control
Mini booster
Full booster
– 168
211
473
0.02
0.00
0.02
Mini vs. control
Full vs. control
Dominated
Dominated
Dominated
Dominated to  dominated
to  dominated
FIGURE 39 Scenario 9. (a) Scatter plot of difference in costs (£) against differences in QALYs; (b) CEAF; and (c) mean
costs, QALYs (to two decimal places) and ICERs.
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FIGURE 40 Scenario 10. (a) Scatter plot of difference in costs (£) against differences in QALYs; (b) CEAF; and (c) mean
costs, QALYs (to two decimal places) and ICERs.
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FIGURE 41 Scenario 11. (a) Scatter plot of difference in costs (£) against differences in QALYs; (b) CEAF; and (c) mean
costs, QALYs (to two decimal places) and ICERs.
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FIGURE 42 Scenario 12. (a) Scatter plot of difference in costs (£) against differences in QALYs; (b) CEAF; and (c) mean
costs, QALYs (to two decimal places) and ICERs.
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Summary of the short-term model results
The results of the separate scenarios for the short-term, questionnaire-based cost-effectiveness model
suggest that the estimated cost-effectiveness of the intervention is subject to a high degree of structural
uncertainty and depends on factors such as which data are used and which time periods are compared. In
the majority of the scenarios, the control intervention, no booster, appears both the optimal choice and
the option with the highest probability of cost-effectiveness at all willingness-to-pay thresholds considered.
However, if the assumptions involved in scenarios 5 and 6 are made, there is an indication that the full
booster may be the optimal choice when assuming a willingness-to-pay threshold of ≥ £20,000.
Looking at the estimated mean costs and mean QALYs for each arm in each scenario, it is apparent that
the differences in costs and QALYs are marginal for all scenarios. For QALYs, the differences in mean
values between arms are typically around or < 0.01 QALYs. The cost of the booster intervention is just one
of a number of costs to the NHS and society that the participant population incurred and, compared
with the costs of other NHS resources accessed by the participants over the trial period, it is not large. As
the mean costs and QALYs observed in all arms are very similar, and the ICER is a ratio of two numbers,
even slight decreases in costs or increases in QALYs could lead to very different indications of the
cost-effectiveness of either intervention and so all results presented are potentially very dependent on
statistical noise.
As previously discussed, the approaches taken to estimate the causal effect of the intervention on mean
resource use and mean utility should be considered cautiously. This is partly because of the small sample
sizes involved but mainly because the population considered does not as a rule suffer from any particular
NHS resource-consuming and quality of life-reducing disease that the intervention is speciﬁcally designed
to treat. Because of this, changes in HRQoL or NHS resource consumption over the relatively short time
horizon of the trial are unlikely to be directly related to the effect of the intervention. As the intervention is
more preventative than curative, the effect of the intervention on NHS resource consumption and HRQoL
is likely to be relatively indirect, mediated by the effect of increased physical activity on lifelong morbidity
and mortality risks, and to operate over a much longer time horizon. The long-term model results
presented in the following section attempt to take these factors into account.
Long-term (epidemiological) model
Individual sampling model results
In the long-term model, 9-month and 3-month mortality RRs associated with individuals within each
intervention arm are based on TEE scores sampled directly from individual participant trial data. Because of
the power law mapping equation used to associate individual TEE scores with mortality RRs, and slight
differences in the age and gender distribution of the trial arms, the mean incremental effects of the
intervention on HRQoL may differ from the effects on TEE. This is particularly likely to be the case when
the distribution of baseline levels of physical activity differs by group, as the mapping equation assumes
that the most sedentary individuals have much higher mortality RRs than slightly less sedentary individuals.
As discussed earlier, a number of separate primary scenarios were considered to investigate the impact of
structural uncertainty on the model results. These are shown in Table 12, which shows mean incremental
life-years and QALYs in each arm, and Table 13, which shows, to two decimal places, estimated
incremental differences in effectiveness in the intervention arms compared with the control arm in each of
the scenarios.
As Table 12 indicates, all estimates for the number of additional life-years lived and QALYs accumulated
are very similar, with all values differing by < 1 life-year and < 0.5 QALYs. As Table 13 indicates, this in
turn leads to very small estimates for incremental differences, of < 1 life-year and < 0.33 of a QALY.
Because of the stochastic qualities of the models, and the effect of initial ages on QALYs and annual QALY
increments, the direction of the incremental differences in life-years and QALYs is different for some of the
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scenarios, highlighting how marginal the differences between the trial arms were and the resulting
inﬂuence on random variation of the estimated results.
Secondary analyses
In addition to the main long-term model results, two supplementary analyses were also conducted. In the
ﬁrst series of analyses, the levels of physical activity of all participants were set to ﬁxed values. These ﬁxed
values were varied from the ﬁrst (lowest) quintile to the fourth quintile observed in the trial. The mean
additional utility that resulted from shifting up by one quintile was estimated for each of these baseline
levels of physical activity so that the relationship between additional physical activity and baseline activity
could be explored. The second series of analyses adopted a similar approach but used a level of physical
activity gain based on the mean differences-in-differences estimates for TEE in the full booster group
compared with the control group.
TABLE 12 Summary of mean additional life-years and QALYs within different arms and scenarios
Arm
Long-term physical activity
scenarios assumed
a
Extra years lived QALYs accrued
Mean SE Mean SE
Control Scenario A 26.73 0.02 12.75 0.01
Scenario B 26.73 0.02 12.75 0.01
Scenario C 26.90 0.02 12.81 0.01
Mini booster Scenario A 26.71 0.02 12.73 0.01
Scenario B 26.82 0.02 12.78 0.01
Scenario C 26.14 0.02 12.52 0.01
Full booster Scenario A 26.58 0.02 12.69 0.01
Scenario B 26.67 0.02 12.72 0.01
Scenario C 26.18 0.02 12.53 0.01
SE, standard error.
a Scenario A: 9-month activity levels for 2 years, then 3-month activity levels thereafter; scenario B: 3-month activity levels
throughout; scenario C: 9-month activity levels throughout.
TABLE 13 Summary of estimates of effectiveness
Scenario Comparison
Extra years lived QALYs accrued
Mean SE Mean SE
Individual-level differences
in differences
Control vs. mini −0.10 0.03 −0.05 0.01
Control vs. full −0.09 0.03 −0.04 0.01
3-month differences Control vs. mini −0.09 0.02 0.03 0.01
Control vs. full 0.06 0.02 −0.02 0.01
9-month differences Control vs. mini 0.76 0.02 −0.29 0.01
Control vs. full 0.72 0.02 −0.27 0.01
SE, standard error.
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Scenarios assuming gains of one quintile
Given the power law relationship that appears to exist linking physical activity with mortality RRs, it is
important to consider the effect of the baseline level of physical activity in estimating the cost-effectiveness
of an intervention. Given that the least physical active quintile has the highest mortality risk, it can be
assumed that a given improvement in physical activity is likely to be disproportionately effective in terms of
reduced mortality in this population compared with less sedentary baseline populations. Within the
scenario analysis it was assumed for simplicity that the intervention led to an improvement in physical
activity of one quintile for 2 years. The effect of this temporary increase in physical activity was modelled
when assuming that the entire population was initially in the ﬁrst (most sedentary) quintile, the second
quintile, the third quintile and then the fourth quintile. The results of this analysis are shown in Table 14
and Figure 43. The maximum acceptable intervention cost for each of these quintiles is presented,
assuming a standard willingness-to-pay threshold of £20,000 per QALY.
‘Value-added’ model
Analyses of available data comparing mean daily TEE levels at 3 months and 9 months, and in the control
arm, mini booster arm and full booster arm, suggest that those in the control arm used on average
66.64 kcal less per day at the end of the trial than at 3 months. In comparison, those in the mini booster
arm used 36.37 kcal less per day at the end of the trial than at 3 months and those in the full booster arm
used 8.85 kcal less at the end of the trial than at 3 months. This indicates a difference of 30.27 kcal
favouring the mini booster over the control and a difference of 57.78 kcal favouring the full booster over
the control. These differences are very small but positive. Because of the non-linear relationship between
TEE gain and baseline TEE level, the main economic model, which used individual-level data from all
TABLE 14 Shift in physical activity quintile
Quintiles moved between Mean utility gain SE
Maximum acceptable
intervention cost (£)
1 (most sedentary) to 2 0.122 0.0119 2430.70
2 to 3 0.046 0.0102 914.36
3 to 4 0.043 0.0094 853.83
4 to 5 (most physically active) 0.032 0.0088 649.66
SE, standard error.
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FIGURE 43 Shift in physical activity quintile.
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participants, produced utility estimates that very slightly favour the control arm over either of the booster
interventions. Within this additional series of analyses, the implications of assuming that the mean relative
gains of the intervention groups relative to the control group were applied equally to all participants was
explored. To do this it was noted that 30.27 kcal is equal to 1.36% of the 3-month median TEE score and
57.78 kcal is equal to 2.53% of the 3-month median TEE score. Just as in the previous series of analyses
an intervention was assumed to lead to a 20 percentage point increase in activity for 2 years relative to no
intervention (i.e. shift activity levels from the ﬁrst to the second quintile, the second to the third quintile,
and so on), so in this series of analyses the full booster was assumed to result in a 2.53 percentage point
increase and the mini booster was assumed to result in a 1.36 percentage point increase.
With these assumptions it appears that the full booster may be cost-effective, assuming a
willingness-to-pay threshold of £20,000 per QALY, if the intervention costs < £332 per participant
(95% credible interval dominated to £725 per participant), as shown in Table 15. However, the clinical
differences between the control arm and the mini booster arm appear so marginal that the mini booster
and control arms appear largely indistinguishable in terms of QALYs and so the central estimate suggests
that the mini booster is ruled out by simple dominance compared with the control (although the 95%
credible intervals of the maximum acceptable intervention cost vary from not acceptable/dominated to
£299 per participant).
TABLE 15 Scenario analyses
Scenario Extra years lived, mean (SE) QALYs accrued, mean (SE)
Control
Untreated 26.70 (0.0175) 12.74 (0.00610)
Treated 26.74 (0.0175) 12.75 (0.00608)
Mini booster
Untreated 26.83 (0.0174) 12.79 (0.00605)
Treated 26.86 (0.0174) 12.80 (0.00605)
Full booster
Untreated 26.70 (0.0175) 12.74 (0.00610)
Treated 26.77 (0.0174) 12.77 (0.00605)
Differences-in-differences
Control vs. mini booster −0.008 (0.0291) −0.0047 (0.0100)
Control vs. full booster 0.033 (0.0292) 0.0166 (0.0100)
SE, standard error.
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Chapter 8 Discussion
Effectiveness of motivational interviewing ‘boosters’
Overall, despite the low recruitment rate and signiﬁcant loss to follow-up in the trial cohort, it is possible to
draw some useful, and relatively robust, conclusions from the results of this randomised trial. The statistical
analysis and economic modelling suggest that the interventions are unlikely to be effective or cost-effective
whilst the process evaluation suggests some potential explanations for both the poor uptake and the lack
of overall effectiveness in this relatively deprived and middle-aged population.
We found no evidence of a difference in TEE between the booster groups and the control group and the
point estimates suggested that the combined booster group was less active than the control group. Even
allowing for sampling uncertainty because of the small sample size, the conﬁdence limits do not cross
101.5 kcal, the clinically important difference on which the trial was re-powered following the internal
pilot/feasibility phase. This effect size represents about 4% of a typical energy expenditure of 2400 kcal
per day.87,88 In the comparison of the two forms of booster, we observed a difference in TEE per day of
112 kcal favouring the full (face-to-face) booster, although this result was not statistically signiﬁcant and of
borderline clinical signiﬁcance.
Although there may be major concerns about the generalisability of the ﬁndings from such a small group
of trial completers relative to the population targeted, the 160 (60%) participants who contributed data to
the primary end point do still represent the target population: they are resident in deprived areas; aged
between 40 and 64 years (if skewed towards the upper end of the range) and mostly highly sedentary
at baseline (with a minority who have previous positive experiences of physical activity). If a similar
intervention was offered outside the context of a trial, we have no reason to suppose that those taking up
the offer of ‘booster’ interventions would differ signiﬁcantly from those who volunteered to participate in
this trial and complied with the intervention.
Views on physical activity and motivational
interviewing ‘boosters’
A wide range of leisure activities were reported in the open-ended survey responses, with few sports and
competitive activities being reported. Locations also varied, encompassing facilities, domestic contexts, the
local area and rural locations. Reasons for taking part in the study were also varied, including wanting to
help with the research; being advised by medical staff to increase activity; wanting to improve or gain
knowledge of health and well-being, physical activity levels and ﬁtness; and to gain personal beneﬁt.
Medical health issues were frequently cited as both barriers to and motivators for being physically active.
Musculoskeletal injuries were a prevalent barrier whereas chronic physical conditions were often a direct
cause of people wanting to become more active than previously. Social support was important with many
people saying that they found exercising with other people encouraging and motivating oneself in
isolation difﬁcult. Friends and strangers from outside of the home were sometimes seen as better
support than family, who were often perceived as a barrier, especially in younger participants who had
young children.
Most people found some beneﬁt from the MI although some people would have liked something more
action oriented (see Chapter 4, Motivational interviewing: consistency with perspectives or world views).
The setting for delivery was generally considered convenient and many people talked about MI meeting
some unmet need, particularly an occasion to talk about goals and barriers relating to physical activity with
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an informed and non-judgemental person (in contrast to family and sometimes friends). The term
‘counsellor’ was used by several participants to describe the MI practitioners, reﬂecting a perception of the
relationship as impartial and supportive.
A prevalent theme was that people were keen to receive feedback (both verbal and accelerometry) on
their performance and strove to meet goals so as not to disappoint the MI practitioners. Monitoring and
normative feedback is an important part of ongoing motivation to maintain behaviour change.
More participants who received a booster intervention said that a face-to-face (full) booster would be
preferable to a telephone (mini) booster, which was seen as less easy to prioritise. This is corroborated in
the literature: speciﬁcally in MI, a face-to-face intervention is identiﬁed as an effective way of developing
client engagement.89 This, together with accurate empathy, is consistently highlighted as an important
factor in supporting health behaviour change and, as technology attempts to substitute this level of
contact with potentially cheaper and more convenient platforms such as smartphone apps, the telephone,
DVDs and online alternatives, trade-offs between cost and efﬁcacy might be expected.
Self-reported moderate to vigorous physical activity often appeared to be at odds with the objective data,
both for individuals, as illustrated in Chapter 4 (see The prevalence of optimistic self-assessment), and for
the participant population as a whole, for whom the correlation between self-report (SPAQ) and objective
(Actiheart) data at 3 months was almost non-existent. This incongruence is common in the measurement
of health behaviours and is widely reported in the literature.90 In terms of physical activity, participants
typically over-report moderate and vigorous activities and under-report low-intensity activities.91 Concerns
are often raised about participants altering their behaviour in response to the knowledge that they are
being monitored, the ‘Hawthorne effect’.92 Reactivity of this kind causes a change in actual behaviour,
rather than a discrepancy between different methods of measurement. Over-reporting of activity may
occur out of a desire to please the researcher and meet with perceived expectations, that is, social
desirability bias, whereas it has been suggested that the under-reporting of lower-intensity activities, such
as walking, may be due to a simple lack of awareness of undertaking them as many instances occur as
part of everyday living rather than as planned activities.93
There are some parallels between the ﬁndings of the process evaluation and the ﬁndings of other
qualitative research examining physical activity in older adults. For instance, engaging in a lifelong habit of
being physically active was a motivator for physical activity in a systematic review of physical activity during
the transition to retirement, and relates to previous practice and also commitment to physical activity
found in the current study.94 Some of the barriers to physical activity identiﬁed in the current study, that is,
preferred alternatives and lack of social support (for certain types of activity), were also identiﬁed in the
review by Barnett and colleagues.94 In both pieces of research physical activity was adopted in response to
felt needs or problems and had social beneﬁts that could be motivational.
The importance of the social context as both a barrier and a facilitator was also identiﬁed in a recent
systematic review of physical activity perceptions among older adults of South Asian origin.95 Speciﬁcally,
‘lack of time’ (encompassed by ‘preferred alternatives’ in the booster study) was a barrier that related to
people’s obligations to others; taking time out from these obligations to exercise could be perceived as
culturally inappropriate behaviour.
Monitoring and feedback have also been found to be desirable in a process evaluation of a primary
care-based walking intervention for older adults. Mutrie and colleagues96 found that pedometers were
perceived as easy to use and were popular as a motivational tool. Unlike the booster study, however, they
found good correspondence between reported and measured increases in physical activity levels.
In a process evaluation of telephone health mentoring for chronic obstructive pulmonary disease patients
(mean age of 65 years) in Australia, Walters and colleagues97 found that the experience of engaging in
telephone health mentoring was valuable to most people and enabled them to reassess their activities of
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daily living, including physical activity. There was a perceived motivational element, with some people
ﬁnding that the health mentoring served as a useful reminder to perform the relevant health behaviours.
As in the booster study, some participants found the anticipation of speaking to someone about their
health behaviour generally, and physical activity in particular, a motivator.
In another study98 the anticipation of mental and physical health beneﬁts motivated the initiation of
physical activity in South Asians aged 60–70 years and motivation for adherence also came from a drive to
maintain good physical and mental health, which were among the reasons given by booster study
participants for maintaining physical activity. In addition, Horne and colleagues98 found social support from
family, friends, peers and statutory and voluntary workers to be important in motivating people to initiate
and maintain physical activity, often through the impact of the social environment on their conﬁdence. The
self-conﬁdence in their own physical ability gained from mastering a speciﬁc activity also served to
motivate maintenance of physical activity among some people, and similarly conﬁdence was given as a
motivator for maintenance in the current study. Another recent study99 exploring the views of older Slavic
immigrants in the USA about physical activity found that motivators included the desire to be active and
go for walks and the anticipated beneﬁts for existing medical health issues (including pain, poor sleep and
use of medication). Anticipated beneﬁts also included greater independence as well as social support, as
physical activity was seen to provide a way of engaging with other family members, especially
grandchildren. Some similar barriers to those in the current study were also reported, namely lack of
desire, limitations imposed by medical health issues such as tiredness, pain and speciﬁc chronic conditions,
and environmental issues such as safety concerns, bad weather and heavy trafﬁc.
Geographical information systems analysis
The primary aim of the GIS analysis was to produce a set of variables for each of the 282 participants in
the booster study that represented their pedestrian access to municipal green space and relevant leisure
facilities (gyms and swimming pools). We found wide variations in pedestrian access across Shefﬁeld, most
notably with regard to proximity to swimming pools and the highest-quality green space. However, there
was no statistical association observed in trial participants between mean TEE per day at 3 months and
proximity to the above variables.
It is unlikely that proximity to either green space or leisure facilities was an important determinant of
activity levels in our participants, which equally suggests that lack of access to green space and facilities
was not a signiﬁcant barrier to activity in trial participants. This is consistent with the qualitative evidence
from the in-depth interviews, which suggests a range of other pertinent barriers.
Cost-effectiveness of motivational interviewing ‘boosters’
Because of the complex processes by which changing levels of physical activity lead to changes in HRQoL,
two qualitatively different approaches to estimating the cost-effectiveness of the interventions were
adopted. One of these approaches utilised resource use and SF-6D utility scores elicited directly from
participants at 3 months and 9 months following the intervention to produce cost-effectiveness estimates
over the short term. The other approach combined data on changes in levels of physical activity recorded
using the Actiheart system with epidemiological data linking exercise capacity to relative mortality risks to
produce individual-level simulations estimating long-term HRQoL effects resulting from the effect of
changing levels of physical activity on participant mortality rates.
Despite adopting qualitatively different approaches and methodologies, both main models indicated that
both the mini booster and the full booster appear to be ruled out by simple dominance and so do not
appear cost-effective at any willingness-to-pay threshold. An additional variation of the long-term model,
however, which incorporated data on physical activity differences in differences between arms in a
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different way from the main analysis, indicated that the full booster intervention may be cost-effective
assuming a willingness-to-pay threshold of £20,000 per QALY as long as the cost of the intervention is
below approximately £300 per participant. The additional assumption made in this model, however, is that
all participants who receive the intervention increase their physical activity levels by equal amounts, which
may be a particularly strong assumption given that it may be those participants who are already
comparatively physically active who increase their physical activity levels most, and the least physically
active who increase their physical activity levels the least. Given that it appears that the greatest health
beneﬁts for a given increase in physical activity are in people who were initially the most sedentary,
patterns of selective take-up of additional physical activity may mean that the health beneﬁts of a mean
increase in physical activity may be less than initially assumed.81
Other recent evidence for the effectiveness and
cost-effectiveness of ‘brief’ and ‘booster’ interventions for
increasing and sustaining physical activity
While the booster trial has been ongoing a number of other trials and non-randomised evaluations of
physical activity interventions have reported, but none with a speciﬁc focus on maintenance. A team at
ScHARR have recently conducted a review of the evidence for the effectiveness of brief interventions in
promoting physical activity in primary care100 and this comprehensive systematic review, together with an
associated review of the cost-effectiveness evidence, has informed an update of the NICE guidance on this
topic,12 which is currently out to consultation (http://www.nice.org.uk). In the NICE-commissioned review
the current evidence base for brief interventions was synthesised and it was found that, although there is
evidence (based mainly on self-reported outcomes) that brief interventions are effective at increasing
physical activity, there is not consistent evidence to suggest a ‘dose–response’ effect with more intensive
or repeated interventions having a greater impact than a simple brief intervention (deﬁned by the review
inclusion criteria as one lasting up to 30 minutes).
Three other recent systematic reviews101–103 provide evidence that interventions in primary care, including
brief interventions and telephone interventions, may be effective and/or cost-effective. The review by
Orrow and colleagues103 also mainly synthesised trials with self-reported activity as the primary outcome,
but included all primary care interventions with at least 12 months’ follow-up. This review found evidence
for an impact of a range of interventions on self-reported activity, but similarly reported that there was no
robust evidence that more intensive interventions (such as exercise on referral) were more effective than a
simple brief intervention. A systematic review by Goode and colleagues102 included eight studies evaluating
maintenance of physical activity behaviour change up to 12 months after a telephone intervention. The
majority of telephone interventions involved > 12 contacts and took place over a period of > 6 months,
with many interventions involving signiﬁcantly more frequent and longer contacts than the mini booster
intervention in our trial. The review deﬁned successful maintenance as between-group differences in at
least 50% of reported outcomes in favour of the telephone intervention group at least 3 months after
completion of the intervention. Of the eight studies reporting on the maintenance of behaviour change,
two reported a maintenance effect for at least 50% of outcomes over 3 months without the intervention.
Garrett and colleagues101 reviewed cost-effectiveness studies of physical activity interventions in primary
care and found that interventions involving advice (in person, by telephone or by mail) were more
cost-effective than supervised exercise interventions. This review did not examine the marginal beneﬁt of
additional interventions to maintain behaviour change as the included studies all compared a speciﬁc
intervention with usual practice or no intervention.
Considering the ﬁndings from the booster trial and the implications of the cost-effectiveness modelling in
the context of these reviews suggests that simple, brief interventions targeting sedentary populations are
likely to be more cost-effective than more expensive and intensive interventions, including ‘boosters’. A
major caveat in assuming the generalisability of the effectiveness of brief interventions is that the majority
of the evidence of effectiveness comes from self-reported outcomes in unblinded studies. The booster trial
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is one of the few trials with objectively measured energy expenditure (or physical activity) as the primary
outcome measure and this conﬁrmed the poor correlation between objectively measured activity levels and
self-reported activity levels in trial participants. Future cost-effective modelling should also take account of
the baseline physical activity levels (and ﬁtness) of participants who achieve an increase in activity levels,
given the exponential relationship between baseline risk and impact on mortality.
Strengths and weaknesses of the study
Recruitment and retention
The principal shortcoming of this study was its failure to recruit 600 participants and retain 450 within the
allotted time and budget. This is a common experience as only 31% of Medical Research Council- and
HTA-funded trials that recruited participants between 1994 and 2002 met their recruitment target on time
and within budget, with 45% closing to recruitment having reached < 80% of their target and 54%
requiring a time extension.104 Furthermore, there is considerable evidence that recruitment to trials
evaluating preventative interventions is considerably more difﬁcult than recruitment to those evaluating
therapeutic interventions, with typical rates of those randomised as a proportion of those screened cited of
1–5% and 20–27%, respectively, according to one overview.105 High levels of deprivation are known to
predict poor consent rates in trials evaluating behavioural interventions for sedentary people.106,107 It may
be particularly difﬁcult to recruit healthy participants in deprived communities for an intervention that may
have signiﬁcant costs to participants, including both the costs of behaviour change and the time and travel
costs of attending for the intervention as well as recruitment, baseline data collection and follow-up. We
were also recruiting participants from an age group (40–65 years) in which many people have both work
and family responsibilities, which may make it particularly likely that perceived costs will outweigh the
perceived beneﬁts of participation.
Our study needed to recruit patients who had already received and responded to a brief intervention but
was hampered by the absence of access to patients already being given a brief intervention in the local
primary care setting whom we could recruit. For this reason the study team had to devise and distribute a
brief intervention (see Chapter 2, Participants) and deliver it in partnership with the local primary care
authorities but outside of the routine NHS care setting. The principal method of approaching participants
was through personalised letters, electronically signed by the local director of public health, inviting people
to contact the study team. This method generated 4964 responses from the 70,388 letters sent, a
response rate of 7.1%. It is possible that we could have generated more responses by recruiting GPs to
carry out the mail-outs. However, this method would have been much more expensive and there is little
evidence that it would have been more effective. The Food and Immunity Trial (FIT), another South
Yorkshire-based public health study, recruited people aged 65–85 years using mail-outs from general
practices.108 Its response rate was 528 out of 7482 (7.1%), identical to our own. The FIT study team used
a wide range of other methods to recruit participants but GP mail-outs accounted for 90% of consented
participants. It is worth noting that there is no good-quality evidence for the superiority of direct
face-to-face recruitment compared with mail-outs in this population.109 Even had there been it is unlikely
that we would have had the reach or the resources required to reach full accrual using face-to-face
accrual. We attempted to recruit through a range of other stakeholders, including GPs, health trainers and
health champions, but this was not successful (see Chapter 3, Recruitmant of trial participants). This
suggests that direct recruitment through primary care and community networks may not have improved
recruitment yields. Previous research comparing targeted mail-outs with recruitment through general
practices has found that mail-outs are more effective and cost-effective, even when there are strong
collaborative links with GPs.110
The brief intervention devised by Shefﬁeld Hallam University reached 1934 (2.7%) of the 70,388 people
who were invited to apply for it, although a further 568 who contacted and were screened by us were
excluded from using the brief intervention, mostly because they were already physically active (see
Chapter 3, Recruitmant of trial participants). Of those who received the brief intervention, 840 (43%) were
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not contactable at 3 months, 538 (28%) were contactable but had not increased their self-reported
physical activity levels sufﬁciently to be eligible for the trial and 274 (14%) who were eligible could not be
randomised (half of whom actively refused consent; the other half did not attend consent appointments).
The concept of the ‘funnel effect’, in which a pool of potential patients who are contacted about entering
a clinical trial becomes progressively smaller as it passes through successive screens and the informed
consent process, is relevant here.105 It is widely believed that the lower the percentage recruitment yield,
the more questionable it is to generalise from the study ﬁndings to the target population.111 We would
assert that the results of this study are generalisable. Although we found it difﬁcult to identify participants
who had beneﬁted from receipt of the brief intervention (the key eligibility criterion), we randomised 51%
(282/556) of those we were able to identify (see Figure 6). The issue is the willingness to take up and
respond to a brief intervention of those who could beneﬁt, as supported by the published evidence. Of the
four published RCTs evaluating brief interventions delivered to UK populations,112–115 none reported
statistically signiﬁcant improvements in self-reported physical activity. For the same reason it is fair to say
that the MI boosters cannot be seen as public health interventions, because they cannot be rolled out at a
community level. Rather, individuals will identify whether the offered intervention is appropriate and
acceptable to them, and only a minority of sedentary individuals are likely to take such an intervention up.
Impact of area deprivation on recruitment
We aimed to recruit people from deprived neighbourhoods. We knew from the outset that there were
pockets of afﬂuence within the predominantly deprived areas that we surveyed. In a few areas people
from LSOAs that were less deprived were recruited to the study (see Figure 9). However, the majority of
the study participants were from relatively deprived LSOAs. Out of 147 LSOAs targeted, 102 were in the
bottom 20% of national IMD 2010 overall scores.
The contact details for each recipient were conﬁrmed as current by the NHS in the week before each
mail-out. Despite this we received 1117 letters (1.6%) returned to sender because of the addressee being
unknown at that address. There were undoubtedly more letters that were not returned to us, suggesting
that a sizable minority of invitations were not received and reﬂecting the inaccuracy of the primary care
databases that depend on patients reliably informing their current general practice when they move.
Registers will be less accurate for more transient populations and this population characteristic may have
had an impact on recruitment in more deprived neighbourhoods. We tested the hypothesis that the
impact might be more severe in areas with transient populations but an exploratory GIS analysis using a
simple linear model found no evidence that response rate was correlated with indicators of population
transience (see Chapter 2, Participants, and Chapter 3, Baseline characteristics of participants). However,
as noted in Chapter 3, there was a statistically signiﬁcant difference in the response rates from different
neighbourhoods, with fewer responses from more deprived LSOAs. It is important to stress that none of
the areas approached was afﬂuent in national terms and that this ﬁnding indicates relative resistance to
recruitment from very deprived communities compared with only moderately deprived communities.
Of the randomised participants, 165 out of 282 were living in LSOAs in the bottom 20% of national IMD
2010 overall scores. This may indicate that, although we surveyed neighbourhoods that are normally
understood to be deprived, the study population from these areas is likely to have been relatively more
afﬂuent. This is most visible in Figure 10 in which the plot for High Green, the geographical outlier to the
north of the city, shows a ‘halo’ of participants from relatively afﬂuent LSOAs.
Operationalisation of eligibility criteria
Four protocol violators (2.5% of the ITT population) were included in the ITT analysis (see Chapter 3,
Baseline characteristics of participants). These participants did not meet the eligibility criterion of increasing
self-reported physical activity by 30 minutes per week over the previous 3 months and did not signal, in
the ﬁnal SPAQ question, that the amount of physical activity that week was atypical. Academic opinion is
divided on the utility of post-randomisation exclusions. For some, ‘the only safe way to deal with [protocol
violations] is to keep all randomized patients in the trials’ (p. 464).116 Others advise excluding ‘ineligible
patients from analysis, provided that the eligibility criteria are absolutely clear and objective’ (p. 176).117
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Guideline E9 of the International Conference on Harmonisation of Technical Requirements for Registration
of Pharmaceuticals for Human Use (ICH) also makes provision for the exclusion of participants if a ‘major’
eligibility criterion was violated.118 Although ICH E9 fails to deﬁne ‘major’, commentators have suggested
that it might include criteria that, the violation of which, produce ‘a less homogeneous set of patients (a
possible loss of power)’ (p. 885).119 With the beneﬁt of hindsight we can see that the SPAQ was a far from
objective screening tool: the reports of physical activity provided by those to whom it was administered
correlated poorly with objective measures of physical activity (using the Actiheart device) during follow-up.
Further, the use by RAs of negative answers to the ﬁnal question (‘Was the last week typical of the
amount of physical activity in minutes you usually do?’) to provide a basis for exemption from the eligibility
criterion and an argument for randomisation was probably inconsistently and subjectively applied across
randomised and non-randomised participants. For this reason it is unlikely that the presence of these
four individuals seriously affects the homogeneity of the analysis set. A post hoc sensitivity analysis also
suggests that the treatment effect was unaffected by their presence (see Chapter 3, Effectiveness of the
booster intervention at 3 months). Although the concurrent use of the SPAQ as a screening tool is clearly
problematic, it is not clear what the alternative might have been, given the need to screen 2502
unconsented members of the public at 3 months before randomisation to randomise just 282. The SPAQ
also has a level of external validity that accelerometry might not, in that it, or self-report measures like it,
are in use by the kind of local services to which our ﬁndings were intended to be generalisable.
Impact of the use of the Actiheart system on the collection of primary
outcome data
The trial design team anticipated a participant attrition rate of up to 25%. In practice, the trial lost 81
participants (29%) to follow-up at the primary outcome assessment time point of 3 months (see Figure 6),
despite deploying many of the preventative measures described by Brueton and colleagues.120 Although
this was disappointing, the loss of a further 18% of participants from the main analysis because of missing
Actiheart data was entirely unexpected. The majority of early Actiheart studies were focused on the
validation of the device for use in young people and healthy adults in controlled laboratory conditions.
There are more recent studies in which Actiheart has been used in hospital settings, free-living
environments and community settings.121–123 However, few provide comments on its acceptability or
suggest the kind of poor compliance observed in this study. The best available evidence on its acceptability
comes from a recent study comparing instruments for the objective assessment of physical activity
frequency and intensity.122 In this study of Native Hawaiian participants, the Actiheart device was deemed
more comfortable than ActiTrainer (an accelerometer and a Polar heart rate monitor; ActiGraph,
Pensacola, FL, USA) and was worn for 6.5 days out of 7 for an average 12 hours per day. However, only
17 people wore the Actiheart in this study and two participants (12%) reported skin irritation. Although
only a few people in our study reported irritation from the electrodes, many found that the electrodes did
not adhere for the full week. As a result of this, and after trying several different brands of electrodes in
addition to the ones recommended by the manufacturer, all participants were issued with spare electrodes
so that they could replace them during the week as necessary. It is also interesting to note that the
manufacturer of Actiheart, CamNtech, now offer a belt as an alternative to electrodes for holding the
Actiheart in place.124 As far as we are aware, this study is one of the ﬁrst studies to suggest problems with
the acceptability of the device in community settings and with repeated measures, with most published
studies having asked participants to use the device on one occasion only. Our relatively large sample and
limited involvement in placing/replacing the device means that this study provides a novel insight into the
use of the Actiheart as a device for community-based assessment of physical activity.
The most problematic characteristic of accelerometer data is that activity is not measured over a uniform
period each day and therefore determining the minimum number of monitoring days with valid
accelerometry measurements is always a challenge in practice, especially in pragmatic trials.38 Ideally, at
least 7 days of physical activity monitoring using the Actiheart device is recommended to achieve estimates
of physical activity in adults of approximately 90% reliability.39 However, in practice, there is a balance
between achieving the required degree of reliability in physical activity estimates and the number of days
with valid accelerometry data required to optimise retention of study participants in the ITT population.
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To achieve 80% reliability with respect to activity counts and time spent in moderate to vigorous activity in
adults, at least 3–4 days (of the 7 days) of activity monitoring are required.39,125 In this regard, in this study,
participants were required to have carried the Actiheart monitor for at least 4 days (of the 7 days) and have
a minimum of approximately 7 hours (not lost > 1000 minutes) of accelerometry measurements each day.
This meant that a signiﬁcant number of participants, despite completing the study, did not provide primary
outcome data at 3 and 9 months and it is impossible to rule out information bias being introduced
because of differences in physical activity levels between those who successfully used and returned the
Actiheart monitor and those who did not.
Potential impact of trial participation on physical activity levels
independent of the trial intervention
The phenomenon of behaviour modiﬁcation caused by the act of being observed (the Hawthorne effect126)
has been reported in some studies127,128 but not in others.129
A speciﬁc concern that inﬂuenced the design of the booster trial was the perceived risk that the objective
measurement of baseline activity (Actiheart) would have an effect on all participants’ physical activity levels
because of their awareness of being monitored, potentially reducing the likelihood of observing an
intervention effect in those also receiving booster interventions over and above this. In other words, the
very act of measuring participants’ baseline activity levels, although an element of the research data
collection process and not part of the intervention, might in itself act as an intervention, thus reducing the
potential to have a ‘true’ control group with no intervention.
In theory we might expect this type of Hawthorne effect, but at least expect it to be similar between the
booster group and the control group if Actiheart devices are administered in all arms. Therefore, we would
not expect the estimated treatment effect, the difference in 3-month post-randomisation energy
expenditure, to be affected by the Hawthorne effect in this scenario, mitigating any potential concern
about an intervention effect masking the measurable impact of the face-to-face or telephone MI sessions.
However, it is possible that a Hawthorne effect did still occur during the study, as several participants
reported in interviews that the expectation of seeing a researcher for their 3-month research study
outcome assessment provided a motivation for staying physically active (see Chapter 4, The importance of
monitoring and feedback). Although the same RA was never used for both the intervention and the
research procedures, visual cues (such as Shefﬁeld Hallam University Centre for Sports and Exercise Science
logos on polo shirts) might have blurred the distinction in the minds of participants.
Lack of objective measurement of physical activity at baseline
The main rationale for not collecting baseline Actiheart data in our trial was to reduce the possibility of
encountering the Hawthorne effect as discussed in the previous section. However, we acknowledge that
baseline measurements could have had three potential advantages in this trial. First, the availability and
utilisation of baseline Actiheart data would have improved the precision around the estimated treatment
effect (the difference in outcomes between the booster group and the control group). Second, in hindsight,
with a baseline assessment of energy expenditure we would have predicted problems with the Actiheart
devices at an earlier stage of our study. We could have then developed strategies to minimise attrition and
improve retention of participants with valid Actiheart data at 3 months. Third, baseline measurements of
activity levels might have provided additional information about whether any differences between groups at
follow-up were due to differential retention in the three arms, rather than intervention effects (which is
always a potential source of bias when participants cannot be blinded to their intervention group).
Strengths and limitations of the process evaluation
Neither the process evaluation survey nor the topic guide for the interviews was piloted, although the
response to questionnaire closed items was generally good. Another weakness was that, because of
sickness and maternity leave, interviews were conducted by Shefﬁeld Hallam University researchers who
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also delivered the intervention. However, no participant was interviewed by the same person who
delivered their intervention and the analysis was conducted independently by University of Shefﬁeld
researchers not involved in the delivery of the intervention.
The use of qualitative research allowed for a nuanced interpretation of the quantitative elements and
raised several supplementary questions that we were able to address through additional analyses, for
instance the importance of relative autonomy in participants’ responses to the intervention.
Strengths and limitations of the trial intervention
The booster trial applied a humanistic counselling approach that attempted to action plan based on
participant readiness, values and perceived resources. The approach was manualised and ﬁdelity calibration
of those delivering the intervention was attempted. This was a clear strength of the study intervention,
which is rarely seen in physical activity counselling settings.18 The theoretical approach (self-determination
theory15) underpinned the cognitive and behavioural intervention in line with the treatment ﬁdelity
framework. This ensured a consistent rubric, based on empirical evidence, providing justiﬁcation for the
content and delivery of the counselling intervention (MI). Measurement of the cognitive effect of factors
such as exercise motivation (measured using the BREQ-226) on behavioural adaptations to physical activity
(measured using accelerometers) also provides evidence for the effectiveness of an MI approach. In the
process evaluation the use of empathy and engagement was reported by the participants throughout,
which is a fundamental part of MI.89 These concepts are clearly distinct from a traditional medical
model in which advice giving, warning and confronting with evidence are often found to generate the
opposite result.
The MI counselling intervention, measurement of behavioural change using objective instruments
(accelerometer) and measurement of epidemiological change (physical markers such as BMI) were again a
strength of the trial in attempting to clearly assess and report the link between cognitive, behavioural and
epidemiological interventions and outcomes. Although objective measures of behaviour change are
difﬁcult to achieve, this is likely to be improved as technology enables smaller and less intrusive
instrumentation. Correlating the cognitive (or affect) and behavioural change pre–post allows inference of
the change in cognitive affect (motivation) mediating a corresponding change in behaviour. Moreover,
process evaluations can provide greater explanations of the reasons for this change.130
The identiﬁcation of the target behaviour (e.g. physical activity, diet or other lifestyle behaviours such as
smoking) is fundamental to MI and yet is challenging to achieve and manage in a brief session
(approximately 30 minutes) such as that delivered in the trial. Moreover, the duration of the full
(face-to-face) and mini (telephone) booster sessions was more akin to the duration of a brief MI
intervention, whereas longer and more frequent sessions are often found to be signiﬁcant in other health
settings.131 The duration of the sessions was usually dictated by the participant, although the RAs’ limited
use of deeper reﬂections and extended exploration of issues and participant values, as reﬂected in the MITI
scores, could also have contributed to sessions being briefer than might be optimal. Multifaceted
behaviours often emerged, which are rarely discrete, and combinations such as diet, alcohol, physical
activity, smoking and medication adherence are challenging to manage in such a short period. Therefore,
a longer period of time would be useful to explore the agenda, target behaviour and carry out action
planning as a result. Lundahl and colleagues131 and Hettema and colleagues132 have suggested that MI
interventions including up to six repeated sessions are the most signiﬁcant and, although briefer
interventions have been found to show positive results, these are more reliant on interventionist effects
and inﬂuence. In the current trial the duration of the individual intervention sessions limited the
opportunity to fully explore client values within the level of MI skillfulness of the RAs.
There was limited opportunity to explore maintenance and relapse prevention with participants within the
mini and full booster MI sessions primarily because of the limited time available for the interaction. It is
clear that action planning in physical activity contexts rarely embeds maintenance strategies (which include
relapse prevention) and these need to be considered in future trials and community-based interventions.
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Although the action plan did attempt to account for setbacks and managing relapse this was not perhaps
explicit enough and speciﬁc ‘active’ compared with ‘passive’ follow-up sessions would support this.60 In
addition to the value of speciﬁc cognitive–behavioural ‘maintenance’ strategies, a number of components
were delivered (e.g. monitoring and normative feedback) although these were not made explicit enough in
the intervention.
More generally, the complexity of the intervention could not be managed sufﬁciently in the short time
available. ‘Adoption’ behaviours such as physical activity and diet change involve multifaceted lifestyle
adaptations over a long duration and the current trial had a limited intervention duration with what could
be described as a ‘passive’ follow-up. There was also limited opportunity for the use of explicit
maintenance strategies that would have embedded cognitive–behavioural content such as adapting
change goals, active follow-up and normative feedback. Future studies should make more explicit the use
of maintenance strategies based on client readiness and changes in levels of motivation and opportunity
for change.
Motivational interviewing training and assessment of practitioner competence
The current trial also demonstrated the value of detailed documentation and reporting of both the MI
training and assessment of MI competence, which identiﬁed both strengths and limitations in these key
factors that inﬂuence intervention delivery and effectiveness.
The trial applied a theoretical underpinning for the intervention in line with treatment ﬁdelity, which was
based on empirical studies and contemporary evidence at the time of conception.16 Since that time the
evidence on the link between MI and self-determination theory has become even more robust, which has
justiﬁed its use.64 This study is one of the ﬁrst to apply a treatment ﬁdelity framework with a clear
description of the design (theoretical underpinning using self-determination theory), training (MI
component and assessment of competence), delivery (to the participant, recorded and reviewed), receipt
(by the participant) and enactment (behavioural change measured using objective and self-report methods)
in a physical activity counselling intervention.
A signiﬁcant strength of this study was the application of a validated and reliable assessment tool to
indicate the competence of those delivering the intervention. This sat comfortably within the treatment
ﬁdelity framework and was a robust approach rarely seen in previous physical activity counselling trials.17,18
The treatment ﬁdelity framework itself provided a sound basis for the design and delivery of the
intervention with an appropriate theoretical framework (self-determination theory16,64) and facilitated a
clear link between the cognitive intervention and the outcome measure using BREQ-2.15,30 No other MI
studies in physical activity settings have attempted this level of assessment and it provides a number of
lessons for future studies that are likely to train and assess those delivering the intervention in situ (health
professionals already positioned in health-care settings as opposed to additional RAs).
One key implication of the trial has been the importance of the assessment of the baseline ability of the
RA before the start of a trial as well as the need for ongoing assessments and self-reﬂection to account for
‘drift’ in counselling competence. Although the RAs were trained in foundation practitioner skills, it was
not possible to optimise the level of competence through speciﬁc ‘real-world’ reﬂective practice in the run
up to intervention delivery to trial participants because the RAs were heavily involved in the recruitment
phase of the study. Practitioners in an existing service might have been less likely to experience this lag
period in skill development (although the risk of skill drift might have been greater).
Other studies in health contexts, such as studies on medication adherence and management and
prevention of transmission of human immunodeﬁciency virus, have assessed the competence of
practitioners at interview stage and ﬁltered out those who do not meet strict criteria. This was not possible
in this study as the practitioners had to be experienced in both physical activity programming and lifestyle
change, which meant that the chance of them also being experienced MI practitioners was limited. In the
current austerity climate there has been a move towards training existing practitioners in health services as
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opposed to attaching practitioners from outside this setting. Although this will increase the ecological
validity and context-speciﬁc nature of the training, existing practitioners are likely to have a broader range
of abilities.
Although a number of studies have emerged in recent years assessing the efﬁcacy of MI in promoting
physical activity behaviour change, few have clearly reported the content, frequency and duration of the
MI intervention; the heuristic value of this trial is therefore the clear reporting for future adaptations.
Those delivering the mini and full booster (RAs) were not existing health professionals, which may
challenge the ecological validity of the intervention and the relevance of the direct inferences for
health-care settings. Although the use of RAs allows for bespoke training and focused attention on the
trial, their awareness of speciﬁc care pathways was limited.
The amount of time required for ensuring MI ﬁdelity and applying self-reﬂection (and accounting for
practitioner competence ‘drift’) was a challenge in the current trial as the RAs were also heavily involved in
the recruitment process and the lead-in time between training and delivery to participants was short. As a
result the RAs trained ‘on the job’ and had little opportunity for group supervision and full-day workshops
followed by reﬂective practice. However, one could argue that this is likely to be similar for any other
practitioner delivering physical activity MI sessions alongside or as part of their full-time job.
Although the use of a treatment ﬁdelity framework provided an outline for all stages of the trial, there is a
risk of a ‘pure’ application of such a framework, constraining the adaptability and innovation often seen in
a health-care setting.133 The value of internal validity and process awareness of training, for example, is
unquestionable, although they may be seen as a ‘dictate for provider adherence to a set of therapist
behaviours rather than as adherence to the delivery of the “active” treatment component’ (p. 454).133
Leventhal and Friedman133 suggest that ‘such manualised approaches can discourage functional analysis of
the complexities of individual cases’ (p. 454).
Strengths and limitations of the geographical information systems analysis
The main strengths of the GIS analysis are the use of network distance rather than straight line distance
and the use of the Sports England database for comprehensive coverage of local leisure facilities. Unlike
some other studies in this ﬁeld, which use Euclidean distance as a proximity measure (including a
well-cited study by Maas and colleagues86), we have calculated walking distance using network
information extracted from OpenStreetMap, which provides extensive coverage of pedestrian access routes.
The main weaknesses are the use of automated geocoding (rather than more precise but labour-intensive
manual geocoding) and the use of a ‘distance to nearest’ measure rather than a more sophisticated
‘gravity’ distance model. A more sophisticated ‘gravity’ measure (such as that used in the study by Dai134)
can take into account multiple facilities in the local area and it is possible that it could be used in future
work; however, the required assumptions meant that it was not suitable for all of the facilities that we
studied in this trial.
Strengths and limitations of the health economic modelling
Because of considerable structural uncertainty and difﬁculties in translating from the measures recorded in
the booster trial to QALYs and costs, two alternative models were developed and within each model a
wide range of scenarios was considered. The majority of these scenarios indicated that both the full
booster intervention and the mini booster intervention appeared to be ruled out by simple dominance,
although a small number of scenarios provide weak indications that the full booster may be the optimal
choice assuming willingness-to-pay thresholds of approximately £20,000 per QALY or more. All scenarios
were reﬂections of the evidence of the trial, indicating that in substantive terms there were only marginal
differences between trial arms.
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Although the short-term model has the beneﬁt of being heavily based on evidence collected during the
trial, it remains an open matter whether a lifestyle intervention such as the booster intervention is likely to
produce a clinically signiﬁcant effect in terms of either participant HRQoL or use of NHS resources over the
duration considered. This is because the intervention is primarily preventative rather than curative and
participants were not selected on the basis of suffering from a particular disease adversely affecting their
HRQoL and NHS resource use. Because of this it may not be plausible to assume that increasing physical
activity now will lead to systematic changes in HRQoL or resource use in the short term. Instead, positive
health effects of the intervention may emerge over a much longer time horizon, reducing the risk of a
range of diseases developing and so improving health outcomes indirectly.
It was because of this concern that the long-term model was developed to be considered alongside the
short-term model. In this modelling approach, the HRQoL gains from increased physical activity result from
the mediating effect of physical activity on relative mortality risks, meaning that a cohort of more physically
active people should be expected to live for slightly longer on average than an otherwise identical cohort
of slightly less physically active people and so experience slightly higher average HRQoL. The model
implicitly incorporates the effect of morbidity on HRQoL, by using age- and gender-speciﬁc mean HRQoL
scores, but does not incorporate an additional mediating effect of physical activity on either the onset or
the severity of non-fatal diseases. As such, it is similar in its approach to the economic model developed by
Brennan and colleagues.135 The Brennan and colleagues’ model uses work by Andersen and colleagues75
to map physical activity levels onto relative mortality risks, whereas this model uses work by Myers and
colleagues for the same purpose.81 Both mapping exercises indicate qualitatively similar relationships
between physical activity and relative mortality risk, suggesting that the greatest beneﬁt of a given increase
in physical activity is likely to be in people who are the most sedentary and that the marginal beneﬁt of
additional physical activity is less in people who are already relatively physically active.
The report by Brennan and colleagues135 contains a review of existing papers on the cost-effectiveness of
physical activity interventions, as well as a brief review of existing model frameworks. Readers are directed
to this publication for further information.
The economic model in this report does not yet directly consider the relationship between physical activity
levels and morbidity risks. Morbidity is indirectly handled through the changing mortality risk ratios and
also by adjusting HRQoL scores for age and gender (e.g. because of differences in disease burden at
different ages). However, speciﬁc disease states are not considered in the model. A further iteration of the
model could consider the additional cost and utility implications of different diseases by modelling annual
probabilities of developing particular conditions and combining these with RR modiﬁers related to physical
exercise levels. In theory, a physical activity intervention could then appear cost saving if the additional cost
of the intervention is outweighed by the additional reduction in NHS resource use costs as a result of a
reduced burden of disease. An important example of such a disease would be type 2 diabetes mellitus,
whose onset is known to be linked to lifestyle factors and whose treatment represents a signiﬁcant and
increasing annual cost to the NHS.136
Given the complex array of mediators and moderators involved in translating changes in physical activity
into changes in mortality and morbidity risks, HRQoL and NHS resource use over the short, medium and
long term, it is important that economic models are based on a solid clinical and epidemiological
foundation. Models should incorporate current expert opinion on how physical activity interventions lead
to sustained changes in lifestyle behaviour and through this to changes in health-related utility and costs,
as well as the range of other mediating and moderating factors that need to be taken into consideration
so that the model represents the patient experience with sufﬁcient accuracy. The paths of causal inﬂuence
linking individual- and ecological-level factors to short-term and long-term mortality and morbidity risks
should be established through extensive consultation with clinical experts and used to establish ﬂexible
public health models that can be used to consistently model a wide range of interventions affecting
different parts of the aetiological pathways. This process of attempting to understand the clinical and
epidemiological consensus in understanding causal processes could be used to form directed acyclic graphs
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and inﬂuence diagrams, which can be used as the basis for economic models.137 When it is identiﬁed that
consensus between clinical experts does not exist with regard to certain causal pathways, the effect of
different structural assumptions could be explored by constructing separate models that reﬂect alternative
clusters of opinion.
Implications for practice and commissioning
The uptake of both the brief intervention and the booster intervention suggests that the potential impact
on population-level change of these types of recruitment approaches and interventions is limited. The
overall ﬁndings suggest that neither the mini booster nor the full booster is likely to be an appropriate
population-level approach to promote physical activity in middle-aged populations in deprived areas. Better
integration in local primary care services, such as GP clinics and IAPT (Improving Access to Psychological
Therapies) programmes, might yield improved take-up and results, although even with better integration
these types of interventions are unlikely to enable sufﬁcient throughput of participants to have the reach
of a true public health intervention.
The qualitative research component identiﬁed large numbers of people who wished to maintain physical
activity levels in the hope of managing chronic disease symptoms. In particular, those with mental health
issues (depression and anxiety) expressed a belief that physical activity would provide symptom relief,
although the same people were often exercising alone in private spaces, were unenthusiastic about doing
so and reported problems maintaining exercise levels. The social element of exercise may mediate some of
the mental health beneﬁts and those making exercise referrals should be aware of this. The needs of people
with long-term injuries are different again; these people are typically seeking highly tailored exercise advice
to suit their physical abilities. Referrers and advisors should be sensitive to these diverse needs.
The duration of both the mini booster and the full booster was approximately 30 minutes, which is more
akin to a ‘brief’ MI session. Longer MI sessions have been found to be more effective and therefore a
greater response might be expected from a higher dose, similar to the ﬁndings in contexts in which MI is
more commonly applied, such as addictions settings and behaviour adoption (e.g. smoking and alcohol).97
Although the current trial attempted to provide an ecologically valid intervention period, delivering a
bespoke, person-centred intervention in this time frame that explored and set the client agenda, managed
resistance and ambivalence and set appropriate goals with effective relapse prevention strategies was
challenging, and delivering a greater number of sessions would be a realistic mechanism for managing this
in the future. It is unlikely that delivering a greater number of sessions would be possible within existing
care pathways, although the Let’s Get Moving programme59 proposes more than two sessions.
Face-to-face contact was more acceptable than telephone contact. More evidence is needed on relative
costs and effectiveness as the results of this trial suggest that neither intervention is cost-effective at
conventional levels of statistical signiﬁcance and willingness-to-pay threholds. At present, PARSs are being
decommissioned by a large number of primary care providers and their local council partners. PARSs
provide a face-to-face physical activity promotion intervention that typically consists of up to 12 practical
sessions, although not all of these are delivered on a one-to-one basis. Currently, the preferred option for
physical activity promotion within the NHS is Let’s Get Moving, which involves multiple one-to-one
contacts regarding physical activity that are either integrated into existing health-care contacts or delivered
by the primary health-care team as standalone appointments.59 This is arguably a cheaper way of
delivering an intervention. It does, however, rely on individuals initiating contact with a member of their
health-care team who is trained to provide the intervention.
Some people seemed to like the MI approach but others seemed to want, or had expected, a more
didactic delivery approach. On the surface this seems counterintuitive and is at odds with the premise
that MI can foster intrinsic motivation, which is linked to longer-term maintenance of activity, whereas
more didactic advice-giving approaches would provide extrinsic motivation for being active. Many
people we interviewed appeared to be extrinsically motivated, with few expressing thoughts about
exercising for enjoyment, despite using a maintenance intervention designed to foster intrinsic motivation.
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This may be related to participants’ stage of readiness to be regularly active. Those in a less advanced
stage such as contemplation or preparation (or even action) may be becoming active for extrinsic reasons
such as to lose weight or improve health; a true appreciation of and desire for physical activity for its own
sake may not come until individuals have been active for some time and entered the maintenance stage of
behaviour change. By deﬁnition, the participants in this study have become active only in the 3 months
preceding the delivery of the booster intervention and are therefore still in the action stage. Thus, although
there is a focus on MI and related interventions that emphasise building intrinsic motivation for physical
activity in the ﬁeld of exercise psychology, it is possible that many people who have only just started to
become more active may prefer to be told what they should be doing or participate in an exercise class.
It is also possible that other differences aside from motivational style may inﬂuence people’s preference for
a certain delivery approach. Whatever the reason, the implication here is that delivery of physical activity
promotion should involve some form of assessment to ascertain each person’s preferred approach and
then a relevant style of delivery should be selected from a toolkit of approaches.138,139
The monitoring and feedback elements of the intervention were identiﬁed as important motivators by
participants. However, this may be another indicator of the prevalence of extrinsic motivation amongst
these participants, and psychological theories of behaviour change suggest that extrinsically (rather
than intrinsically) motivated behaviour change might impact negatively on the sustainability of the
treatment effect.
The role of a professional has traditionally been seen as one of diagnosis and prescription for both
pharmacological and behavioural interventions. In recent years, this has given way to a more inclusive
person-centred approach, which challenges the individual, with empathy, to take a more active role in
their behaviour change. The focus of more health practitioner sessions, also described as a ‘directive
approach’, can resolve people’s resistance to change.140 However, the process evaluation suggested that
some people have concerns about the client centeredness of MI consultations (see Chapter 4, Motivational
interviewing: consistency with perspectives or world views). As in other studies involving low
socioeconomic status groups, some of our participants said that they had hoped for more paternalistic and
didactic communication approaches.63 Although autonomy-supported communication is understood to
enhance intrinsic motivation (whereas paternalistic approaches diminish it), it has been suggested that MI
can be adapted to suit client communication preferences.63–65 Therefore, if the motivational interviewer
becomes aware that the client would prefer a more didactic approach, the consultation can be directed
towards that need. This ‘way of being’ with the client is a key part of skilful MI and a ﬂexible and adaptive
approach is an important part of challenging with empathy in a bespoke manner.
The process evaluation also suggested that two key motivators for adherence to physical activity targets
are the anticipated shame, when face to face with a professional monitor, if one does not achieve the
agreed objectives, and the pleasure of receiving feedback on one’s performance (see Chapter 4, The
importance of monitoring and feedback). Different methods of feedback are the subject of the Feedback,
Awareness and Behaviour (FAB) study (ISRCTN92551397; funded by the National Institute for Health
Research programme).141 The FAB team aims to randomly allocate 500 people aged 30–55 years to either
a control group (no feedback) or one of three types of personalised physical activity feedback (‘simple’,
‘visualised’ or ‘contextualised’) and complete repeat measures of self-rated physical activity and
psychosocial correlates.
One concern for physical activity promotion and ongoing patient behaviour change support is that there
is no clear pathway for physical activity promotion at the moment in the UK. Current provision is limited
to GP advice to individual patients to become active or, at best, referral to a PARS. Although other
community-based interventions such as ‘green gyms’ and walking programmes do exist, these are rarely
integrated into the care pathway. The traditional approach to physical activity promotion delivered in
health-care settings is one of information exchange, which can often be seen as provision of unsolicited
advice. In 2009, the Department of Health launched Let’s Get Moving59 to be delivered by health-care
professionals and complement the PARS. Let’s Get Moving is physical activity counselling intervention
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based on MI principles and designed to be delivered by health-care professionals within usual care
settings. Early research questioned the feasibility of using Let’s Get Moving in a primary care setting.82,142
Materials have recently been revised and were relaunched in March 2012. Aside from referral to a PARS
and Let’s Get Moving, there are some nurse practitioners who do deliver diet and exercise counselling
within primary care. This provision, however, is variable by nurse and practice.
It is therefore essential that local strategies for physical activity promotion and local commissioning by
clinical commissioning groups and local authorities is in future informed by the wider evidence base in
relation to the broad range of potential community and individual interventions. As resources are limited
and the potential for population beneﬁts large, a systematic approach, prioritising the most cost-effective
interventions and targeting the groups with the greatest baseline risk and ability to beneﬁt from supportive
interventions, is required.
Implications for future research
The process evaluation suggested that some participants were confused about the initiation and
maintenance components and also between data collection and delivery of the intervention. They often
seemed to perceive that the data collection sessions were part of the intervention and a source of support
and there is therefore a need to be aware of a Hawthorne effect, which will inﬂuence participant
behaviour and therefore both self-reported and objectively measured primary outcomes. Future research
should ensure that clear goals, and the agenda for speciﬁc sessions, are discussed and agreed with the
participants. When baseline information is required this has a different role (unless part of normative
feedback) and should be treated accordingly in the session. Therefore, future interventions should clearly
deﬁne (and report) the content of the intervention so that aspects such as agenda setting, exploring pros
and cons of change and action planning or information exchange are systematic and meaningful.
Because some participants seemed to like the MI approach whereas others seemed to expect or prefer a
more didactic approach, future research could investigate the impact of people’s intervention style
preferences (i.e. didactic information giving vs. MI) on the effectiveness of a physical activity maintenance
intervention. A suitable comparison might be to examine preferred style compared with not preferred style
(compared with the control).
There is a clear need to ensure that counselling interventions such as MI are delivered as intended and that
the content and approach are accurately reported. Recent studies have explored the potential use of
integrating MI and cognitive–behavioural therapy to form physical activity interventions and unless a clear
description of the components of interventions are clearly stated it is difﬁcult for practitioners to adapt and
embed such approaches when they are shown to be efﬁcacious in research settings. Until studies have
demonstrated that an intervention is consistently delivered and internal validity is gained, it is not possible
to infer accurately its likely efﬁcacy in increasingly varied contexts.
Our research suggests that correlation between activity questionnaires and accelerometer data is poor (see
Chapter 3, Effectiveness of the mini booster intervention compared with the full booster intervention at
3 months, and Chapter 4, The prevalence of optimistic self-assessment), a phenomenon that has been
noted previously in the peer-reviewed literature.143 This might be an indication of social desirability bias,
the tendency to answer questions in a fashion that will be viewed positively by others. Social desirability
has been found to bias self-reports of diet and physical activity and some research teams recommend
methods to measure and control for social desirability bias when self-report questionnaires are used.144,145
In Chapter 4 (see The prevalence of optimistic self-assessment) we reviewed claims of large amounts of
moderate to vigorous physical activity when 7-day accelerometry data showed low levels of physical
activity across the week. Nicaise and colleagues143 make the point that, although low-income Latinas often
over-report the amount of moderate to vigorous activity carried out (compared with accelerometry results),
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they do substantial amounts of light-intensity activity. Healy and colleagues146 have suggested that
light-intensity physical activity is associated with improved glycaemic control that is independent of the
amount of moderate and vigorous physical activity carried out. Researchers and policy-makers may need to
adjust unreasonable expectations of those who are constrained by motivational, physical, social or
environmental factors; for such people, reducing sedentary behaviour and increasing low-intensity activity
may be both appropriate and clinically important.
DISCUSSION
100
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Chapter 9 Conclusions
Although some individuals do ﬁnd a community-based, brief MI ‘booster’ intervention supportive, thelow levels of recruitment and retention in this trial and the lack of impact on objectively measured
physical activity levels in those with adequate outcome data suggest that it is unlikely to represent a
clinically effective or cost-effective intervention for the maintenance of recently acquired physical activity
increases in deprived, middle-aged, urban populations.
The gap between the size of the sedentary population who could achieve signiﬁcant long-term health
beneﬁts from relatively small but sustained increases in physical activity levels and the numbers taking up
the offers of both the initial brief intervention and the subsequent ‘booster’ interventions suggests that this
type of MI-based approach will be appropriate only for a minority of the sedentary population who could,
in principle, beneﬁt from being more physically active. Other approaches that require less proactive (and
potentially time-consuming) engagement from individuals, including environmental interventions to
encourage active travel and recreational activity, may be particularly important for deprived communities
and middle-aged populations who are less likely to prioritise their own physical ﬁtness and well-being over
other demands on their time and resources.
Many types of physical activity interventions can exacerbate health inequalities because they are more
likely to be taken up, and subsequent behaviour change achieved and maintained, by those who are
already active and those in better health. The booster study was therefore explicitly designed to target
recruitment in communities that were known to have poorer health outcomes. The lessons learnt in
undertaking this trial should inform both the design of future physical activity intervention trials and the
development of more effective interventions that not only are feasible and affordable but also will have
sufﬁcient reach to have an impact in the most deprived and most sedentary populations who could beneﬁt
most from sustained increases in their physical activity levels.
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Appendix 1 Protocol
Booster Study
A randomised controlled trial and cost-effectiveness evaluation of ‘booster’ interventions to sustain
increases in physical activity in middle-aged adults in deprived urban neighbourhoods.
RESEARCH PROTOCOL (Version 05) 09 March 2011
University of Shefﬁeld (Sponsor) 120243
Shefﬁeld CTRU J07-012
HTA 07/25/02
IRAS 08/H1308/270
Authorised by: Liddy Goyder
Shefﬁeld Clinical Trials Research Unit (CTRU)
A randomised controlled trial and cost-effectiveness evaluation of ‘booster’ interventions to sustain
increases in physical activity in middle-aged adults in deprived urban neighbourhoods.
Booster Activity Trial
This document describes a clinical trial, and provides information about procedures for entering
participants. The protocol is not intended for use as a guide to the treatment of other patients.
Amendments may be necessary; these will be circulated to known participants in the trial.
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Abbreviations
A&E Accident and Emergency
ANCOVA Analysis of Covariance
BMI Body Mass Index
BREQ-2 Behavioural Regulation in Exercise Questionnaire
CONSORT Consolidated Standards of Reporting Trials
CI Conﬁdence Interval
CTRU Clinical Trials Research Unit
DMEC Data Monitoring and Ethics Committee
EXERT Exercise Evaluation Randomised Trial
GCP Good Clinical Practice
HRQoL Health Related Quality of Life
HTA (National Institutes for Health Research) Health Technology Assessment programme
IMD Index of Multiple Deprivation
MI Motivational Interviewing
NICE National Institute for Health and Clinical Excellence
QALY Quality-Adjusted Life Year
RA Research Assistant
ScHARR School of Health And Related Research
SD Standard Deviation
SF-12v2 plus 4 16-item Short Form Health Survey of the Medical Outcomes Study
SF-6D Short Form Health Survey – 6 Dimensions
SMART Speciﬁc, Measurable, Achievable, Realistic, Time-related goals
SPAQ Scottish Physical Activity Questionnaire
TMG Trial Management Committee
TSC Trial Steering Committee
TTM Trans-Theoretical Model
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Trial Summary
This study assesses whether it is worth providing further support, 3 months after giving initial advice, to
those who have managed to do more physical activity. All participants will initially be given an interactive
DVD, supported by advice from a trained facilitator. The facilitator will provide two telephone follow ups at
one month intervals. Only those that have increased their physical activity at this point will remain in the
study. These participants will receive a ‘mini booster’, a ‘full booster’ or no booster. The ‘mini booster’
consists of a two telephone calls one month apart to discuss physical activity and usage of the DVD. A ‘full
booster’ consists of a face-to-face meeting with the facilitator at the same intervals. The purpose of these
booster sessions is to help the individual to maintain their increase in physical activity. We will measure the
differences in physical activity, quality of life and costs, associated with the booster interventions, 3 months
and 9 months from randomisation. The research will be carried out in 20 of the most deprived
neighbourhoods in Shefﬁeld. These locations have large, ethnically diverse populations, high levels of
economic deprivation, low levels of physical activity, poorer health and shorter life expectancy. Participants
will be recruited through general practices and community groups, as well as by postal invitation to ensure
the participation of minority ethnic groups and those with lower levels of literacy. Shefﬁeld City Council
and Primary Care Trust fund a range of facilities and activities to promote physical activity and variations in
access to these between neighbourhoods will make it possible to examine whether the effectiveness of the
intervention is modiﬁed by access to community facilities.
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Adults aged 40 – 64 offered brief intervention (n ~ 30 000) via post,
GP surgery or community groups - asked to return postcard with
age/sex/ethnicity/preferred language and contact telephone number
Respondents contacted by facilitator by telephone, baseline
physical activity assessed and offered brief intervention
(DVD and telephone follow-up ×2) (n ~ 1500) (At minus 3 months)
After 3 months repeat physical activity assessment by telephone.
If increased, eligible for participation in trial (n ~ 900)
Enrolment: obtain fully informed consent.
First face-to-face meeting for baseline (pre-booster) assessment of outcome measures
Randomised at baseline
(n = 600)
Excluded if no increase in activity or
unwilling/unable to participate further
or have further contacts with facilitator
(n ~ 300)
Excluded if already meeting activity
guidelines, if limited by chronic
ill-health, if unable or unwilling to
participate (n ~ 600)
Allocated to "mini-booster" at 1 and
2 months from randomisation
(n = 200)
Allocated to no booster (n = 200)
Allocated to "full booster" at 1 and
2 months from randomisation
(n = 200)
3-month follow-up (face to face
assessment) (n ~ 150)
3-month follow-up (face to face
assessment) (n ~ 150)
3-month follow-up  (face to face
assessment ) (n ~ 150)
9-month follow-up (face to face
assessment) (n ~ 140)
9-month follow-up (face to face
assessment) (n ~ 140)
9-month follow-up (face to face
assessment) (n ~ 140)
Introduction
Rationale
There are a number of published systematic reviews of evidence for interventions that increase physical
activity.1–5 More recently the evidence base for brief interventions in primary care has been reviewed.6
This review identiﬁed a sufﬁcient evidence base for NICE to recommend the use of brief interventions to
promote physical activity but also identiﬁed speciﬁc evidence gaps that this trial will be able to address,
particularly in relation to the value of follow up beyond three months, for the longer term maintenance of
physical activity.
Searches of the National Research Register and ClinicalTrials.gov for research in progress conﬁrm that
although there are a number of physical activity intervention trials in progress in speciﬁc patient groups
and in older age groups or in children, there are few trials including ‘healthy’ middle-aged participants
and no other trials speciﬁcally examining the value of further intervention after an initially successful
‘brief intervention’.
Investigational interventions
The trial will compare a ‘mini booster’ of two telephone physical activity consultations and a ‘full booster’
of two face-to-face physical activity consultations, offered four and ﬁve months after an initial brief
intervention, to a standardised three month brief intervention alone. The purpose of these booster sessions
is to help participants to sustain their physical activity levels and prevent relapse. The brief intervention will
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involve provision of an interactive DVD based on a MI approach that is directive, client-centred and
replicates the style of other successful behaviour change programmes.7,8 All interventions, including the
initial brief intervention, will be delivered by trained facilitators (employed as research assistants and
trained by the research team) to ensure consistent delivery.
Theoretical underpinning of interventions
Meta-analytical and systematic reviews of physical activity and behaviour change9,10 suggest that the
transtheoretical model (TTM)11 is the most commonly adopted theoretical framework for promoting
physical activity. The TTM has demonstrated effectiveness as an approach to increasing exercise adoption
and adherence in adults.10,12–14 The TTM describes how people modify problem behaviours or acquire
positive new ones.11,15,16 The TTM determines behaviour change as a process rather than a single event
and offers practical suggestions for how individuals can change behaviour. The TTM consists of the
following constructs: stages of change (describes when people change), processes of change (outlines
techniques for helping people to change), decisional balance (weighing up the pro’s and con’s of change)
and self-efﬁcacy (increasing one’s conﬁdence to change behaviour).11 The TTM offers practitioners a
common, validated framework for guiding participants through periods of change and proposes strategies
for maintaining positive behaviours. We will also adopt a client centred approach to all interventions based
upon the style of motivational interviewing.
Motivational Interviewing and its use in promoting physical activity
Motivational interviewing (MI) is a directive, client-centred counselling style for eliciting behaviour change
by helping clients to explore and resolve ambivalence.17 Motivational interviewing has been used in many
settings and ethnic groups and meta-analysis suggests effect sizes from motivational interviewing-based
interventions are larger in ethnic minority populations.18 A MI approach has been shown to impact
positively on lifestyle and health outcomes including physical activity behaviours in adults.18–21 MI has been
applied in a number of formats including technology-based, such as internet and video,7,8,22,23 telephone24
and face-to-face consultations.19 An example of a technology-based intervention adopting an MI approach
is The Drinker’s Check-up.7,8,23 The Drinker’s Check-up offers a comprehensive assessment of the client’s
drinking and related behaviours. A key element of the programme is providing feedback that matches the
user’s individual circumstances, motivational readiness and conﬁdence for changing their behaviour.
Justification of use of interactive DVD:
The use of video format in the promotion of physical activity has been shown to increase self-reported
physical activity,25–27 positively inﬂuence user engagement and self-efﬁcacy and yield health beneﬁts in
low-income populations.28,29 Survey data reveals that at least 80% of adults aged 35–64 own a DVD
player.30 Furthermore, 84% of households classiﬁed as ‘hard pressed’ (which includes: inner city adversity,
high rise hardship, burdened singles, struggling families, ACORN classiﬁcation, 2007) own a DVD player.
The DVD clearly represents an opportunity to reach a wide audience, at relatively low cost, using a
medium that is familiar and accessible. We will ensure participants without home access to a DVD player
have community access by arranging that DVD players are provided and accessible in community venues
including neighbourhood centres, libraries and GP surgeries. The content of the DVD has already been
developed based on existing materials already used for face-to-face interventions and the ﬁrst phase of the
trial will include translation, production, and piloting of the DVD. This potentially offers a very cost-
effective way to promote change and utilises technology that will already be familiar to most participants.
Practical support with using the DVD will also be available from local library staff in libraries where the
DVD can be played on public access computers.
Content of the Brief Intervention (Interactive DVD and telephone follow up)
Consistent with NICE guidance on physical activity interventions, the brief intervention will aim to help
middle age adults consider, initiate and maintain physical activity behaviours.6 The DVD represents an
interactive tool that is based on the style of motivational interviewing and the principles of the TTM. The
DVD offers individuals the opportunity to choose information on the following: the beneﬁts (social, health,
environmental) of physical activity; current physical activity recommendations; things to consider before
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starting; different types of physical activity; building conﬁdence and efﬁcacy to become physically active;
myths and misconceptions about physical activity; staying motivated; sign-posting of opportunities to be
physically active in Shefﬁeld/South Yorkshire and example case studies.
Compliance with NICE guidance and UK practice
A. NICE Physical Activity Guidance (March 2006)6
‘identify inactive adults and advise to aim for 30 minutes of moderate activity on 5 days of the week (or
more)’. The DVD will allow individuals to assess their own physical activity relative to current physical
activity recommendations that will be provided on the DVD. Information will be provided that will help
individuals to understand what is meant by ‘active’ and ‘moderate intensity’.
‘When providing physical activity advice, primary care practitioners should take into account the
individual’s needs, preferences and circumstances. They should follow them up at appropriate intervals
over a 3 to 6 month period’. The DVD offers trainers a tool to support individuals in making healthier
lifestyle choices regarding positive change in physical activity. The DVD is theoretically underpinned by the
Trans-theoretical model of behaviour change and the Theory of Planned Behaviour – which both place
emphasis upon the individual considering their perceived behavioural control, subjective norms and
attitudes when initiating behaviour change – such as increasing physical activity. The DVD asks the
individual to reﬂect upon their individuals needs, preferences and circumstances and this is done within an
evidence-based stage matched approach – meaning that greater emphasis will be placed on those factors
(such as circumstances and needs) that mediate behaviour change at the early stages of change adoption
(pre-contemplation) and factors that mediate sustaining the new behaviour such as reinforcement
management that will be more salient for those individuals who have already decided to take action but
need help to implement change.
‘Practitioners should agree goals with them’. Goal setting, what it means and examples of goal setting for
physical activity will be given in the DVD. This will put the potentially abstract theory of goal setting into a
real life context. Appropriate language will be used to facilitate understanding and relevance.
‘They should also provide written information about the benefits of activity and the local opportunities to
be active’. The DVD will provide a comprehensive list of physical activity opportunities within the Shefﬁeld
area with contact details. These will include activities that have already been found to be popular with
minority ethnic groups eg. dance activities.
‘Local policy makers, commissioners and managers, together with primary care practitioners, should pay
particular attention to the needs of hard to reach and disadvantaged communities, including minority
ethnic groups, when developing service infrastructures to promote physical activity.’ The information given
within the DVD will have been discussed with local ethnic minority community groups to ensure it is
culturally and contextually appropriate. The local strategic partnership will be consulted about current
service provision for disadvantaged and ethnic minority groups.
B. NICE Behaviour Change Guidance (October 2007)31
‘Employ a range of behaviour change methods and approaches, according to the best available evidence.
These concepts could be used to structure and inform interventions.’ Action planning, implementation-
intention action plans, promoting user autonomy, providing tips and practical strategies to develop
physical activity self-efﬁcacy, adopting a client centred approach, information giving, expert based advice,
peer modelling, engaging in reﬂective tasks, contingency planning are all features of the DVD intervention
that comply with the list of concepts that are advocated by NICE to structure behaviour change
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interventions. Through engagement with the DVD, individuals will be able to devise their own personal
physical activity plan, understand the beneﬁts of physical activity, be given information regarding safe
physical activity, how to monitor intensity, myths about activity, information re the difference between
activity for health and ﬁtness.
‘It should be taken into account behaviour is embedded in social, cultural & material circumstances.’ The
complexity of an individual’s personal circumstances, their socioeconomic and cultural context and their
interactions with health behaviours will be considered in the content of the DVD and in ensuring
associated advice is realistic and culturally appropriate.
Compliance with pragmatic practice
The brief intervention will be delivered as part of the local strategy for promoting physical activity in
more deprived neighbourhoods within the Enhanced Public Health Programme which is based on a
comprehensive needs assessment and targets speciﬁc neighbourhoods with poorer health outcomes. The
use of DVDs is in line with the strategic approach and methods developed locally by Active Shefﬁeld and
supported by the partnership of bodies that deliver support for increasing physical activity across Shefﬁeld.
Use of DVDs is already being introduced in other areas with anecdotal success but without systematic
evaluation. Health First, the specialist health promotion agency for Lambeth, Southwark and Lewisham,
has recently produced a DVD designed to promote physical activity. This DVD includes similar content to
that in our proposed intervention, tailored for a local population. The DVD ‘Choosing Physical Activity’ is in
the public domain and can be viewed using http://video.google.co.uk.
The main reasons for not using existing community or primary care practitioners to deliver an initial brief
intervention were both to ensure ﬁdelity to the intervention protocol (so an ineffective intervention can be
distinguished from inadequate delivery of an effective intervention) and also because in practice, if the
intervention is effective and introduced into practice, it will need to be delivered consistently and efﬁciently
across a large population with capacity to beneﬁt by a range of health trainers and other community staff
as well as primary care staff. The proposed DVD has the potential to reach a wide targeted audience at
minimal cost compared to a one to one based intervention with a health professional.
Content of the Full Booster:
The full booster will comprise two 20–30 minute face-to-face physical activity consultations that aim to
promote and sustain change in physical activity status. The full booster sessions will take place in
community venues. The consultation will be underpinned by the principle of the TTM15 and replicate a
brief version of motivational interviewing based on a method designed for time limited consultations in
medical settings.32 Such an approach has been successfully employed to change health-related behaviours
previously.33 This approach also mirrors that adopted by the health trainer initiative which provides a
current model of face-to-face promotion of healthy behaviours. For the Full booster, a menu of
six strategies has been developed32 to guide the 30-minute consultation. Each strategy is suitable for
participants who are in the maintenance stage of motivational readiness for physical activity behaviour
change. They are:
l Assessment of motivation and conﬁdence for maintaining physical activity
l Increasing knowledge of the beneﬁts of physical activity; awareness of the risks of a sedentary lifestyle;
increasing awareness of physical activity opportunities; increasing awareness of the current
recommendations for physical activity
l Increasing conﬁdence to be physically active – self-efﬁcacy
l Goal setting and tracking using SMART (speciﬁc, measurable, achievable, realistic, time-related)
goal principles
l Strategies for staying motivated
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l Relapse prevention strategies
¢ During the full booster consultations, strategies will be worked through at a pace dictated by the
participant and the menu used to structure information exchange without being prescriptive.
Content of the Mini Booster:
Although face-to-face interventions have been found to be efﬁcacious in promoting physical activity,33
many of the barriers associated with this approach, including time and ﬁnancial costs, highlight the need
for pragmatic alternatives that are both relatively cheap to deliver and may make it easier for the
participant to access the intervention. The Mini Booster will consist of two 20-minute telephone based
physical activity consultations. The telephone consultation will follow the same menu of six behaviour
change strategies as the Full Booster (outlined above) and aim to promote and sustain change in physical
activity status. A number of studies using telephone support for physical activity in older adults have been
carried out.3,34 A telephone based approach has been effective in increasing physical activity participation
at six months compared to no telephone support35 and has also been shown to increase physical activity
participation to a greater extent than standard reading materials in adult populations.34 The telephone
consultations will follow a script of known efﬁcacy that has been implemented in previous physical activity
promotion studies delivered by members of this research team.
Quality assurance:
The proposed interventions will adhere to an intervention ﬁdelity framework based on the Behaviour
Change Consortium.36 This framework provides quality assurance parameters based on the intervention
design, training, delivery, receipt and enactment. Further detail of this can be found elsewhere.36 A recent
review has highlighted inconsistent delivery and levels of competence of physical activity interventionists
reporting to deliver a physical activity counselling components37 and it has been suggested that the
effectiveness of behaviour change counselling is predicted by the length, the intensity, the content of
interventions and the competence of the deliverer.38 The sessions will therefore be delivered by a team of
four research assistants trained in MI and behaviour change techniques and assessed to ensure their
competency. A framework will be developed for each session to ensure consistency of advice across
sessions and between participants. All research assistants (RAs) will be trained (by JB, HC and RC) using a
training package and a detailed manual to ensure standardised delivery of the booster interventions. All
booster interventions will be audio-recorded. A random selection of 5% of all booster consultations
(20 telephone and 20 face-to-face) will be reviewed and assessed by an independent clinical psychologist
(LJ) using a pre-determined check list. The RAs will be provided with individual feedback if required, to
ensure intervention ﬁdelity is maintained.
Population
Men and women aged between 40 and 64 who have increased their physical activity by at least
30 minutes per day.
This trial will be conducted in compliance with the protocol, GCP and regulatory requirements.
Aims and objectives
The overall aim is to measure the effectiveness and cost effectiveness of ‘mini’ and ‘full’ booster sessions,
as an adjunct to a brief intervention, in sustaining physical activity in middle-aged adults.
Primary objective
To determine whether physical activity measured by accelerometry three months after randomisation
(six months after a brief intervention) is signiﬁcantly increased in participants allocated to two intervention
groups (receiving two booster physical activity consultations, delivered in a motivational interviewing style,
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either by telephone or face-to-face) compared to participants allocated to a control group (receiving no
further contact after the baseline assessment).
Secondary objectives
1. To determine whether physical activity nine months after randomisation (12 months after the brief
intervention) is signiﬁcantly increased in participants allocated to the two intervention groups compared
to participants allocated to the control group.
2. To compare physiological measures of ﬁtness (12 minute walk test) and self-reported physical activity
(SPAQ instrument) between allocated groups.
3. To compare health related quality of life, resource use (including health and social care contacts) and
economic costs between allocated groups.
4. To investigate whether the impact of the intervention may be modiﬁed by gender, ethnicity or the types
of physical activity undertaken (including use of community facilities for physical activity).
5. To undertake a process evaluation to identify, using both quantitative and qualitative methods,
psychosocial and environmental factors that may mediate or modify the effectiveness of
the intervention.
Trial Design
Design
This is a three-arm, parallel group, randomised controlled trial with a feasibility study.
Feasibility study
In the ﬁrst year a pilot trial will be undertaken to assess the feasibility of both trial recruitment plans and
the proposed interventions39,40. A total of 3000 mailshots will be sent to the patients of a general practice
situated in a ‘typical’ deprived ward (Manor Ward), at least 150 will receive the brief intervention and
60 randomised to the three trial arms. This will allow outcome measurement in 15–20 individuals in each
study arm to estimate a mean and standard deviation for the primary outcome, total energy expenditure
per day (averaged over a 7-day accelerometry assessment period in each group using the Actiheart
Device). The main risks to trial success identiﬁed by reviewers that the feasibility trial will test are:
1. Recruitment targets for the brief intervention will not be met;
2. The brief intervention will not be effective enough to generate sufﬁcient individuals eligible for the trial;
3. Insufﬁcient eligible individuals will consent to participate in the trial.
These three issues in combination will determine whether the trial recruitment rate is adequate.
The success criteria for the feasibility study will therefore be:
A. At least 60 patients recruited to the pilot trial and 45 having 3 month follow-up measurements
including accelerometry completed on the basis of an initial mailshot to 3000 individuals. (We will not
use community recruitment at this stage since it may represent a more limited pool for recruitment that
we can use to booster participants from ‘hard-to-reach’ groups as required in the main trial)
B. At least 70% of those randomised to booster interventions actually receiving the interventions
per protocol
C. On the basis of the pilot primary outcome (accelerometry) data collected, the sample size for
the main trial will be re-calculated. The trial will not proceed if the revised sample size calculation
suggests a total sample size > 600 will be required. Assuming the protocol and intervention
remain unchanged, the participants recruited during the feasibility phase will be included in the full
trial population.
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Main trial
The trial participants will be recruited from the 20 most deprived neighbourhoods of the city
of Shefﬁeld, based on Index of Multiple Deprivation (IMD) 2004 and health indicators. Average life
expectancy is six years lower in lowest versus highest quintile of IMD (based on data from
www.neighbourhoodstatistics.gov.uk). Up to 30 000 middle-aged residents, (aged 40 to 64 years at
recruitment), will be invited to participate in a brief intervention to help them get more physically active.
Up to 1500 residents who respond to the invitation will receive an initial assessment telephone call to
determine their physical activity status. Eligible participants (i.e. those not already meeting current
recommendations of 30 minutes moderate activity, 5 times a week) will then receive an interactive DVD
and supporting written materials through the post. Follow up telephone contacts will be made one month
and two months from initial contact. Active Shefﬁeld, the organisation responsible for promoting physical
activity in Shefﬁeld, will ensure participants have access to a range of community facilities for exercise and
will provide regularly updated information on current provision.
After three months, the Study Introduction letter will be sent to all DVD recipients and a further telephone
assessment will establish whether they are eligible to participate in the booster trial (i.e. have increased
their activity by at least 30 minutes per week and are willing to have further assessment and follow up).
Eligible participants will then be invited to attend a baseline assessment appointment at a community
venue and they will be randomly allocated to one of three groups:
1. a control group who will be assessed at randomisation, after three months and after nine months and
receive no additional intervention between those assessments;
2. a ‘mini booster’ group also receiving an intervention comprising two telephone-based physical activity
consultations, delivered in a motivational interviewing style, at one month and two months
from randomisation;
3. a ‘full booster’ group also receiving an intervention comprising two face-to-face physical activity
consultations, delivered in a motivational interviewing style, at one month and two months
from randomisation.
Written consent to trial participation will be obtained at the start of the trial baseline assessment meeting.
All randomised participants will be assessed at baseline, 3 months and 9 months from randomisation
(i.e. 3 months, 6 months and 12 months from the initial contact for the brief intervention). Where
possible, staff conducting assessments will not know participants’ group allocation and participants will be
asked not to tell them.
Endpoints
1. Objective measure of physical activity including:
– Total Energy Expenditure (TEE), in Kcal per day, from seven-day accelerometry and heart rate
monitoring using Actiheart
– Physical activity counts (PAC) per week;
– Minutes of moderate/vigorous physical activity per day;
– Meeting the current physical activity recommendation of at least 30 min per day (continuous or in
bouts of at least 10 min] of at least moderate intensity) for at least 5 days a week (yes or no).
2. Self-reported moderate or strenuous physical activity using the Scottish Physical Activity Questionnaire
(SPAQ) which records type and duration of activities in the previous week;
3. Health-related quality of life using the Shefﬁeld Version of the 16-item Short Form health survey
instrument (SF-12v2 plus 4);
4. Self-reported use of community facilities for physical activity;
5. Self-reported health and social care contacts;
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6. Psychological measures of motivation, intentions, attitudes, beliefs, social inﬂuences and self-efﬁcacy
towards physical activity, measured using the Theory of Planned Behaviour.41 Exercise stages of
change42, and self-determination will be assessed using Behavioural Regulation in Exercise
Questionnaire43 and questions used in the HTA-funded Exercise Evaluation Randomised Trial (EXERT).44
This will allow comparison with results from other physical activity trials including EXERT.
7. Body weight and height (to allow calculation of BMI)
8. Physiological measures of ﬁtness (12 minute walk test)45
Design measures to avoid bias
The allocation schedule will be concealed through the use of a centralised web-based randomisation
service. The randomisation sequence is computer-generated. Data analysts will be blind to treatment
allocation, but the study manager, participants (who are also outcome assessors) will not be blinded.
Analysis will be by intention-to-treat. Where individuals are lost to follow-up or data is missing, imputation
methods will be employed, which will be described in the statistical analysis plan.
Randomisation codes and allocation concealment
The randomisation schedule is generated prior to the study by the Clinical Trials Unit Randomisation
Service. On identiﬁcation of an eligible volunteer, the study manager or data manager will randomise and
inform the patient and their general practitioner on the treatment allocation.
Selection and withdrawal of participants
Inclusion criteria for brief intervention
1. Residents of the 20 most deprived neighbourhoods in the city of Shefﬁeld
2. Aged 40 to 64 years
3. Not achieving the current recommended activity level (30 minutes of moderate activity on at least
5 days) assessed using the SPAQ46 and wishing to have support to become more active
Additional inclusion criteria for booster trial:
1. Have increased their physical activity level by at least 30 minutes of moderate or vigorous activity per
week (assessed using the SPAQ) since initial assessment of activity level
2. Capacity to give written informed consent to trial participation
Exclusion criteria
Individuals with chronic conditions who can beneﬁt from physical activity will not be excluded unless their
condition signiﬁcantly impairs their ability to exercise. They will be asked to consult their GP if they have a
condition that increases their risk of adverse events during exercise (i.e. chronic cardiovascular or
pulmonary disease).
Criteria for withdrawal from trial treatment
Participants may withdraw from active participation in the study on request. If a participant experiences
chest pain or severe breathlessness during the 12-minute walk test, then the researcher will advise the GP
directly and immediately, and will also advise the participant to make an appointment with their GP at
their earliest convenience.
If analysis of Actiheart (accelerometer) readings suggests pre-existing arrhythmias, this information will be
shared with the participant and their GP.
Subjects removed from active participation will not be replaced and, with their consent, will be followed
up for all outcome information.
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Randomisation and enrolment
We will use a remote web-based randomisation service. Eligible participants will be randomised to one of
the three arms by the study manager, after receiving the consent form, via a centralised telephone
randomisation service provided through the Clinical Trials Research Unit (CTRU).
Assessments and procedures
Procedures required at screening or before randomisation
Letter 1. Up to 30 000 middle-aged residents will be sent a letter and business response envelope inviting
them to enroll in a programme to help them get more physically active.
Scottish Physical Activity questionnaire. The research team will send this out to potential participants
with Letter 1. It will be administered face-to-face by a member of the research team at screening
and sent out again by post on two subsequent occasions to participants (3 months and 9 months
after randomisation).
Brief intervention
Interactive DVD and supporting written materials, delivered through the post. The research team will send
this out to potential participants who respond to Letter 1.
Procedures required at initial follow-up
Follow up telephone contacts, one month and two months from initial contact to assess DVD usage and offer
advice on physical activity. A member of the research team will contact the individual at home by telephone.
Procedures required at screening
After three months, the Study Introduction letter will be sent to all DVD recipients and eligibility to
participate in the booster trial will be assessed by telephone. Eligible participants will be invited to attend a
baseline assessment.
Procedures required before randomisation
Participant information sheet sent to potential participant at home. The research team will send this out to
potential participants who are eligible and willing to participate in the trial (see above).
Visit to a community venue for informed consent, baseline assessment and randomisation. A member of
the research team will meet and consent the individual, take baseline assessments and randomise them.
A member of the research team will administer:
l Scottish Physical Activity questionnaire;
l Short-Form 12v2 plus 4 questionnaire, plus one wellbeing question;
l Behavioural Regulation in Exercise Questionnaire (BREQ-2);
l Exercise Evaluation Randomised Trial (EXERT) questionnaire ;
l Personal information questionnaire (Questionnaire 1).
l Questions about use of community facilities for physical activity, and about health and social care
service contacts; and,
l Measurement of weight and height.
Procedures required at three month follow-up
A member of the research team will meet the individual, take baseline assessments and randomise
them. A member of the research team will administer:
l Scottish Physical Activity questionnaire;
l Short-Form 12v2 plus 4 questionnaire, plus one wellbeing question;
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l Behavioural Regulation in Exercise Questionnaire (BREQ-2);
l Exercise Evaluation Randomised Trial (EXERT) questionnaire’
l Questions about use of community facilities for physical activity, and about health and social care
service contacts;
l Measurement of weight and height;
l Twelve-minute walk test; and,
l Seven-day accelerometry using Actiheart.
Procedures required at nine month follow-up
A member of the research team will meet the individual, take baseline assessments and randomise them.
A member of the research team will administer:
l Scottish Physical Activity questionnaire;
l Short-Form 12v2 plus 4 questionnaire, plus one wellbeing question;
l Behavioural Regulation in Exercise Questionnaire (BREQ-2);
l Exercise Evaluation Randomised Trial (EXERT) questionnaire ;
l Questions about use of community facilities for physical activity, and about health and social care
service contacts;
l Measurement of weight and height;
l Twelve-minute walk test; and,
l Seven-day accelerometry using Actiheart.
List procedures for attempted follow-up of patients ‘lost to follow-up’
Patients will be considered lost-to-follow-up if they fail to respond to questionnaires, one reminder letter
and two telephone calls. There are no procedures for further follow-up.
Procedures required when closing a trial (premature or planned)
At the point at which all questionnaires have been collected (or participants have failed to respond despite
reminders) and all data have been entered and cleaned, the management group will approve closure of
the database. Further details will be presented in the data management protocol.
Procedures required to record serious adverse events
At each follow-up, participants will be asked if they have experienced any event or illness which:
l has required unscheduled hospitalisation; or,
l has resulted in persistent or signiﬁcant disability/incapacity.
The details of serious adverse events will be conﬁrmed with the participant’s general practitioner
before classiﬁcation.
It is the Chief Investigator’s responsibility:
1. To follow the procedure outlined in the study protocol for the reporting of SAEs;
2. To assess each event for causality and AE category;
3. To provide the Dean of ScHARR and the University Research Ofﬁce (in their capacity as representatives
of the sponsor) with details of all SAEs identiﬁed within agreed timeframes;
4. To notify the Trial Steering Committee and Data Monitoring and Ethics Committee of any SAEs; and,
5. To submit the annual safety report to the REC.
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Statistics
Number of patients to be enrolled
600.
Reason for choice of sample size
The original sample size calculation assumed that physical activity would be measured using a simple
hip-mounted accelerometer. It was also assumed that a mean difference of 400,000 PAC per week
between the intervention and control groups at three months was the smallest clinically and practically
important difference and that the SD of this outcome was 1.2 million counts/per week. Hence with
450 participants (300 intervention: 150 control), the main trial was determined to have 90% power to
detect this mean difference or greater between the intervention and control arms as statistically signiﬁcant
at the 5% (two-sided) level using a two independent samples t-test. Assuming an approximate 25% loss
to follow-up by three-months, it was proposed to recruit and randomise 200 participants per group giving
total sample size of 600. The Actiheart accelerometer measures physical activity counts per week on a
different scale of magnitude to a simple hip mounted accelerometer with a considerably lower mean and
standard deviation.
When re-estimating the sample size using data from an internal pilot study the revised sample size
estimate either stays the same or increases (it cannot be less than the original estimate). The original
sample size calculation of 450 subjects with valid outcome data at 3 months post-randomisation, was
based on detecting a standardised effect size of 0.33 or a mean difference of one-third of a standard
deviation in the outcome measures between the intervention and control groups. This equates to an
estimated mean difference between the Booster and Control groups, based on the observed standard
deviation from the feasibility stage of 34,465 PAC per week and 102 kcal per day for TEE.
To have a 90% power of detecting a mean difference of 102 kcal in mean TEE per day is between the
groups would require 426 participants in total with evaluable data (control = 142; intervention = 254).
Similarly, the total required sample size under the above conditions to detect a mean difference of a
34,465 PAC per week is 429. Therefore since the re-estimated sample size, of around 430 participants, is
lower than the original estimate of 450 participants the trial will proceed with the original sample size
estimate of 450 participants with evaluable data.
Statistical criteria to terminate the trial
There are no statistical criteria for stopping the trial early; as the intervention is considered low risk, there is
no DMEC and decisions to stop the trial will be made on safety grounds by the Trial Steering Committee.
Procedure for accounting for missing data
The primary analysis will be an ITT analysis with participants with complete accelerometry data at three
months post-randomisation. A sensitivity analysis will be undertaken to impute missing accelerometry data
using baseline and follow-up data from the group of patients with valid accelerometry data at three
months post-randomisation. As this is an ITT analysis, withdrawals and protocol violations will be analysed
in their groups as randomised.
Analysis of primary objective
As the trial is a parallel group RCT data will be reported according to the revised CONSORT statement.47
The statistical analyses will be performed on an intention-to-treat basis. All statistical exploratory tests will
be two-tailed with alpha = 0.05. Baseline demographic variables (age, gender), physical measurements
(e.g. weight, height, BMI), and health-related quality of life data (SF-36) will be summarised with
appropriate summary statistics, tabulated and assessed for comparability between the treatment groups.
For example, categorical variables (e.g. gender, the number and percentage who are male and female will
be reported). For continuous variables, e.g. age, depending on the distribution of the data, if it is
APPENDIX 1
130
NIHR Journals Library www.journalslibrary.nihr.ac.uk
symmetric, the data will be summarised with a mean and standard deviation; if it has a non-symmetric
distribution it will be summarised with a median and inter-quartile range.
The primary aim is to compare the intervention (Full or Mini Booster) versus control treatment (No booster).
Secondary aims are to compare the two interventions (Full versus Mini booster). The primary comparison
will be between the mean physical activity levels from the Actiheart accelerometer (average Total
Energy Expenditure per day in Kcal, from a seven-day assessment) in the two ‘booster’ arms combined
compared with the mean physical activity levels in the control arm at 6 months follow-up (3 months
post-randomisation). This difference in means, between the intervention and control groups, will be
compared using a two independent samples t-test and a 95% conﬁdence interval for estimated mean
difference between the groups will also be calculated. In the event of differences between the Booster and
Control groups with respect to baseline demographic, physical, and health-related quality of life and
accelerometer measurements, multiple regression will be used to adjust the treatment effect for these
variables. The ordinary least squares adjusted regression coefﬁcient estimate for the treatment group
parameter along with its 95% conﬁdence interval (CI) will then be reported.
The research hypothesis is that the booster interventions will have greater levels of physical activity than
the control. The statistical and null hypothesis is that there are no differences between the intervention
and control groups at follow up. The alternative hypothesis is that there is a difference in physical activity
levels between the intervention and control groups at follow up.
Secondary aims are to compare the effect of the two interventions (Full versus Mini booster). This will be
done using the same methods as for the primary endpoint as described above. Interim analyses will not be
required. An exploratory sub-group analysis using multiple linear regression, with the primary outcome the
mean physical activity levels from the Actiheart accelerometer (average Total Energy Expenditure per day in
Kcal, from a seven-day assessment) at 6 months (3 months post-randomisation), will look for an interaction
between treatment group (Booster or control) and sub-groups deﬁned by gender, ethnicity and access to
community facilities (self reported use versus no use of community facilities).
Analysis of secondary outcomes
Analyses will identify any signiﬁcant different between groups for each outcome measure, at three months
and nine months from randomisation:
1. Objective measures of physical activity from the Actiheart:
– Physical activity counts (PAC) per week;
– Minutes of moderate/vigorous physical activity per day;
– Meeting the current physical activity recommendation of at least 30 min per day (continuous or in
bouts of at least 10 min of at least moderate intensity) for at least 5 days a week (yes or no).
2. Physiological measures of ﬁtness (12 minute walk test) and types of physical activity (self report) and
change in self-reported physical activity levels
3. Change in health-related quality of life measured by changes in SF-12v2 plus 4 (converted to SF-6D)
4. Health and social care contacts
5. Changes in psychological measures of motivation, intention and stages of change, and self-efﬁcacy
Secondary categorical outcomes such as the proportions maintaining (or increasing) their weekly duration
of physical activity in the two ‘booster’ arms combined compared with the proportion in the control arm at
6 months follow-up (3 months post-randomisation), will be compared between the intervention and
control groups, using a continuity corrected chi squared test and a 95% conﬁdence interval for estimated
differences in proportions will also be calculated. In the event of differences between the groups with
respect to baseline demographic, physical, and health-related quality of life measurements, multiple logistic
regression will be used to adjust the treatment effect for these variables. The maximum likelihood
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estimated regression coefﬁcient for the treatment group parameter (odds ratio) along with its
95% conﬁdence interval (CI) will then be reported.
Secondary outcomes such as HRQoL (SF-12v2 plus 4 dimension scores) and distance walked on 12 minute
walk test, at six month follow-up, will be assumed to be continuous outcomes. A two independent
samples t-test will be used to compare mean outcomes between the Booster and control groups in this
parameter. A 95% conﬁdence interval (CI) for the mean difference in this parameter between the groups
will also be calculated. In the event of differences between the Booster and Control groups with respect to
baseline demographic, physical, and health-related quality of life measurements, multiple regression or
analysis of covariance (ANCOVA) will be used to adjust the treatment effect for these variables. The
ordinary least squares adjusted regression coefﬁcient estimate for the treatment group parameter along
with its 95% conﬁdence interval (CI) will then be reported. Twelve month outcomes will be analysed in a
similar way. We shall also compare the effect of the two interventions (Full versus Mini booster) on these
secondary outcomes at 3 and 9 months post-randomisation, using the same methods as described above.
Economic analysis
The basic design of the health economic component of the study will be to estimate the incremental cost
effectiveness of the mini-booster and full booster interventions compared to no booster. It will include
an estimation of the cost effectiveness of the intervention from a NHS perspective in terms of their
incremental cost per quality adjusted life year (QALY) and a broader societal assessment of efﬁciency
that includes costs for other Government agencies and productivity (inside and outside the home).
It uses similar methods to those used in the successfully completed evaluation of a community
exercise programme.48
There will be two components to the costing. The interventions will be costed, as well as the
consequences for the use of health and social services in general. The costs of the booster consultations
will be assessed in a micro costing study. The costs will include enrolment of participants, training and time
of facilitators, travel and telephone calls. Actual cost data will be collected for consumables and facilitator
time will be costed using national grades. Despite being a highly pragmatic trial, there are some features
of the programme which are speciﬁc to the research study and it will be necessary to adjust for these in
order to make the results generalisable. Care will also be taken to compare costs assuming a routine level
of throughput, rather than that achieved in the trial. Any research related costs will be excluded.
The consequences for use of health and social services will use resource data collected from participants.
Use of primary, secondary, community and social services will be obtained using a self-completed resource
questionnaire administered to participants at each assessment at baseline, three months and nine months.
Resources will be costed using the best available national estimates. Where appropriate, national unit costs
will be used.49
SF-12v2 plus 4 data will be converted into health state utility values using the SF-6D preference-based
algorithm.50 The area under the curve between assessments will be used to provide an overall estimate of
the QALY difference between the intervention arms and the control arm after adjusting for signiﬁcant
baseline variables.51 Given cost and beneﬁt data will only be collected for nine months, the on-going costs
and health beneﬁts will not be discounted, though start-up costs, including training costs, will be
annuitised over a ﬁve year period. The sensitivity of the results to possible uncertainties in key parameters
will be explored by a full sensitivity analysis, including a probabilistic sensitivity analysis.
Trial supervision
Details of the composition of the Trial Steering Committee (TSC) and Trial Management Group (TMG) are
given at the front of this protocol. Shefﬁeld CTRU standard operating procedures Gov001 and Gov002
apply. Shefﬁeld CTRU trials require an independent Chair for a TSC.
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There is no interim analysis. The responsibility of the TSC is to evaluate serious adverse events and make
decisions about the continuation or discontinuation of the trial on safety grounds. In the event that any
women consented into the trial are, or become pregnant, the safety of these individuals will also be
monitored by the TSC.
There is no Endpoint Review Committee.
Data handling and record keeping
Data from the study will be stored in accordance with the Archiving Standard Operating Procedure (Shef/
CTRU/DM002) for at least 5 years following completion. It will be stored in a commercial archive in
Shefﬁeld, which will protect the data from damage by ﬁre, water, etc. The data will be packed into boxes
and labelled with a number, the study title/reference no., the sponsor, the investigator and date until
which it is to be archived. Named individuals will be responsible for archiving the data and for retrieving
data from the archives. It will be necessary for the named individuals to go to the commercial archive to
physically retrieve the data. Access will be restricted to the investigator and regulatory authorities. Details
of what is kept in the archive will be logged on a register. These details will be the same as is detailed on
the archive box labels. When data is removed from the archive, this is also logged on a register by one of
the named individuals. Electronic data will be stored in an ‘archive’ area of the secure CTRU server for a
minimum of ﬁve years to ensure that access is future-proofed against changes in technology. Electronic
data may also be stored (e.g. on a compact disc) with the paper ﬁles.
The detailed data management and data quality issues will be set out in a data management and
monitoring protocol in conjunction with the CTRU database manager.
Publication
Dissemination will be undertaken through peer reviewed scientiﬁc journals and clinical and
academic conferences.
Ethics approval
The protocol will be approved by North Shefﬁeld Research Ethics Committee.
Indemnity/Compensation/Insurance
The University of Shefﬁeld has in place insurance against liabilities for which it may be legally liable and
this cover includes any such liabilities arising out of this research project.
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Appendix 2 Changes to protocol
Change to Protocol Progress Report Date Approved by
Protocol Version 2 (3rd Feb 2009),
changes for accuracy, clariﬁcation and
internal consistency were never approved
by the REC
Not reported – Shefﬁeld REC
Protocol Version 3 (25 Jun 09) Shefﬁeld
Research Ethics Committee approved a
protocol amendment on 14 July 2009.
The amendment related to the collection
of data during the brief intervention
(pre-randomisation or screening) phase
of the study
01 03 Aug 2009 Shefﬁeld REC
Protocol Version 04 (13 Jan 2011). This
change involved the way the primary
outcome was collected and analysed.
The primary outcome remained an
objective measure of physical activity
obtained through seven-day
accelerometry using Actiheart. However,
the chair of the Trial Steering Committee
recommended that we change the way
this was calculated from the use of
physical activity counts to energy
expenditure. On the request of the NIHR
HTA monitors the rationale for this
change was externally peer reviewed and
approved by the NIHR HTA (please see
‘Letter from HTA 04 Aug 2010.pdf’).
The changes to the protocol reﬂected
the decision of the funding body that the
method of calculating the primary
outcome should change. There was no
difference to participants in terms of
how data is collected
HTA instructed team to make
change (correspondence:
04 Aug 2010); not reported
due to an oversight
– Shefﬁeld REC
Protocol Version 5 (09 Mar 2011), given
a favourable opinion by Shefﬁeld REC on
06 Jun 2011, refers to a new piece of
study documentation, the study
introduction letter. This letter is sent to
study candidates before the participant
information sheet and delivers key
information in simple language
05 01 Aug 2011 Shefﬁeld REC
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Appendix 3 Motivational interviewing
Motivational interviewing: principles and key elements
Ground work and typical day
Using key skills in MI including Open ended questions, Afﬁrmations of change talk, Reﬂective listening and
Summarising (OARS) to elicit client attitudes towards adopting lifestyle change. This opening exchange will
also ensure client centredness through empathetic listening and respectfulness. The main outcome is a
greater understanding (for both the client and therapist) of the client’s current situation and their relevant
health history and envisaging the impact of changing and not changing. TYPICAL DAY: Exploration
(guiding and supporting the client) to understand a typical day and what ‘high risk’ scenario’s exist as well
as opportunities for change and adapting current behaviours. Key skills used are again OARS.
Assess importance and readiness
A. How important is the change? (e.g. physical activity) (1–10) ( ) Why X Not Y?
B. How ready are you to change? (1–10) ( ) Why X Not Y?
C. How conﬁdent are you to maintain the change? (1–10) ( ) Why X Not Y?
This measure is mapped (conceptually) onto the transtheoretical model (TTM) of behaviour change,147
although, unlike most other applications, the MI interview integrates more than stages of change and
incorporates ‘decisional balance’, ‘self-efﬁcacy/temptation’ and ‘processes of change’. Many other
interventions in health settings wrongly assume that stages of change and TTM are the same thing when
stages of change is just one of four dimensions. This measure helps both parties understand the client
readiness to change across his or her own selected health behaviour change aspects (i.e. smoking, diet,
exercise, alcohol).
Assessing ambivalence
Whenever a client is considering change (from a position of contemplation, for example), ambivalence is a
normal consequence. Eliciting all aspects of this position is important and can be done in MI using a
four-cell decisional balance grid.
When we think about making changes, most of us don’t really consider all ‘sides’ in a complete way.
Instead, we often do what we think we ‘should’ do, avoid doing things we don’t feel like doing, or just
feel confused or overwhelmed and give up thinking about it at all.
Thinking through the pros and cons of both changing and not making a change is one way to help us
make sure we have fully considered a possible change. This can help us to ‘hang on’ to our plan in times
of stress or temptation. Below, write in the reasons that you can think of in each of the boxes.
Beneﬁts/pros Costs/cons
Making a change
Not changing
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Summary
Again, the key counselling skill applied here is reﬂective listening, in which the therapist draws together
the main facets of the conversation and provides a reﬂective summary for the client. This enables the client
to ‘listen back’ to the points they have raised themself and provides an opportunity to clarify points, adjust
the inference or level of importance or merely have it verbalised from an objective source. This is an
important phase in preparation for action planning and will include a recapitulation and asking key
questions about subsequent stages.
Action plan
When there are clear signs of preparatory change talk,84 which are Desire, Ability, Reasons, Need (DARN),
then greater elicitation and strengthening is required to increase the likelihood of predictor change talk,
which is Commitment, Activation, Taking steps (CAT). Use the ‘ten strategies for eliciting and
strengthening change talk’ worksheet to achieve this.
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Motivational interviewing practice resources pack
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Appendix 4 Questionnaire for participants in the
full booster arm
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 Facility (e.g. gym, pool, community centre, track)  please state ________________ 
     _____________________________________________________________________ 
 As part of daily activities (e.g. in work, shopping, walking the dog, commuting) 
 Other  please state ___________________________________________________ 
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4. What influences whether or not you are able to perform your chosen activity? (Please tick one 
box per reason to indicate how much each reason relates to you personally) 
 
Not at all Not really Neutral Slightly Very 
much 
Value for money      
Activity is available when I want      
Childcare available      
Within walking distance/home/work      
Within easy reach on public transport      
If I feel I'm getting something out of it      
Whether there is someone else to do it with      
 
     
Whether I can make time to do it      
My own health      
Other 
 
     
5. Do you do physical activity with anyone else? 
 Yes 
 No 
If you answered yes, who do you usually do physical activity with? (Please tick all that apply) 
 Spouse/partner 
 Other family member/s 
 Friend/s 
 Other adult/s 
 Child/children under 16 years 
 As part of a group/class (including walking group) 
 Other (please state) ______________________ 
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If you answered yes, how useful do you find this support in helping you to stay active? (please tick 
one) 
Very Useful Fairly useful Neither useful 
nor useless 
Fairly useless Very useless Not applicable 
      
 
 
 
6. Why did you decide to take part in this project? (Please write in the space below) 
 
 
 
 
 
 
 
 
 
 
 
 
7. If 
would you prefer it to be delivered? 
 Over the telephone 
 In person (face to face) 
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 Written advice 
 
counselling/advice, what did you expect to 
gain from the two sessions? (Please write in the space below) 
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  Yes 
 No 
 
Questions 10-14  please indicate your agreement with the following statements. 
one) 
Strongly disagree Disagree Neutral Agree Strongly agree 
     
 
counselling/advice sessions were conducted at a convenient 
location (please only tick one) 
Strongly disagree Disagree Neutral Agree Strongly agree 
     
 
 being judged by the 
project worker (please tick one) 
Strongly disagree Disagree Neutral Agree Strongly agree 
     
 
-confrontational in nature (please tick 
one) 
Strongly disagree Disagree Neutral Agree Strongly agree 
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understood what I was saying (please tick one) 
Strongly disagree Disagree Neutral Agree Strongly agree 
     
 
15. How involved did you feel  
 I spoke more than the project worker 
 I spoke less than the project worker 
 I spoke roughly the same amount as the project worker 
 
16. How do you feel about the amount of contact time that occurred between you and the 
project worker? (Please tick one) 
Too long Slightly too long About right Slightly too short Too short 
     
 
physical activity (please tick one) 
Not 
Discussed 
Strongly Disagree Disagree Neutral Agree Strongly agree 
      
 
barriers towards physical activity (please tick one) 
Strongly disagree Disagree Neutral Agree Strongly agree 
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of physical activity (please tick one) 
Not 
Discussed 
Strongly Disagree Disagree Neutral Agree Strongly agree 
      
 
associated with living an inactive lifestyle (please tick one) 
Not 
Discussed 
Strongly Disagree Disagree Neutral Agree Strongly agree 
      
 
physical activity facilities and opportunities (please tick one) 
Not 
Discussed 
Strongly Disagree Disagree Neutral Agree Strongly agree 
      
 
22. As a 
increased (please tick one) 
Strongly disagree Disagree Neutral Agree Strongly agree 
     
 
23. If you are more physically active now than you were before taking part in this study, what 
helped you? (Please write in the space below) 
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Finally, would you be happy to discuss some of the things mentioned in this questionnaire 
further in an interview with a different person to the person you have been in contact with 
about this study so far, either face-to-face or on the telephone? 
 Yes  face to face 
 Yes  over the telephone 
 No 
If you would like us to contact you by telephone, please give a telephone number we can contact you 
on: 
_________________________________ 
 
Thank you very much for your help. 
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Appendix 5 Interview topic guide
Introduction: Just like to talk to you about your experiences of taking part in the telephone/face-to-face‘booster’/advice and whether this inﬂuenced you being physically active.
Prompts:
Firstly, how long did your session last?
Where did it take place? Was that convenient for you
What did you think of the advice session?
Can you tell us if you felt the advice session helped in any way to keep you active? How/why do you think
that was? (Probe: attitude change, reafﬁrm message)
What else inﬂuenced you in being able to stay active or deterred you from staying active? (e.g. costs,
facilities, personal circumstances, people to be active with, priorities, others who support you/discourage
you from being active, motivation for being active). How/why?
Can you describe the things that motivate you the most to be physically active? (e.g. external/internal; why
feel the need to do or not do something active?)
Can you describe if and how physical activity ﬁts into your lifestyle? (i.e. explore habits/routines)
What type of activity/activities did you participate in and why? (Interviewer refer to survey and
follow up answers)
What were you expecting from the study? Was it what you expected?
Prompt: have you received any advice like this before?
What beneﬁts do you feel there are to staying active?
Prompts:
Physical/medical?
Mood/well-being?
Social?
Other behaviours, e.g. eating habits, smoking?
Saving money? (e.g. by walking/cycling as transport)
What disadvantages do you think there are to staying active?
Prompts:
Time
Cost
Planning
Was this a good way to give you advice/help you needed? Why?
Prompts:
What would you have preferred? What, if anything, would you change about the ‘booster’/support and
advice for keeping active?
If a friend was thinking of becoming/staying active, how would you advise them to go about this?
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Appendix 6 Results tables from the main trial
TABLE 16 Mail-out areas
Mail-out Neighbourhoods Letters sent, n
Replies received,
n (%)
Randomised,
n (%)
1 High Green 3300 329 (10.0) 48 (1.5)
2 Southey Green, Longley, New
Parsons Cross, Old Parsons Cross,
Shirecliffe, Tinsley, Darnall, Flower,
Shiregreen, Stubbin, Brushes, Acres
Hill, Winn Gardens
15,366 1045 (6.8) 88 (0.6)
3 Gleadless Valley, Hemsworth,
Lowedges, Batemoor,
Jordanthorpe, Manor, Woodthorpe,
Park Hill, Norfolk Park,
Arbourthorne, Tinsley, Darnall,
Acres Hill
18,784 974 (5.2) 60 (0.3)
4 Broomhall, Sharrow (including the
Abbeydale corridor), Highﬁeld,
Burngreave, Abbeyﬁeld, Fir Vale,
Firshill, Woodside, Netherthorpe,
Upperthorpe, Langsett, Wybourn,
City Centre
16,072 1185 (7.4) 52 (0.3)
5 Brightside, Firth Park, Fox Hill,
Richmond, Wincobank
6862 385 (5.6) 8 (0.1)
6 Base Green, Beighton, Charnock,
Gleadless, Halfway, Handsworth,
Hollins End, Mosborough,
Owlthorpe, Sothall
10,000 836 (8.4) 26 (0.3)
TABLE 17 Baseline characteristics of all randomised study participants (n = 282)
Variable Control (n = 96) Booster (n = 186) Total (n = 282)
Gender, n (%)
Male 37 (38.5) 93 (50.0) 130 (46.1)
Female 59 (61.5) 93 (50.0) 152 (53.9)
Employment status, n (%)
Part-time 18 (18.8) 34 (18.3) 52 (18.4)
Full-time 34 (35.4) 59 (31.7) 93 (33.0)
Not employed 44 (45.8) 90 (48.4) 134 (47.5)
Missing 0 (0.0) 3 (1.6) 3 (1.1)
Ethnicity, n (%)
White British 83 (86.5) 163 (87.6) 246 (87.2)
Other 13 (13.5) 20 (10.8) 33 (11.7)
Missing 0 (0.0) 3 (1.6) 3 (1.1)
continued
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TABLE 17 Baseline characteristics of all randomised study participants (n = 282) (continued )
Variable Control (n = 96) Booster (n = 186) Total (n = 282)
Marital status, n (%)
Single 16 (16.7) 29 (15.6) 45 (16.0)
Married 50 (52.1) 101 (54.3) 151 (53.5)
Co-habiting 5 (5.2) 15 (8.1) 20 (7.1)
Divorced/separated 20 (20.8) 35 (18.8) 55 (19.5)
Widowed 5 (5.2) 6 (3.2) 11 (3.9)
Stage of change, n (%)
Contemplation 1 (1.0) 11 (5.9) 12 (4.3)
Preparation 39 (40.6) 86 (46.2) 125 (44.3)
Action 36 (37.5) 55 (29.6) 91 (32.3)
Maintenance 18 (18.8) 32 (17.2) 50 (17.7)
Missing 2 (2.1) 2 (1.1) 4 (1.4)
Age (years)
n (%) 96 (100.0) 186 (100.0) 282 (100.0)
Mean (SD) 54.5 (6.8) 54.6 (7.6) 54.6 (7.3)
Median (IQR) 54.9 (50.3 to 60.0) 55.6 (48.1 to 61.8) 55.3 (48.8 to 61.4)
Min. to max. 40.5 to 65.5 40.4 to 65.1 40.4 to 65.5
Height (m)
n (%) 95 (99.0) 186 (100.0) 281 (99.6)
Mean (SD) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1)
Median (IQR) 1.7 (1.6–1.7) 1.7 (1.6–1.8) 1.7 (1.6–1.8)
Min. to max. 1.5 to 1.9 1.5 to 1.9 1.5 to 1.9
Weight (kg)
n (%) 96 (100.0) 186 (100.0) 282 (100.0)
Mean (SD) 84.5 (19.2) 85.5 (18.5) 85.2 (18.7)
Median (IQR) 82.8 (70.1 to 95.0) 83.0 (73.0 to 96.8) 82.9 (72.5 to 96.6)
Min. to max. 50.8 to 160.0 46.9 to 145.8 46.9 to 160.0
BMI (kg/m2)
n (%) 95 (99.0) 186 (100.0) 281 (99.6)
Mean (SD) 30.3 (6.3) 30.3 (5.7) 30.3 (5.9)
Median (IQR) 28.9 (25.7 to 33.0) 29.8 (26.4 to33.2) 29.8 (26.3 to 33.0)
Min. to max. 20.3 to 53.4 17.1 to 49.4 17.1 to 53.4
SPAQ change
a
(3 months post randomisation)
n (%) 96 (100.0) 186 (100.0) 282 (100.0)
Mean (SD) 199.8 (261.6) 215.3 (416.1) 210.0 (370.4)
Median (IQR) 120.0 (75.0 to 255.0) 120.0 (50.0 to 255.0) 120.0 (60.0 to 255.0)
Min. to max. −1010.0 to 1240.0 −1840.0 to 3360.0 −1840.0 to 3360.0
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TABLE 17 Baseline characteristics of all randomised study participants (n = 282) (continued )
Variable Control (n = 96) Booster (n = 186) Total (n = 282)
SF-12v2 plus 4 (PCS)
n (%) 90 (93.8) 180 (96.8) 270 (95.7)
Mean (SD) 46.8 (11.2) 46.2 (10.6) 46.4 (10.8)
Median (IQR) 51.8 (39.9 to 54.8) 49.1 (39.6 to 53.9) 49.9 (39.7 to 54.5)
Min. to max. 13.9 to 60.7 13.0 to 66.7 13.0 to 66.7
SF-12v2 plus 4 (MCS)
n (%) 90 (93.8) 180 (96.8) 270 (95.7)
Mean (SD) 47.8 (10.2) 49.2 (9.6) 48.7 (9.8)
Median (IQR) 50.4 (41.7 to 54.9) 51.0 (41.9 to 57.1) 50.8 (41.9 to 56.2)
Min. to max. 20.8 to 65.8 15.9 to 68.5 15.9 to 68.5
BREQ-2 (RAI)
n (%) 93 (96.9) 181 (97.3) 274 (97.2)
Mean (SD) 5.4 (3.7) 5.2 (3.7) 5.3 (3.7)
Median (IQR) 5.8 (3.3 to 7.9) 6.3 (3.3 to 8.0) 6.0 (3.3 to 8.0)
Min. to max. −3.3 to 12.0 −9.1 to 11.5 −9.1 to 12.0
max., maximum; min., minimum.
a Twenty-eight participants reported an increase in physical activity of < 30 minutes at pretrial screening (23 reported
atypical activity either at brief intervention or pretrial screening; ﬁve reported typical activity on both occasions and a
change in activity less than the required amount of at least 30 minutes).
TABLE 18 Baseline characteristics of ITT study participants (n = 160)
Variable Control (n = 61) Booster (n = 99) Total (n = 160)
Gender, n (%)
Male 26 (42.6) 42 (42.4) 68 (42.5)
Female 35 (57.4) 57 (57.6) 92 (57.5)
Employment status, n (%)
Part-time 14 (23.0) 19 (19.2) 33 (20.6)
Not employed 27 (44.3) 55 (55.6) 82 (51.3)
Ethnicity, n (%)
White British 54 (88.5) 89 (89.9) 143 (89.4)
Any other 7 (11.5) 8 (8.1) 15 (19.4)
Missing 0 (0.0) 2 (2.0) 2 (1.3)
Marital status, n (%)
Single 11 (18.0) 13 (13.1) 24 (15.0)
Married 30 (49.2) 55 (55.6) 85 (53.1)
Co-habiting 5 (8.2) 6 (6.1) 11 (6.9)
Divorced/separated 11 (18.0) 20 (20.2) 31 (19.4)
Widowed 4 (6.6) 5 (5.1) 9 (5.6)
continued
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TABLE 18 Baseline characteristics of ITT study participants (n = 160) (continued )
Variable Control (n = 61) Booster (n = 99) Total (n = 160)
Stage of change, n (%)
Contemplation 0 (0.0) 5 (5.1) 5 (3.1)
Preparation 24 (39.3) 40 (40.4) 64 (40.0)
Action 23 (37.7) 34 (34.3) 57 (35.6)
Maintenance 13 (21.3) 19 (19.2) 32 (20.0)
Missing 1 (1.6) 1 (1.0) 2 (1.3)
Age (years)
n (%) 61 (100.0) 99 (100.0) 160 (100.0)
Mean (SD) 54.3 (7.0) 55.3 (7.7) 54.9 (7.4)
Median (IQR) 54.0 (50.4 to 60.6) 57.0 (48.5 to 62.3) 56.0 (49.4 to 61.8)
Min. to max. 40.5 to 65.5 40.5 to 65.1 40.5 to 65.5
Height (m)
n (%) 61 (100.0) 99 (100.0) 160 (100.0)
Mean (SD) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1)
Median (IQR) 1.7 (1.6 to 1.7) 1.6 (1.6 to 1.7) 1.7 (1.6 to 1.7)
Min. to max. 1.5 to 1.9 1.5 to 1.9 1.5 to 1.9
Weight (kg)
n (%) 61 (100.0) 99 (100.0) 160 (100.0)
Mean (SD) 81.7 (15.1) 82.1 (17.9) 82.0 (16.9)
Median (IQR) 82.0 (70.1 to 92.0) 80.6 (70.1 to 91.1) 80.6 (70.1 to 91.5)
Min. to max. 50.8 to 115.0 47.1 to 142.2 47.1 to 142.2
BMI (kg/m2)
n (%) 61 (100.0) 99 (100.0) 160 (100.0)
Mean (SD) 29.2 (5.0) 29.6 (5.7) 29.4 (5.4)
Median (IQR) 27.9 (25.6 to 32.2) 29.2 (25.5 to 32.2) 28.9 (25.6 to 32.2)
Min. to max. 20.3 to 43.7 17.1 to 49.4 17.1 to 49.4
SPAQ change (3 months post randomisation)
n (%) 61 (100.0) 99 (100.0) 160 (100.0)
Mean (SD) 216.9 (243.1) 188.6 (316.4) 199.4 (290.2)
Median (IQR) 120.0 (90.0 to 255.0) 110.0 (45.0 to 225.0) 120.0 (60.0 to 237.5)
Min. to max. −210.0 to 1240.0 −480.0 to 1740.0 −480.0 to 1740.0
SF-12v2 plus 4 (PCS)
n (%) 58 (95.1) 95 (96.0) 153 (95.6)
Mean (SD) 48.4 (9.3) 47.3 (9.8) 47.7 (9.6)
Median (IQR) 52.0 (42.0 to 54.8) 49.9 (42.8 to 54.3) 50.7 (42.6 to 54.5)
Min. to max. 17.5 to 60.6 20.7 to 60.9 17.5 to 60.9
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TABLE 18 Baseline characteristics of ITT study participants (n = 160) (continued )
Variable Control (n = 61) Booster (n = 99) Total (n = 160)
SF-12v2 plus 4 (MCS)
n (%) 58 (95.1) 95 (96.0) 153 (95.6)
Mean (SD) 47.7 (9.8) 50.0 (8.7) 49.1 (9.2)
Median (IQR) 50.1 (41.1 to 54.9) 51.2 (44.2 to 57.1) 51.0 (43.2 to 56.3)
Min. to max. 20.8 to 63.8 21.7 to 65.5 20.8 to 65.5
BREQ-2 (RAI)
n (%) 59 (96.7) 96 (97.0) 155 (96.9)
Mean (SD) 5.6 (3.6) 5.6 (3.6) 5.6 (3.6)
Median (IQR) 6.1 (3.4 to 8.0) 6.4 (3.7 to 8.3) 6.3 (3.5 to 8.3)
Min. to max. −3.3 to 12.0 −9.1 to 11.5 −9.1 to 12.0
max., maximum; min., minimum.
Note: the ITT set is deﬁned as randomised participants with at least 4 complete days on the Actiheart device as measured by
lost minutes during the day of not more than 1000 minutes at 3 months of follow-up.
TABLE 19 Comparability of baseline characteristics of completers and non-completers
Variable
Non-completers Completers
Control Booster All Control Booster All
Age (years)
n 35 87 122 61 99 160
Mean
(SD)
55.4 (6.6) 54.3 (7.4) 54.6 (7.2) 54.7 (7.0) 55.7 (7.7) 55.3 (7.4)
Median
(IQR)
58
(50.5 to 60.3)
52.9
(48.4 to 61.9)
54.6
(48.9 to 60.7)
54.7
(50.7 to 61.0)
57.8
(49.0 to 62.7)
56.4
(49.8 to 62.3)
Height (m)
n 34 87 121 61 99 160
Mean
(SD)
1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1)
Median
(IQR)
1.6
(1.6 to 1.7)
1.7
(1.6 to 1.8)
1.7
(1.6 to 1.8)
1.7
(1.6 to 1.7)
1.6
(1.6 to 1.7)
1.7
(1.6 to 1.7)
Weight (kg)
n 35 87 122 61 99 160
Mean
(SD)
89.4 (24.1) 89.4 (18.4) 89.4 (20.1) 81.7 (15.1) 82.1 (17.9) 82.0 (16.9)
Median
(IQR)
82.8
(69.0 to 105.0)
87.7
(76.0 to 99.5)
87.5
(75.9 to 101.9)
82
(70.1 to 92.0)
80.6
(70.1 to 91.1)
80.6
(70.1 to 91.5)
BMI (kg/m2)
n 34 87 121 61 99 160
Mean
(SD)
32.2 (7.8) 31.2 (5.7) 31.5 (6.4) 29.2 (5.0) 29.6 (5.7) 29.4 (5.4)
Median
(IQR)
30
(26.3 to 37.9)
30.9
(26.9 to 34.0)
30.9
(26.9 to 34.4)
27.9
(25.6 to 32.2)
29.2
(25.5 to 32.2)
28.9
(25.6 to 32.2)
continued
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TABLE 19 Comparability of baseline characteristics of completers and non-completers (continued )
Variable
Non-completers Completers
Control Booster All Control Booster All
SPAQ change (3 months post randomisation)
n 35 87 122 61 99 160
Mean
(SD)
170.0 (292.2) 245.7 (506.6) 224.0 (455.6) 216.9 (243.1) 188.6 (316.4) 199.4 (290.2)
Median
(IQR)
110
(60.0 to 270.0)
120
(60.0 to 300.0)
120
(60.0 to 275.0)
120
(90.0 to 255.0)
110
(45.0 to 225.0)
120
(60.0 to 237.5)
SF-12v2 plus 4 (PCS)
n 32 85 117 58 95 153
Mean
(SD)
43.9 (13.6) 45.0 (11.4) 44.7 (12.0) 48.4 (9.3) 47.3 (9.8) 47.7 (9.6)
Median
(IQR)
51.4
(32.1 to 54.2)
48.0
(37.3 to 53.6)
48.7
(35.8 to 53.9)
52.0
(42.0 to 54.8)
49.9
(42.8 to 54.3)
50.7
(42.6 to 54.5)
SF-12v2 plus 4 (MCS)
n 32 85 117 58 95 153
Mean
(SD)
48.1 (11.1) 48.3 (10.5) 48.3 (10.6) 47.7 (9.8) 50.0 (8.7) 49.1 (9.2)
Median
(IQR)
51.2
(43.1 to 55.5)
49.8
(41.2 to 56.2)
49.9
(41.2 to 56.2)
50.1
(41.1 to 54.9)
51.2
(44.2 to 57.1)
51.0
(43.2 to 56.3)
BREQ-2 (RAI)
n 34 85 119 59 96 155
Mean
(SD)
5.0 (3.9) 4.8 (3.9) 4.8 (3.9) 5.6 (3.6) 5.6 (3.6) 5.6 (3.6)
Median
(IQR)
5.5
(2.5 to 7.4)
5.5
(2.0 to 7.8)
5.5
(2.2 to 7.8)
6.1
(3.4 to 8.0)
6.4
(3.7 to 8.3)
6.3
(3.5 to 8.3)
Gender
n 35 87 122 61 99 160
Male,
n (%)
11 (31.4) 51 (58.6) 62 (50.8) 26 (42.6) 42 (42.4) 68 (42.5)
Female,
n (%)
24 (68.6) 36 (41.4) 60 (49.2) 35 (57.4) 57 (57.6) 92 (57.5)
Ethnicity, n (%)
White
British
29 (82.9) 74 (85.1) 103 (84.4) 54 (88.5) 89 (89.9) 143 (89.4)
Other 6 (17.1) 12 (13.8) 18 (14.8) 7 (11.5) 8 (8.1) 15 (9.4)
Missing 0 (0.0) 1 (1.1) 1 (0.8 0 (0.0) 2 (2.0) 2 (1.3)
Employment status, n (%)
Part-time 4 (11.4) 15 (17.2) 19 (15.6) 14 (23.0) 19 (19.2) 33 (20.6)
Full-time 14 (40.0) 34 (39.1) 48 (39.3) 20 (32.8) 25 (25.3) 45 (28.1)
Not
employed
17 (48.6) 35 (40.2) 52 (42.6) 27 (44.3) 55 (55.6) 82 (51.2)
Missing 0 (0.0) 3 (3.4) 3 (2.5) 0 (0.0) 0 (0.0) 0 (0.0)
Note: completers and non-completers are those with and without evaluable data at 3 months for any reason respectively.
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TABLE 20 Exploratory analysis of the risk factors (categorical) associated with completing evaluable data at
3 months
Variable
Completers
(n = 160), n (%)
Non-completers
(n = 122), n (%) OR (95% CI)a p-value
Interaction
OR (95% CI)b p-value
Gender
Female 92 (57.5) 60 (49.2) 1.40 (0.87 to 2.24) 0.165 0.3 (0.1 to 0.9) 0.034
Male 68 (42.5) 62 (50.8) 1.00
Treatment group
Booster 99 (61.9) 87 (71.3) 0.65 (0.39 to 1.08) 0.098
Control 61 (38.1) 35 (28.7) 1.00 NA
Treatment group
Full 52 (33) 42 (34) 0.71 (0.40 to 1.27) 0.249
Mini 47 (29) 45 (37) 0.60 (0.33 to 1.07) 0.085 NA
Control 61 (38) 25 (27) 1.00
Employment status
Yes 78 (48.8) 70 (57.4) 0.71 (0.44 to 1.14) 0.151 0.5 (0.2 to 1.3) 0.127
No 82 (51.3) 52 (42.3) 1.00
Ethnicityc
n 158 121
White British 143 (90.5) 103 (85.1) 1.67 (0.80 to 3.46) 0.171 NA
Any other 15 (9.5) 18 (14.9) 1.00
NA, not applicable.
a The odds of completing a 3-months assessment with evaluable data compared with not completing a 3-months
assessment with evaluable data for any other reasons using logistic regression.
b Interaction effect between treatment (booster and control) and completers group (completer or non-completer) using
logistic regression.
c Excludes three participants with missing ethnicity data at baseline (no interaction test because of small sample
within subgroups).
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TABLE 21 Exploratory analysis of the risk factors (continuous) associated with completing evaluable data at 3 months
Variable
Non-completers Completers
Mean difference
(95% CI)a p-valuea
Interaction
n Mean (SD) n Mean (SD) Effect (95% CI)b p-valueb
Age (years) 122 54.6 (7.2) 160 55.3 (7.4) 0.7 (−1.0 to 2.4) 0.426 2.1 (−1.6 to 5.8) 0.267
BMI (kg/m2) 121 31.5 (6.4) 160 29.4 (5.4) −2.0 (−3.4 to −0.6) 0.005 1.5 (−1.5 to 4.5) 0.320
Weight (kg) 122 89.4 (20.1) 160 82.0 (16.9) −7.4 (−11.7 to −3.1) 0.001 0.5 (−8.9 to 9.8) 0.924
SF-12v2 plus 4 (PCS) 117 44.7 (12.0) 153 47.7 (9.6) 3.1 (0.5 to 5.7) 0.019 −2.2 (−7.8 to 3.5) 0.452
SF-12v2 plus 4 (MCS) 117 48.3 (10.6) 153 49.1 (9.2) 0.8 (−1.6 to 3.2) 0.508 2.1 (−3.1 to 7.2) 0.430
Height (m) 121 1.7 (0.1) 160 1.7 (0.1) −0.0 (−0.0 to 0.0) 1.000 −0.0 (−0.1 to 0.0) 0.080
SPAQ changec 122 199.8 (261.6) 160 215.3 (416.1) −15.5 (−95.3 to 64.3) 0.703 −104.0 (−292.6 to 84.6) 0.279
BREQ-2 (RAI) 119 4.8 (3.9) 155 5.6 (3.6) 0.8 (−0.1 to 1.7) 0.077 0.2 (−1.7 to 2.1) 0.843
a Using a two independent sample t-test.
b Interaction effect between treatment (control or booster) and completers group (completer or non-completer) using logistic regression.
c Using independent two-sample t-test with unequal variances.
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TABLE 22 Difference in mean TEE per day between the booster intervention group (mini plus full) and the control group at 3 months (n = 160)
Outcome
Control (n = 61),
mean (SD)
Booster (n = 99),
mean (SD)
Mean difference
(95% CI)a p-valuea
Adjusted mean difference
(95% CI)b p-valuec
Mean TEE per day (kcal) 2265.9 (410.8) 2226.9 (422.6) −39.0 (−173.4 to 95.4) 0.567 −40.3 (−117.2 to 36.6) 0.302
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
Note: a negative mean difference favours the control over the booster interventions and indicates decreased physical activity in the booster intervention group compared with the control group.
TABLE 23 Sensitivity analysis: difference in mean TEE per day between the booster intervention group (mini plus full) and the control group at 3 months
Mean TEE per day (kcal)
Control,
mean (SD)
Booster,
mean (SD)
Mean difference
(95% CI)
a
p-value
a
Adjusted mean difference
(95% CI)b p-value
c
Multiple imputation (≥ 4 days) (n = 61) (n = 99)
2252.3 (393.6) 2215.1 (366.0) −37.2 (−174.9 to 100.6) 0.595 −34.5 (−118.1 to 49.0) 0.415
Regression imputation (≥ 4 days) (n = 58) (n = 95)
2263.1 (398.6) 2245.2 (409.4) −18.0 (−151.5 to 115.5) 0.790 −27.0 (−97.3 to 43.3) 0.449
Complete cases (7 complete days) (n = 44) (n = 68)
2241.7 (393.6) 2222.5 (366.0) −19.2 (−163.8 to 125.4) 0.793 −31.2 (−114.3 to 51.9) 0.458
Per protocold (n = 61) (n = 96)
2265.9 (410.8) 2231.3 (426.6) −34.6 (−170.6 to 101.4) 0.616 −35.6 (−112.5 to 41.3) 0.362
Multiple imputation (≥ 1 day) (n = 70) (n = 113)
2194.0 (393.6) 2215.3 (366.0) 21.3 (−133.1 to 175.7) 0.786 9.9 (−111.3 to 131.1) 0.872
Mean TEE per day (kcal)e (n = 61) (n = 98)
2265.9 (410.8) 2211.4 (395.5) −54.5 (−183.8 to 74.8) 0.406 −43.6 (−119.9 to 32.7) 0.260
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
d ‘Per protocol’ deﬁned as received intended intervention at 1 and 2 months post brief intervention.
e Excluding an outlier (only for sensitivity analysis).
Note: a positive mean difference favours the booster interventions over the control and indicates increased physical activity in the booster intervention group compared with the control group.
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TABLE 24 Difference in mean TEE per day between the full booster intervention group and the control group at 3 months
Outcome
Control (n = 61),
mean (SD)
Full booster (n = 52),
mean (SD)
Mean difference
(95% CI)a p-valuea
Adjusted mean difference
(95% CI)b p-valuec
Mean TEE per day (kcal) 2265.9 (410.8) 2279.9 (425.6) 14.0 (−142.2 to 170.2) 0.859 −6.7 (−96.6 to 83.2) 0.883
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
Note: a positive mean difference favours the full booster intervention over the control and indicates increased physical activity in the full booster intervention group compared with the
control group.
TABLE 25 Difference in mean TEE per day between the mini booster intervention group and the control group at 3 months
Outcome
Control (n = 61),
mean (SD)
Mini booster (n = 47),
mean (SD)
Mean difference
(95% CI)
a
p-value
a
Adjusted mean difference
(95% CI)b p-value
c
Mean TEE per day (kcal) 2265.9 (410.8) 2168.2 (415.8) −97.7 (−256.6 to 61.2) 0.226 −69.6 (−165.4 to 26.2) 0.153
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
Note: a negative mean difference favours the control over the mini booster intervention and indicates decreased physical activity in the mini booster intervention group compared with the
control group.
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TABLE 26 Subgroup evaluation: difference in mean TEE per day between the mini booster intervention group and the full booster intervention group at 3 months
Outcome
Mini booster,
mean (SD)
Full booster,
mean (SD)
Mean difference
(95% CI)
a
p-value
a
Adjusted mean difference
(95% CI)b p-value
c
Mean TEE per day (kcal) (n = 47) (n = 52)
2168.2 (415.8) 2279.9 (425.6) 111.7 (−56.5 to 279.9) 0.190 55.5 (−38.2 to 149.2) 0.242
Mean TEE per day (kcal)d (n = 47) (n = 51)
2168.2 (415.8) 2251.2 (375.6) 82.9 (−75.8 to 241.6) 0.302 47.0 (−45.2 to 139.2) 0.314
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
d Sensitivity analysis excluding an outlying participant.
Note: a positive mean difference favours the full booster intervention over the mini booster intervention and indicates increased physical activity in the full booster intervention group
compared with the mini booster intervention group.
TABLE 27 Difference in mean TEE per day between the booster intervention group (mini plus full) and the control group at 9 months
Outcome
Control,
mean (SD)
Booster,
mean (SD)
Mean difference
(95% CI)
a
p-value
a
Adjusted mean difference
(95% CI)b p-value
c
Mean TEE per day (kcal) (n = 36) (n = 55)
2177.2 (390.7) 2308.2 (646.3) 131.0 (−107.5 to 369.5) 0.278 51.5 (−137.2 to 240.2) 0.589
Mean TEE per day (kcal)d (n = 36) (n = 54)
2177.2 (390.7) 2239.1 (397.1) 61.9 (−106.8 to 230.6) 0.468 −7.1 (−115.8 to 101.6) 0.897
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
d Sensitivity analysis excluding one participant with extreme mean TEE per day of 6041.6 kcal (see Figure 16) (data were queried but record assumed to be correct).
Note: a positive mean difference favours the booster interventions over the control and indicates increased physical activity in the booster intervention group compared with the control group.
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TABLE 28 Sensitivity analysis: difference in mean TEE per day between the booster intervention group (mini plus full) and the control group at 9 months
Mean TEE per day (kcal)
Control,
mean (SD)
Booster,
mean (SD)
Mean difference
(95% CI)a p-valuea
Adjusted mean difference
(95% CI)b p-valuec
Multiple imputation (≥ 4 days) (n = 36) (n = 55)
2163.0 (298.9) 2235.2 (395.5) 72.3 (−101.8 to 246.3) 0.411 18.1 (−102.9 to 139.1) 0.766
Regression imputation (≥ 4 days) (n = 34) (n = 52)
2202.0 (371.3) 2281.7 (379.8) 79.6 (−85.5 to 244.7) 0.341 13.9 (−80.1 to 107.9) 0.769
Complete cases (n = 21) (n = 39)
2118.1 (298.9) 2315.5 (726.2) 197.5 (−134.8 to 529.8) 0.239 118.6 (−152.7 to 389.9) 0.384
Complete casesd (n = 21) (n = 38)
2118.1 (298.9) 2217.5 (395.5) 99.4 (−99.1 to 297.9) 0.320 31.7 (−88.7 to 152.1) 0.599
Multiple imputation (≥ 1 days) (n = 37) (n = 61)
2168.4 (298.9) 2215.9 (395.5) 47.5 (−122.5 to 217.5) 0.581 14.5 (−105.6 to 134.6) 0.811
Per protocol (n = 36) (n = 55)
2177.2 (390.7) 2308.2 (646.3) 131.0 (−107.5 to 369.5) 0.278 51.5 (−137.2 to 240.2) 0.589
Per protocold (n = 36) (n = 54)
2177.2 (390.7) 2239.1 (397.1) 61.9 (−106.8 to 230.6) 0.468 −7.1 (−115.8 to 101.6) 0.897
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
d Sensitivity analysis excluding one participant with extreme mean TEE per day of 6041.6 kcal (see Figure 16) (data were queried but record assumed to be correct).
Note: a positive mean difference favours the booster interventions over the control and indicates increased physical activity in the booster intervention group compared with the control group.
A
P
P
E
N
D
IX
6
1
7
4
N
IH
R
Jo
u
rn
a
ls
Lib
ra
ry
w
w
w
.jo
u
rn
a
lslib
ra
ry.n
ih
r.a
c.u
k
TABLE 29 Subgroup evaluation: difference in mean TEE per day between the mini booster intervention group and the full booster intervention group at 9 months
Outcome
Mini booster,
mean (SD)
Full booster,
mean (SD)
Mean difference
(95% CI)
a
p-value
a
Adjusted mean difference
(95% CI)b p-value
c
Mean TEE per day (kcal) (n = 25) (n = 30)
2204.0 (415.9) 2395.1 (785.7) 191.1 (−159.3 to 541.5) 0.279 100.9 (−203.8 to 405.6) 0.508
Mean TEE per day (kcal)d (n = 25) (n = 29)
2204.0 (415.9) 2269.4 (384.9) 65.4 (−153.4 to 284.2) 0.551 −9.3 (−175.2 to 156.6) 0.911
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
d Sensitivity analysis excluding one participant with extreme mean TEE per day of 6041.6 kcal (see Figure 16) (data were queried but record assumed to be correct).
Note: a positive mean difference favours the full booster intervention over the mini booster intervention and indicates increased physical activity in the full booster intervention group
compared with the mini booster intervention group.
TABLE 30 Difference in PACs per week between the booster intervention group (mini plus full) and the control group at 3 months
Outcome
Control,
mean (SD)
Booster,
mean (SD)
Mean difference
(95% CI)
a
p-value
a
Adjusted mean difference
(95% CI)b p-value
c
PACs per week (×1000) (n = 61) (n = 99)
339.0 (146.0) 331.7 (169.4) −7.2 (−59.0 to 44.5) 0.783 0.4 (−49.9 to 50.6) 0.988
PACs per week (×1000)d (n = 61) (n = 98)
339.0 (146.0) 324.4 (154.0) −14.5 (−63.1 to 34.1) 0.556 −7.1 (−53.3 to 39.2) 0.763
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
d Sensitivity analysis excluding one participant with extreme PACs per week.
Note: a positive mean difference favours the booster interventions over the control and indicates increased physical activity in the booster intervention group compared with the control
group; a negative difference favours the control over the booster interventions.
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TABLE 31 Sensitivity analysis: difference in PACs per week between the booster intervention group (mini plus full) and the control group at 3 months
PACs per week (×1000)
Control,
mean (SD)
Booster,
mean (SD)
Mean difference
(95% CI)a p-valuea
Adjusted mean difference
(95% CI)b p-valuec
Multiple imputation (≥ 4 days) (n = 61) (n = 99)
379.4 (135.0) 368.5 (155.6) –10.9 (–77.6 to 55.8) 0.747 –2.7 (–67.1 to 61.8) 0.935
Regression imputation (≥ 4 days) (n = 58) (n = 95)
332.5 (133.8) 328.1 (157.1) –4.4 (–53.4 to 44.6) 0.859 –1.6 (–48.0 to 44.9) 0.946
Complete cases (7 complete days) (n = 44) (n = 68)
325.1 (134.9) 322.6 (155.6) –2.6 (–59.3 to 54.1) 0.929 –12.3 (–65.1 to 40.4) 0.644
Per protocol (n = 61) (n = 96)
339.0 (146.0) 335.6 (170.5) –3.3 (–55.6 to 48.9) 0.900 2.9 (–47.8 to 53.6) 0.910
Per protocold (n = 61) (n = 95)
339.0 (146.0) 328.2 (154.9) –10.8 (–59.9 to 38.3) 0.665 –4.9 (–51.6 to 41.8) 0.836
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
d Sensitivity analysis excluding one participant with extreme PACs per week.
Note: a positive mean difference favours the booster interventions over the control and indicates increased physical activity in the booster intervention group compared with the control group.
TABLE 32 Difference in PACs per week between the booster intervention group (mini plus full) and the control group at 9 months
Outcome
Control,
mean (SD)
Booster,
mean (SD)
Mean difference
(95% CI)
a
p-value
a
Adjusted mean difference
(95% CI)b p-value
c
PACs per week (×1000) (n = 36) (n = 55)
319.0 (158.9) 315.4 (202.1) –3.6 (–83.0 to 75.7) 0.928 –14.5 (–90.8 to 61.7) 0.705
PACs per week (×1000)d (n = 36) (n = 54)
319.0 (158.9) 302.5 (179.6) –16.6 (–90.0 to 56.8) 0.655 –29.4 (–100.0 to 41.4) 0.411
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
d Sensitivity analysis excluding one participant with extreme PACs per week.
Note: a positive mean difference favours the booster interventions over the control and indicates increased physical activity in the booster intervention group compared with the control group.
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TABLE 33 Sensitivity analysis: difference in PACs per week between the booster intervention group (mini plus full) and the control group at 9 months
PACs per week (×1000)
Control,
mean (SD)
Booster,
mean (SD)
Mean difference
(95% CI)a p-valuea
Adjusted mean difference
(95% CI)b p-valuec
Multiple imputation (≥ 4 days) (n = 36) (n = 55)
351.2 (102.0) 353.2 (176.0) 19.8 (–120.0 to 123.8) 0.974 –1.3 (–120.0 to 117.5) 0.982
Regression imputation (≥ 4 days) (n = 34) (n = 52)
323.0 (151.6) 319.8 (188.2) –3.3 (–79.9 to 73.4) 0.933 –13.5 (–83.3 to 56.3) 0.702
Complete cases (7 complete days) (n = 21) (n = 39)
299.4 (102.0) 295.0 (176.0) –4.4 (–88.1 to 79.3) 0.916 –15.2 (–110.0 to 74.9) 0.735
Complete cases (7 complete days)d (n = 21) (n = 37)
299.4 (102.0) 265.8 (123.7) –33.7 (–97.4 to 30.0) 0.294 –37.3 (–110.0 to 31.6) 0.282
Per protocol (n = 36) (n = 55)
319.0 (158.9) 315.4 (202.1) –3.6 (–83.0 to 75.7) 0.928 –14.5 (–90.8 to 61.7) 0.705
Per protocold (n = 36) (n = 54)
319.0 (158.9) 302.5 (179.6) –16.6 (–90.0 to 56.8) 0.655 –29.4 (–100.0 to 41.4) 0.411
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
d Sensitivity analysis excluding one participant with extreme PACs per week.
Note: a positive mean difference favours the booster interventions over the control and indicates increased physical activity in the booster intervention group compared with the control group.
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TABLE 34 Difference in SF-12v2 plus 4 dimension scores between the booster intervention group (mini plus full) and the control group at 3 and 9 months (ITT set)
Follow-up (months) Outcome
Control Booster
Mean difference
(95% CI)
a
p-value
a
Adjusted mean difference
(95% CI)b p-value
c
n Mean (SD) n Mean (SD)
3 PCS score 57 49.3 (8.9) 89 48.8 (9.9) 0.7 (–1.4 to 2.7) 0.509 0.9 (–1.2 to 2.9) 0.394
MCS score 57 47.2 (9.5) 89 49.5 (9.1) 0.8 (–1.5 to 3.1) 0.499 0.8 (–1.6 to 3.1) 0.525
SF-6D utility score 56 0.644 (0.064) 88 0.648 (0.070) 0.002 (–0.017 to 0.021) 0.826 0.005 (–0.014 to 0.024) 0.623
9 PCS score 38 46.1 (9.4) 62 48.3 (10.4) 1.8 (–1.2 to 4.7) 0.244 1.7 (–1.2 to 4.6) 0.260
MCS score 38 48.3 (10.4) 62 52.3 (8.7) 2.0 (–0.7 to 4.8) 0.149 1.7 (–1.1 to 4.5) 0.237
SF-6D utility score 38 0.651 (0.083) 62 0.665 (0.080) –0.000 (–0.028 to 0.028) 0.989 0.001 (–0.027 to 0.030) 0.921
a Adjusted for baseline using the ANCOVA model.
b Adjusted for age, gender, BMI, total minutes of physical activity at –3 months and –1 week before randomisation, HRQoL (SF-12v2 plus 4 total score) and baseline outcome measurement.
c Using multiple regression.
Note: higher PCS and MCS scores indicate a better physical and mental health status respectively; higher SF-6D utility scores indicate a better health status; a positive mean difference
indicates improved health status in favour of the booster intervention.
A
P
P
E
N
D
IX
6
1
7
8
N
IH
R
Jo
u
rn
a
ls
Lib
ra
ry
w
w
w
.jo
u
rn
a
lslib
ra
ry.n
ih
r.a
c.u
k
TABLE 35 Difference in SF-12v2 plus 4 dimension scores between the booster intervention group (mini plus full) and the control group at 3 and 9 months (for all available data)
Follow-up (months) Outcome
Control Booster
Mean difference
(95% CI)
a
p-value
a
Adjusted mean difference
(95% CI)b p-value
c
n Mean (SD) n Mean (SD)
3 PCS score 70 48.6 (9.7) 118 48.8 (9.6) 0.7 (–1.1 to 2.5) 0.449 0.8 (–0.9 to 2.6) 0.354
MCS score 70 47.9 (9.4) 118 48.8 (10.2) –0.2 (–2.4 to 2.0) 0.849 –0.3 (–2.6 to 1.9) 0.770
SF-6D utility score 71 0.645 (0.071) 117 0.649 (0.075) –0.001 (–0.017 to 0.016) 0.920 0.001 (–0.016 to 0.018) 0.934
9 PCS score 46 46.2 (9.0) 81 48.6 (10.1) 2.2 (–0.5 to 4.9) 0.102 1.8 (–0.9 to 4.5) 0.191
MCS score 46 49.1 (10.2) 81 50.4 (9.3) –0.2 (–3.0 to 2.6) 0.892 –0.4 (–3.3 to 2.6) 0.804
SF-6D utility score 47 0.651 (0.083) 81 0.655 (0.077) –0.004 (–0.028 to 0.021) 0.755 –0.005 (–0.030 to 0.020) 0.709
a Adjusted for baseline using the ANCOVA model.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, HRQoL (SF-12v2 plus 4 total score) and baseline outcome measurement.
c Using multiple regression.
Note: higher PCS and MCS scores indicate a better physical and mental health status respectively; higher SF-6D utility scores indicate a better health status; a positive mean difference
indicates improved health status in favour of the booster intervention.
TABLE 36 Difference in the average number of minutes spent on type of activity per day (over a week) between the booster intervention group (mini plus full) and the control
group at 3 months based on an objective measure (ITT set; n = 160)
Outcome
Control (n = 61),
mean (SD)
Booster (n = 99),
mean (SD)
Mean difference
(95% CI)
a
p-value
a
Adjusted mean difference
(95% CI)b p-value
c
At least moderate activity (minutes) 48.4 (42.9) 46.8 (39.6) –1.6 (–14.7 to 11.5) 0.810 –1.9 (–15.1 to 11.3) 0.776
Moderate activity (minutes) 47.1 (42.1) 44.7 (37.9) –2.3 (–15.0 to 10.4) 0.721 –2.4 (–15.1 to 10.3) 0.710
Vigorous activity (minutes) 1.3 (2.4) 2.0 (4.2) 0.7 (–0.5 to 1.9) 0.236 0.5 (–0.7 to 1.7) 0.409
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at –3 months and -1 week prior to randomisation, and HRQoL (SF12v2 plus 4 total score).
c Using multiple regression.
Note: at least moderate, moderate and vigorous activity were deﬁned as having at least 3 METs, 3–6 METs and > 6 METs respectively.
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TABLE 37 Difference in the average number of minutes spent on type of activity per day (over a week) between the booster intervention group (mini plus full) and the control
group at 9 months based on an objective measure (ITT set; n = 91)
Outcome
Control,
mean (SD)
Booster,
mean (SD)
Mean difference
(95% CI)
a
p-value
a
Adjusted mean difference
(95% CI)b p-value
c
Main analysis (n = 36) (n = 55)
At least moderate activity (minutes) 36.6 (22.7) 50.8 (71.9) 14.2 (–10.4 to 38.8) 0.255 17.0 (–7.9 to 41.9) 0.177
Moderate activity (minutes) 35.7 (22.2) 44.9 (47.9) 9.1 (–7.9 to 26.1) 0.289 11.8 (–5.1 to 28.7) 0.168
Vigorous activity (minutes) 0.9 (2.2) 6.0 (29.0) 5.1 (–4.6 to 14.8) 0.297 5.2 (–4.8 to 15.2) 0.306
Sensitivity analysisd (n = 36) (n =54)
At least moderate activity (minutes) 36.6 (22.7) 42.5 (36.7) 5.8 (–7.8 to 19.4) 0.400 8.9 (–5.0 to 22.8) 0.208
Moderate activity (minutes) 35.7 (22.2) 40.3 (34.6) 4.6 (–8.3 to 17.5) 0.482 7.6 (–5.5 to 20.7) 0.252
Vigorous activity (minutes) 0.9 (2.2) 2.1 (4.7) 1.2 (–0.5 to 2.9) 0.159 1.3 (–0.5 to 3.1) 0.150
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
d Sensitivity analysis excluding a participant with an extreme value.
Note: at least moderate, moderate and vigorous activity were deﬁned as having at least 3 METs, 3–6 METs and > 6 METs respectively.
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TABLE 38 Difference in the proportions of participants who maintained or increased physical activity at 3 and
9 months from baseline [based on self-reported measure of physical activity (SPAQ) for ITT participants]
Follow-up
(months) Outcome
Control,
n (%)
Booster,
n (%)
Difference in proportion
maintaining or increasing
physical activity
(95% CI) (%)
a
p-value
a
3 Maintained or increased
physical activity
(n = 60) (n = 96)
30 (50.0) 55 (57.3) 7.3 (–8.8 to 23.3) 0.374
9 Maintained or increased
physical activity
(n = 44) (n = 66)
23 (52.3) 41 (62.1) 9.8 (–9.0 to 28.7) 0.305
a Based on a two independent sample proportion test with continuity correction.
Note: a positive difference in proportion indicates increased self-reported physical activity in the booster intervention group
compared with the control group.
TABLE 39 Difference in the proportions of participants who maintained or increased physical activity at 3 and
9 months from baseline [based on self-reported measure of physical activity (SPAQ) for all participants]
Follow-up
(months) Outcome
Control,
n (%)
Booster,
n (%)
Difference in proportion
maintaining or increasing
physical activity
(95% CI) (%)
a
p-value
a
3 Maintained or
increased activity
(n = 76) (n = 125)
41 (53.9) 71 (56.8) 2.9 (–11.0 to 17.1) 0.693
9 Maintained or
increased activity
(n = 54) (n = 85)
25 (46.3) 49 (57.6) 11.4 (–5.6 to 28.3) 0.191
a Based on a two independent sample proportion test with continuity correction.
Note: a positive difference in proportion indicates increased self-reported physical activity in the booster intervention group
compared with the control group.
TABLE 40 Differences in change in the BREQ-2 multidimensions between the booster intervention group (mini plus
full) and the control group at 3 months (all available data)
Outcome
Control Booster
Mean
difference
(95% CI)
a
p-valueb
Adjusted mean
difference
(95% CI)
c
p-valuedn
Mean
(SD) n
Mean
(SD)
Amotivation 75 0.3 (0.5) 123 0.2 (0.5) –0.0 (–0.2 to 0.1) 0.515 –0.0 (–0.2 to 0.1) 0.762
External regulation 75 0.3 (0.5) 123 0.4 (0.6) 0.1 (–0.1 to 0.2) 0.406 0.1 (–0.1 to 0.2) 0.408
Introjected regulation 76 1.1 (1.0) 123 1.4 (1.2) 0.3 (0.1 to 0.6) 0.018 0.3 (–0.0 to 0.6) 0.053
Identiﬁed regulation 75 2.9 (0.7) 123 3.0 (0.6) 0.2 (0.0 to 0.3) 0.047 0.1 (–0.0 to 0.3) 0.092
Intrinsic regulation 73 2.8 (1.0) 120 2.9 (1.0) 0.2 (–0.0 to 0.4) 0.077 0.2 (–0.0 to 0.4) 0.103
RAI 73 6.2 (3.4) 120 6.2 (3.3) 0.3 (–0.5 to 1.0) 0.478 0.2 (–0.5 to 0.9) 0.606
a Adjusted for baseline.
b Using the ANCOVA model.
c Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, HRQoL
(SF-12v2 plus 4 total score) and baseline outcome measurement.
d Using multiple regression.
Note: a higher RAI score indicates higher self-determination and a positive mean difference favours the booster
interventions over the control.
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TABLE 41 Differences in change in the BREQ 2 multidimensions between the booster intervention group (mini plus
full) and the control group at 9 months (all available data)
Outcome
Control Booster
Mean
difference
(95% CI)
a
p-valueb
Adjusted mean
difference
(95% CI)
c
p-valuedn
Mean
(SD) n
Mean
(SD)
Amotivation 54 0.3 (0.6) 84 0.2 (0.5) −0.0 (−0.2 to 0.1) 0.751 −0.0 (−0.2 to 0.1) 0.785
External regulation 54 0.3 (0.6) 84 0.3 (0.5) 0.0 (−0.2 to 0.2) 0.895 0.0 (−0.2 to 0.2) 0.939
Introjected regulation 54 1.2 (1.1) 84 1.4 (1.1) 0.1 (−0.2 to 0.4) 0.479 0.1 (−0.2 to 0.4) 0.657
Identiﬁed regulation 55 2.9 (0.7) 84 3.0 (0.6) 0.1 (−0.1 to 0.3) 0.412 0.1 (−0.1 to 0.3) 0.515
Intrinsic regulation 54 2.8 (1.1) 81 2.8 (1.0) 0.2 (−0.1 to 0.4) 0.239 0.2 (−0.1 to 0.4) 0.210
RAI 53 6.0 (3.8) 81 6.1 (3.5) 0.2 (−0.8 to 1.2) 0.711 0.2 (−0.8 to 1.3) 0.649
a Adjusted for baseline.
b Using the ANCOVA model.
c Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, HRQoL
(SF-12v2 plus 4 total score) and baseline outcome measurement.
d Using multiple regression.
Note: a higher RAI score indicates higher self-determination and a positive mean difference favours the booster
interventions over the control.
TABLE 42 Differences in change in the BREQ-2 multidimensions between the booster intervention group (mini plus
full) and the control group at 3 months (ITT set)
Outcome
Control Booster
Mean
difference
(95% CI)
a
p-valueb
Adjusted mean
difference
(95% CI)
c
p-valuedn
Mean
(SD) n
Mean
(SD)
Amotivation 59 0.3 (0.5) 95 0.2 (0.5) −0.1 (−0.2 to 0.1) 0.510 −0.0 (−0.2 to 0.1) 0.735
External regulation 59 0.3 (0.5) 95 0.4 (0.6) 0.0 (−0.1 to 0.2) 0.514 0.0 (−0.1 to 0.2) 0.565
Introjected regulation 60 1.1 (1.1) 95 1.4 (1.2) 0.2 (−0.1 to 0.5) 0.175 0.1 (−0.2 to 0.5) 0.434
Identiﬁed regulation 59 2.9 (0.8) 95 3.1 (0.6) 0.2 (0.1 to 0.4) 0.011 0.2 (0.0 to 0.4) 0.020
Intrinsic regulation 57 2.8 (1.0) 92 3.0 (0.9) 0.3 (0.0 to 0.5) 0.028 0.2 (0.0 to 0.5) 0.049
RAI 57 5.8 (3.4) 92 6.4 (3.4) 0.6 (−0.3 to 1.5) 0.168 0.6 (−0.3 to 1.4) 0.192
a Adjusted for baseline.
b Using the ANCOVA model.
c Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, HRQoL
(SF-12v2 plus 4 total score) and baseline outcome measurement.
d Using multiple regression.
Note: a higher RAI score indicates higher self-determination and a positive mean difference favours the booster
interventions over the control.
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TABLE 43 Differences in change in the BREQ-2 multidimensions between the booster intervention group (mini plus
full) and the control group at 9 months (ITT set)
Outcome
Control Booster
Mean difference
(95% CI)
a
p-valueb
Adjusted mean
difference
(95% CI)
c
p-valuedn
Mean
(SD) n
Mean
(SD)
Amotivation 44 0.3 (0.6) 65 0.2 (0.3) −0.1 (−0.2 to 0.1) 0.386 −0.1 (−0.2 to 0.1) 0.454
External regulation 44 0.3 (0.6) 65 0.2 (0.4) −0.1 (−0.2 to 0.1) 0.328 −0.1 (−0.3 to 0.1) 0.340
Introjected regulation 44 1.3 (1.1) 65 1.4 (1.1) −0.0 (−0.4 to 0.3) 0.894 −0.1 (−0.4 to 0.2) 0.527
Identiﬁed regulation 44 2.9 (0.7) 65 3.0 (0.6) 0.1 (−0.1 to 0.3) 0.483 0.1 (−0.2 to 0.3) 0.558
Intrinsic regulation 43 2.8 (1.1) 62 3.0 (0.9) 0.2 (−0.0 to 0.5) 0.072 0.3 (0.0 to 0.6) 0.043
RAI 43 5.9 (3.9) 62 6.8 (2.6) 0.7 (−0.4 to 1.7) 0.218 0.8 (−0.3 to 1.9) 0.169
a Adjusted for baseline.
b Using the ANCOVA model.
c Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, HRQoL
(SF-12v2 plus 4 total score) and baseline outcome measurement.
d Using multiple regression.
Note: a higher RAI score indicates higher self-determination and a positive mean difference favours the booster
interventions over the control.
TABLE 44 Difference in BMI between the booster intervention group (mini plus full) and the control group at 3 and
9 months (all available data)
Follow-up
(months) Outcome
Control Booster
Mean
difference
(95% CI)
a
p-valueb
Adjusted
mean
difference
(95% CI)
c
p-valuedn
Mean
(SD) n
Mean
(SD)
3 BMI
(kg/m2)
75 29.6 (5.9) 124 30.1 (5.5) −0.2 (−0.5
to 0.1)
0.194 −0.1 (−0.4
to 0.2)
0.385
9 BMI
(kg/m2)
55 28.4 (5.4) 85 29.1 (5.1) 0.1 (−0.3
to 0.6)
0.601 0.1 (−0.4
to 0.6)
0.594
a Adjusted for baseline BMI.
b Using the ANCOVA model.
c Adjusted for age, gender, total minutes of physical activity at 3 months and 1 week before randomisation, HRQoL
(SF-12v2 plus 4 total score) and baseline BMI.
d Using multiple regression.
Note: a negative mean difference in BMI favours the booster interventions over the control.
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TABLE 45 Difference in BMI between the booster intervention group (mini plus full) and the control group at 3 and
9 months (ITT set)
Follow-up
(months) Outcome
Control Booster
Mean
difference
(95% CI)
a
p-valueb
Adjusted
mean
difference
(95% CI)
c
p-valuedn
Mean
(SD) n
Mean
(SD)
3 BMI
(kg/m2)
59 29.0
(4.5)
95 29.6
(5.5)
−0.2 (−0.6
to 0.1)
0.160 −0.2 (−0.5
to 0.1)
0.300
9 BMI
(kg/m2)
44 28.4
(4.9)
66 28.6
(5.2)
0.1 (−0.5
to 0.6)
0.844 0.1 (−0.5
to 0.6)
0.839
a Adjusted for baseline BMI.
b Using the ANCOVA model.
c Adjusted for age, gender, total minutes of physical activity at 3 months and 1 week before randomisation, HRQoL
(SF-12v2 plus 4 total score) and baseline BMI.
d Using multiple regression.
Note: a negative mean difference in BMI favours the booster interventions over the control.
TABLE 46 Difference in total minutes of self-reported physical activity over a week period between the booster
intervention group (mini plus full) and the control group at 3 and 9 months (ITT set)
Follow-up
(months) Outcome
Control Booster
Mean
difference
(95% CI)a p-valuea
Adjusted
mean
difference
(95% CI)b p-valuecn
Mean
(SD) n
Mean
(SD)
3 Total minutes of
physical activity
60 383.8
(404.5)
96 419.8
(527.9)
49.5 (−109.4
to 206.3)
0.545 32.1 (−131.1
to 195.3)
0.698
9 Total minutes of
physical activity
44 461.0
(457.4)
66 535.0
(560.2)
74.0 (−128.2
to 276.2)
0.470 120.0 (−92.1
to 332.1)
0.264
a Adjusted for baseline total minutes of physical activity using the ANCOVA model.
b Adjusted for age, gender, BMI, HRQoL (SF-12v2 plus 4 total score) and total minutes of physical activity.
c Using multiple regression.
Note: a positive mean difference in self-reported total minutes of physical activity favours the booster interventions over
the control.
TABLE 47 Difference in total minutes of self-reported physical activity over a week period between the booster
intervention group (mini plus full) and the control group at 3 and 9 months (all available data)
Follow-up
(months) Outcome
Control Booster
Mean
difference
(95% CI)
a
p-value
a
Adjusted
mean
difference
(95% CI)b p-value
c
n
Mean
(SD) n
Mean
(SD)
3 Total minutes of
physical activity
76 458.0
(681.2)
125 411.2
(498.3)
−35.4 (−200.0
to 129.2)
0.672 −52.5 (−222.6
to 117.6)
0.543
9 Total minutes of
physical activity
54 446.1
(472.4)
81 508.6
(597.4)
62.4 (−128.4
to 253.3)
0.519 88.4 (−114.3
to 291.1)
0.390
a Adjusted for baseline total minutes of physical activity using the ANCOVA model.
b Adjusted for age, gender, BMI, HRQoL (SF-12v2 plus 4 total score) and total minutes of physical activity.
c Using multiple regression.
Note: a positive mean difference in self-reported total minutes of physical activity favours the booster interventions over
the control.
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TABLE 48 Difference in distance walked between the booster intervention group (mini plus full) and the control
group at 3 and 9 months (all available data)
Follow-up
(months) Outcome
Control,
mean (SD)
Booster,
mean (SD)
Mean
difference
(95% CI)
a
p-value
a
Adjusted
mean
difference
(95% CI)b p-value
c
3 Distance walked (m)
on 12-minute
walk test
(n = 75) (n = 118)
898.9
(257.5)
962.4
(227.5)
63.5 (−6.3
to 133.3)
0.074 80.3 (13.8
to 146.8)
0.018
9 Distance walked (m)
on 12-minute
walk test
(n = 51) (n = 82)
992.2
(292.7)
1077.4
(301.0)
85.2 (−19.9
to 190.3)
0.111 80.6 (−26.8
to 188.0)
0.140
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and
HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
TABLE 49 Difference in distance walked between the booster intervention group (mini plus full) and the control
group at 3 and 9 months (ITT set)
Follow-up
(months) Outcome
Control,
mean (SD)
Booster,
mean (SD)
Mean
difference
(95% CI)
a
p-value
a
Adjusted
mean
difference
(95% CI)b p-value
c
3 Distance walked (m)
on 12-minute
walk test
(n = 59) (n = 91)
917.6
(254.9)
984.2
(226.2)
66.6 (−12.0
to 145.2)
0.096 90.8 (14.5
to 167.1)
0.020
9 Distance walked (m)
on 12-minute
walk test
(n = 42) (n = 64)
1000.2
(308.8)
1102.4
(285.4)
102.2 (−13.9
to 218.3)
0.084 115.9 (1.1
to 230.7)
0.048
a Using a two independent sample t-test.
b Adjusted for age, gender, BMI, total minutes of physical activity at 3 months and 1 week before randomisation, and
HRQoL (SF-12v2 plus 4 total score).
c Using multiple regression.
TABLE 50 Proportions of participants meeting current recommendations of at least 30 minutes of at least
moderate physical activity for at least 5 days a week at 3 and 9 months
Follow-up
(months) Outcome
Control,
n (%)
Mini
booster,
n (%)
Full
booster,
n (%)
Mini + full
booster,
n (%)
Difference in
proportion
maintaining or
increasing
physical activity
(95% CI) (%) p-value
3 Meeting current
physical activity
recommendations
(n = 73) (n = 57) (n = 59) (n = 116)
25 (34.2) 12 (21.1) 27 (45.8) 39 (33.6) −0.6 (−14.5 to 13.2) 0.929
9 Meeting current
physical activity
recommendations
(n = 39) (n = 27) (n = 35) (n = 62)
11 (28.2) 7 (25.9) 12 (34.3) 19 (30.6) 2.4 (−15.7 to 20.6) 0.794
Note: at least moderate physical activity was deﬁned as having at least 3 METs.
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TABLE 51 Subgroup evaluation: interaction effect at 3 months between gender and intervention
Outcome measure Subgroup
Control,
mean (SD)
Booster,
mean (SD)
Mean difference
(95% CI) p-value
Mean TEE per day (kcal) Male (n = 26) (n = 42)
2483.0 (421.8) 2455.2 (416.3) –27.8 (–236.3 to 180.6) 0.791
Female (n = 35) (n = 57)
2104.6 (322.7) 2058.6 (343.0) –46.0 (–189.1 to 97.1) 0.525
All (n = 61) (n = 99)
2265.9 (410.8) 2226.9 (422.6) –39.0 (–173.4 to 95.4) 0.567
Interaction
test
NA NA –18.2 (–260.6 to 224.3)
a
0.882
NA, not applicable.
a Interaction test mean difference is the difference in the mean difference in treatment effect between men and women.
Note: positive and negative mean difference in mean TEE favours the booster group and the control group respectively.
TABLE 52 Subgroup evaluation: interaction effect at 9 months between gender and intervention
Outcome measure Subgroup
Control,
mean (SD)
Booster,
mean (SD)
Mean difference
(95% CI) p-value
Mean TEE per day (kcal) Male (n = 13) (n = 27)
2425.9 (402.6) 2409.2 (382.1) –16.8 (–282.4 to 248.9) 0.899
Female (n = 23) (n = 27)
2036.6 (311.9) 2069.1 (339.6) 32.4 (–154.2 to 219.1) 0.728
Alla (n = 36) (n = 54)
2177.2 (390.7) 2239.1 (397.1) 61.9 (–106.8 to 230.6) 0.468
Interaction
test
NA NA 49.2 (–262.6 to 361.0)b 0.755
NA, not applicable.
a Excluding a participant with an extreme value (mean TEE per day of 6047.6 kcal).
b Interaction mean difference is the difference in the mean difference in treatment effect between men and women.
Note: positive and negative mean difference in mean TEE favours the booster group and the control group respectively.
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TABLE 53 Subgroup evaluation: interaction effect at 3 months between use of community facilities in the last
month (yes or no) and intervention
Outcome measure Subgroup
Control,
mean (SD)
Booster,
mean (SD)
Mean difference
(95% CI) p-value
Mean TEE per day (kcal) Yes (n = 16) (n = 22)
2097.5 (244.0) 2181.1 (358.8) 83.6 (–127.0 to 294.2) 0.426
No (n = 45) (n = 76)
2325.8 (442.5) 2249.2 (435.7) –76.6 (–239.8 to 86.6) 0.355
All (n = 61) (n = 98)
2265.9 (410.8) 2233.9 (418.9) –32.0 (–166.0 to 101.9) 0.638
Interaction
test
NA NA –160.2 (–469.1 to 148.7)
a
0.307
NA, not applicable.
a Interaction test mean difference is the difference in the mean difference in treatment effect between men and women.
Note: positive and negative mean difference in mean TEE favours the booster group and the control group respectively.
TABLE 54 Subgroup evaluation: interaction effect at 9 months between use of community facilities in the last
month (yes or no) and intervention
Outcome measure Subgroup
Control,
mean (SD)
Booster,
mean (SD)
Mean difference
(95% CI) p-value
Mean TEE per day (kcal) Yes (n = 11) (n = 14)
2084.8 (398.5) 2079.7 (230.0) –5.1 (–267.2 to 257.1) 0.968
No (n = 25) (n = 39)
2217.9 (388.4) 2313.1 (419.0) 95.2 (–113.4 to 303.9) 0.365
All
a
(n = 36) (n = 53)
2177.2 (390.7) 2251.5 (390.3) 74.2 (–93.4 to 241.9) 0.381
Interaction
test
NA NA 100.3 (–264.8 to 465.3)b 0.586
NA, not applicable.
a Excluding a participant with an extreme value (mean TEE per day of 6047.6 kcal).
b Interaction mean difference is the difference in the mean difference in treatment effect between men and women.
Note: positive and negative mean difference in mean TEE favours the booster group and the control group respectively.
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TABLE 55 Subgroup evaluation: interaction effect at 3 months between seasonality (time of initial contact) and
intervention (full booster vs. control)
Outcome measure Subgroup
Control,
mean (SD)
Full booster,
mean (SD)
Mean difference
(95% CI) p-value
Mean TEE per day (kcal) Summer/
spring
(n = 48) (n = 33)
2275.8 (417.6) 2315.2 (444.9) 39.4 (–153.7 to 232.4) 0.686
Winter/
autumn
(n = 13) (n = 19)
2229.3 (398.3) 2218.6 (394.0) –10.8 (–301.6 to 280.1) 0.940
All (n = 61) (n = 52)
2265.9 (410.8) 2279.9 (425.6) 14.0 (–142.2 to 170.2) 0.860
Interaction
test
NA NA –50.1 (–404.0 to 303.7)
a
0.779
NA, not applicable.
a Interaction test mean difference is the difference in the mean difference in treatment effect between those approached
in summer/spring and those approached in winter/autumn.
Note: positive and negative mean difference in mean TEE favours the full booster group and the control group respectively.
TABLE 56 Subgroup evaluation: interaction effect at 3 months between seasonality (time of initial contact) and
intervention (mini booster vs. control)
Outcome measure Subgroup
Control,
mean (SD)
Mini booster,
mean (SD)
Mean difference
(95% CI) p-value
Mean TEE per day (kcal) Summer/
spring
(n = 48) (n = 35)
2275.8 (417.6) 2154.5 (411.9) –121.4 (–305.0 to 62.3) 0.192
Winter/
autumn
(n = 13) (n = 12)
2229.3 (398.3) 2208.4 (442.8) –20.9 (–368.8 to 327.0) 0.902
All (n = 61) (n = 47)
2265.9 (410.8) 2168.2 (415.8) –97.7 (–256.6 to 61.2) 0.226
Interaction
test
NA NA 100.4 (–277.6 to 478.5)
a
0.599
NA, not applicable.
a Interaction test mean difference is the difference in the mean difference in treatment effect between those approached
in summer/spring and those approached in winter/autumn.
Note: positive and negative mean difference in mean TEE favours the full booster group and the control group respectively.
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Appendix 7 Results tables from the process
evaluation
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TABLE 57 Process evaluation survey responders’ baseline characteristics
Variable
Non-responders
(n = 207)
Responders (process evaluation participants)
All participants
(n = 282)
All
(n = 75)
Control
(n = 26)
Mini booster
(n = 25)
Full booster
(n = 24)
Gender, n (%)
Male 98 (47) 32 (43) 11 (42) 7 (28) 14 (58) 130 (46)
Female 109 (53) 43 (57) 15 (58) 18 (72) 10 (42) 152 (54)
Employment status, n (%)
Part-time 35 (17) 17 (23) 5 (19) 9 (36) 3 (13) 52 (18)
Full-time 69 (33) 24 (32) 12 (46) 6 (24) 6 (25) 93 (33)
Not employed 100 (48) 34 (45) 9 (35) 10 (40) 15 (63) 134 (48)
Missing 3 (1) 0 (0) 0 (0) 0 (0) 0 (0) 3 (1)
Ethnicity, n (%)
White British 179 (87) 67 (89) 23 (88) 22 (88) 22 (92 246 (87)
Any other 25 (13) 8 (11) 3 (12) 3 (12) 2 (8%) 33 (12)
Missing 3 (1) 0 (0) 0 (0) 0 (0) 0 (0) 3 (1)
Stage of change, n (%)
Contemplation 11 (5.3) 1 (1.3) 0 (0) 0 (0.0) 1 (4.2) 12 (4.3)
Preparation 91 (44.0) 34 (45.3) 13 (50.0) 13 (52.0) 8 (33.3) 125 (44.3)
Action 66 (31.9) 25 (33.3) 8 (30.8) 6 (24.0) 11 (45.8) 91 (32.3)
Maintenance 37 (17.9) 13 (17.3) 4 (15.4) 6 (24.0) 3 (12.5) 50 (17.7)
Missing 2 (1.0) 2 (2.7) 1 (3.8) 0 (0.0) 1 (4.2) 4 (1.4)
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Variable
Non-responders
(n = 207)
Responders (process evaluation participants)
All participants
(n = 282)
All
(n = 75)
Control
(n = 26)
Mini booster
(n = 25)
Full booster
(n = 24)
Marital status, n (%)
Single 33 (16) 12 (16) 5 (19) 6 (24) 1 (4) 45 (16)
Married 112 (54) 39 (52) 12 (46) 10 (40) 17 (71) 151 (54)
Co-habiting 14 (7) 6 (8) 1 (4) 3 (12) 2 (8) 20 (7)
Divorced/separated 40 (19) 15 (20) 7 (27) 5 (20) 3 (13) 55 (20)
Widowed 8 (4) 3 (4) 1 (4) 1 (4) 1 (4) 11 (4)
Age (years)
n (%) 207 (100) 75 (100) 26 (100) 25 (100) 24 (100) 282 (100)
Mean (SD) 54.1 (7.4) 56.0 (7.0) 54.9 (5.9) 55.6 (8.1) 57.5 (6.8) 54.6 (7.3)
Median (IQR) 54.2 (47.9 to 60.8) 56.0 (50.4 to 62.7) 52.7 (50.5 to 60.9) 59.1 (49.9 to 62.0) 59.5 (51.2 to 63.8) 55.3 (48.8 to 61.4)
Min. to max. 40.5 to 65.5 40.4 to 65.0 46.3 to 64.8 40.4 to 65.0 44.0 to 64.9 40.4 to 65.5
Height (m)
n (%) 206 (100) 75 (100) 26 (100) 25 (100) 24 (100) 281 (100)
Mean (SD) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 1.6 (0.1) 1.7 (0.1) 1.7 (0.1)
Median (IQR) 1.7 (1.6 to 1.7) 1.7 (1.6 to 1.8) 1.7 (1.6 to 1.7) 1.6 (1.6 to 1.7) 1.7 (1.6 to 1.8) 1.7 (1.6 to1.8)
Min. to max. 1.5 to 1.9 1.5 to 1.9 1.5 to 1.9 1.5 to 1.8 1.5 to 1.9 1.5 to 1.9
Weight (kg)
n (%) 207 (100) 75 (100) 26 (100) 25 (100) 24 (100) 282 (100)
Mean (SD) 84.7 (19.2) 86.5 (17.3) 86.4 (17.1) 82.6 (17.9) 90.7 (16.7) 85.2 (18.7)
Median (IQR) 82.0 (71.7 to 97.3) 84.3 (74.5 to 95.2) 84.4 (72.6 to 92.5) 83.0 (73.0 to 89.8) 87.7 (76.9 to 102.3) 82.9 (72.5 to 96.6)
Min. to max. 46.9 to 160.0 54.7 to 141.0 65.3 to 135.0 54.7 to 141.0 67.7 to 124.0 46.9 to 160.0
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TABLE 57 Process evaluation survey responders’ baseline characteristics (continued )
Variable
Non-responders
(n = 207)
Responders (process evaluation participants)
All participants
(n = 282)
All
(n = 75)
Control
(n = 26)
Mini booster
(n = 25)
Full booster
(n = 24)
BMI (kg/m2)
n (%) 206 (100) 75 (100) 26 (100) 25 (100) 24 (100) 281 (100)
Mean (SD) 30.2 (6.1) 30.7 (5.5) 31.1 (6.7) 30.3 (5.5) 30.8 (3.9) 30.3 (5.9)
Median (IQR) 29.7 (25.7 to 33.0) 29.8 (27.3 to 33.2) 28.8 (27.2 to 33.1) 29.9 (26.9 to 32.6) 29.9 (28.2 to 34.2) 29.8 (26.3 to 33.0)
Min. to max. 17.1 to 48.3 21.6 to 53.4 21.6 to 53.4 22.5 to 49.4 25.0 to 39.1 17.1 to 53.4
SPAQ change (3 months post randomisation)
n (%) 207 (100) 75 (100) 26 (100) 25 (100) 24 (100) 282 (100)
Mean (SD) 227.2 (401.0) 162.7 (265.0) 159.8 (191.6) 143.0 (245.6) 186.3 (349.4) 210.0 (370.4)
Median (IQR) 125.0 (70.0 to 260.0) 90.0 (40.0 to 210.0) 117.5 (65.0 to 180.0) 90.0 (40.0 to 260.0) 80.0 (35.0 to 182.5) 120.0 (60.0 to 255.0)
Min. to max. –1840.0 to 3360.0 –480.0 to 1500.0 –210.0 to 690.0 –480.0 to 795.0 –150.0 to 1500.0 –1840.0 to 3360.0
BREQ-2 (RAI)
n (%) 201 (97) 73 (97) 24 (92) 25 (100) 24 (100) 274 (97)
Mean (SD) 5.2 (3.6) 5.4 (4.0) 5.8 (3.9) 3.9 (4.5) 6.4 (3.1) 5.3 (3.7)
Median (IQR) 5.8 (3.3 to 7.9) 6.4 (2.9 to 8.3) 6.5 (4.3 to 8.0) 5.8 1.3 to 7.3) 6.9 (3.7 to 9.0) 6.0 (3.3 to 8.0)
Min. to max. –9.1 to 11.5 –5.3 to 12.0 –2.6 to 12.0 –5.3 to 9.2 –0.2 to 11.0 –9.1 to 12.0
max., maximum; min., minimum.
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TABLE 58 Responses to process evaluation closed questions
Survey question Scoring
Control
(n = 26),
n (%)
Mini
(n = 25),
n (%)
Full
(n = 24),
n (%)
Total
(n = 75),
n (%)
Q1: Over the last 3 months have you taken part in any of the following?
Recreational/leisure
activities (e.g.
gardening, cycling)
Not ticked 6 (23.1) 2 (8.0) 4 (16.7) 12 (16.0)
Ticked 20 (76.9) 23 (92.0) 20 (83.3) 63 (84.0)
Competitive
sports/exercise
Not ticked 22 (84.6) 22 (88.0) 22 (91.7) 66 (88.0)
Ticked 4 (15.4) 3 (12.0) 2 (8.3) 9 (12.0)
Structured exercise
(e.g. exercise class)
Not ticked 16 (61.5) 18 (72.0) 15 (62.5) 49 (65.3)
Ticked 10 (38.5) 7 (28.0) 9 (37.5) 26 (34.7)
Active commuting
(e.g. walking/cycling
to work)
Not ticked 11 (42.3) 7 (28.0) 4 (16.7) 22 (29.3)
Ticked 15 (57.7) 18 (72.0) 20 (83.3) 53 (70.7)
Q2: Please specify the places where you have done your chosen activities over the last 3 months
Home Not ticked 12 (46.2) 12 (48.0) 14 (58.3) 38 (50.7)
Ticked 14 (53.8) 13 (52.0) 10 (41.7) 37 (49.3)
Local open space
(e.g. park)
Not ticked 14 (53.8) 12 (48.0) 8 (33.3) 34 (45.3)
Ticked 12 (46.2) 13 (52.0) 16 (66.7) 41 (54.7)
Facility (e.g. gym,
pool, community
centre, track)
Not ticked 16 (61.5) 12 (48.0) 14 (58.3) 42 (56.0)
Ticked 10 (38.5) 13 (52.0) 10 (41.7) 33 (44.0)
As part of daily activities
(e.g. in work, shopping,
walking the dog,
commuting)
Not ticked 8 (30.8) 8 (32.0) 7 (29.2) 23 (30.7)
Ticked 18 (69.2) 17 (68.0) 17 (70.8) 52 (69.3)
Other places Not ticked 23 (88.5) 21 (84.0) 20 (83.3) 64 (85.3)
Ticked 3 (11.5) 4 (16.0) 4 (16.7) 11 (14.7)
Q3: Why have you chosen to stay physically active?
To improve my health Not at all 1 (3.8) 1 (4.0) 0 (0.0) 2 (2.7)
Neutral 0 (0.0) 2 (8.0) 1 (4.2) 3 (4.0)
Slightly 4 (15.4) 3 (12.0) 4 (16.7) 11 (14.7)
Very much 20 (76.9) 19 (76.0) 19 (79.2) 58 (77.3)
To get ﬁtter/stay ﬁt Not at all 0 (0.0) 1 (4.0) 0 (0.0) 1 (1.3)
Slightly 6 (23.1) 5 (20.0) 4 (16.7) 15 (20.0)
Very much 19 (73.1) 19 (76.0) 20 (83.3) 58 (77.3)
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TABLE 58 Responses to process evaluation closed questions (continued )
Survey question Scoring
Control
(n = 26),
n (%)
Mini
(n = 25),
n (%)
Full
(n = 24),
n (%)
Total
(n = 75),
n (%)
To lose weight Not at all 4 (15.4) 2 (8.0) 0 (0.0) 6 (8.0)
Not really 0 (0.0) 0 (0.0) 1 (4.2) 1 (1.3)
Neutral 1 (3.8) 1 (4.0) 0 (0.0) 2 (2.7)
Slightly 7 (26.9) 8 (32.0) 10 (41.7) 25 (33.3)
Very much 14 (53.8) 14 (56.0) 13 (54.2) 41 (54.7)
To look better Not at all 0 (0.0) 0 (0.0) 1 (4.2) 1 (1.3)
Not really 3 (11.5) 2 (8.0) 2 (8.3) 7 (9.3)
Neutral 6 (23.1) 3 (12.0) 2 (8.3) 11 (14.7)
Slightly 6 (23.1) 12 (48.0) 7 (29.2) 25 (33.3)
Very much 10 (38.5) 7 (28.0) 12 (50.0) 29 (38.7)
To encourage my family
to be more active
Not at all 6 (23.1) 8 (32.0) 6 (25.0) 20 (26.7)
Not really 6 (23.1) 5 (20.0) 3 (12.5) 14 (18.7)
Neutral 8 (30.8) 7 (28.0) 4 (16.7) 19 (25.3)
Slightly 4 (15.4) 2 (8.0) 9 (37.5) 15 (20.0)
Very much 1 (3.8) 2 (8.0) 2 (8.3) 5 (6.7)
To make new friends Not at all 6 (23.1) 8 (32.0) 7 (29.2) 21 (28.0)
Not really 8 (30.8) 10 (40.%) 5 (20.8) 23 (30.7)
Neutral 7 (26.9) 5 (20.0) 7 (29.2) 19 (25.3)
Slightly 3 (11.5) 1 (4.0) 4 (16.7) 8 (10.7)
Very much 2 (7.7) 1 (4.0) 1 (4.2) 4 (5.3)
To have fun/enjoyment Not at all 2 (7.7) 3 (12.0) 0 (0.0) 5 (6.7)
Not really 2 (7.7) 2 (8.0) 1 (4.2) 5 (6.7)
Neutral 6 (23.1) 5 (20.0) 5 (20.8) 16 (21.3)
Slightly 10 (38.5) 7 (28.0) 13 (54.2) 30 (40.0)
Very much 5 (19.2) 8 (32.0) 5 (20.8) 18 (24.0)
To spend time
with family
Not at all 9 (34.6) 9 (36.0) 7 (29.2) 25 (33.3)
Not really 8 (30.8) 5 (20.0) 3 (12.5) 16 (21.3)
Neutral 6 (23.1) 7 (28.0) 5 (20.8) 18 (24.0)
Slightly 2 (7.7) 2 (8.0) 7 (29.2) 11 (14.7)
Very much 0 (0.0) 1 (4.0) 1 (4.2) 2 (2.7)
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TABLE 58 Responses to process evaluation closed questions (continued )
Survey question Scoring
Control
(n = 26),
n (%)
Mini
(n = 25),
n (%)
Full
(n = 24),
n (%)
Total
(n = 75),
n (%)
To spend time
with friends
Not at all 6 (23.1) 9 (36.0) 7 (29.2) 22 (29.3)
Not really 10 (38.5) 8 (32.0) 3 (12.5) 21 (28.0)
Neutral 8 (30.8) 4 (16.0) 6 (25.0) 18 (24.0)
Slightly 1 (3.8) 1 (4.0) 5 (20.8) 7 (9.3)
Very much 0 (0.0) 2 (8.0) 3 (12.5) 5 (6.7)
For competition/to win Not at all 19 (73.1) 16 (64.0) 17 (70.8) 52 (69.3)
Not really 4 (15.4) 3 (12.0) 1 (4.2) 8 (10.7)
Neutral 2 (7.7) 5 (20.0) 4 (16.7) 11 (14.7)
Very much 0 (0.0) 0 (0.0) 2 (8.3) 2 (2.7)
It’s part of my job Not at all 18 (69.2) 17 (68.0) 16 (66.7) 51 (68.0)
Not really 2 (7.7) 1 (4.0) 4 (16.7) 7 (9.3)
Neutral 2 (7.7) 3 (12.0) 2 (8.3) 7 (9.3)
Slightly 2 (7.7) 2 (8.0) 0 (0.0) 4 (5.3)
Very much 1 (3.8) 1 (4.0) 1 (4.2) 3 (4.0)
Missing 1 (3.8) 1 (4.0) 1 (4.2) 3 (4.0)
It gives me a sense
of achievement
Not at all 0 (0.0) 1 (4.0) 1 (4.2) 2 (2.7)
Not really 0 (0.0) 0 (0.0) 1 (4.2) 1 (1.3)
Neutral 3 (11.5) 4 (16.0) 2 (8.3) 9 (12.0)
Slightly 9 (34.6) 7 (28.0) 9 (37.5) 25 (33.3)
Very much 14 (53.8) 13 (52.0) 11 (45.8) 38 (50.7)
To reduce the risks
of health problems
(e.g. diabetes,
heart disease)
Not at all 1 (3.8) 1 (4.0) 0 (0.0) 2 (2.7)
Not really 2 (7.7) 0 (0.0) 0 (0.0) 2 (2.7)
Neutral 0 (0.0) 3 (12.0) 1 (4.2) 4 (5.3)
Slightly 3 (11.5) 3 (12.0) 5 (20.8) 11 (14.7)
Very much 19 (73.1) 18 (72.0) 18 (75.0) 55 (73.3)
Missing 1 (3.8) 0 (0.0) 0 (0.0) 1 (1.3)
I haven’t stayed active Not at all 16 (61.5) 11 (44.0) 18 (75.0) 45 (60.0)
Not really 2 (7.7) 4 (16.0) 1 (4.2) 7 (9.3)
Neutral 3 (11.5) 4 (16.0) 3 (12.5) 10 (13.3)
Slightly 3 (11.5) 3 (12.0) 0 (0.0) 6 (8.0)
Very much 1 (3.8) 1 (4.0) 0 (0.0) 2 (2.7)
Missing 1 (3.8) 2 (8.0) 2 (8.3) 5 (6.7)
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TABLE 58 Responses to process evaluation closed questions (continued )
Survey question Scoring
Control
(n = 26),
n (%)
Mini
(n = 25),
n (%)
Full
(n = 24),
n (%)
Total
(n = 75),
n (%)
A health professional
recommended that
I should
Not at all 11 (42.3) 12 (48.0) 14 (58.3) 37 (49.3)
Not really 2 (7.7) 1 (4.0) 0 (0.0) 3 (4.0)
Neutral 0 (0.0) 2 (8.0) 1 (4.2) 3 (4.0)
Slightly 5 (19.2) 1 (4.0) 3 (12.5) 9 (12.0)
Very much 1 (3.8) 2 (8.0) 1 (4.2) 4 (5.3)
Missing 7 (26.9) 7 (28.0) 5 (20.8) 19 (25.3)
Other reasons Not at all 4 (15.4) 2 (8.0) 2 (8.3) 8 (10.7)
Neutral 0 (0.0) 0 (0.0) 1 (4.2) 1 (1.3)
Missing 22 (84.6) 23 (92.0) 21 (87.5) 66 (88.0)
Q4: What inﬂuences whether or not you are able to perform your chosen activity?
Value for money Not at all 6 (23.1) 4 (16.0) 10 (41.7) 20 (26.7)
Not really 5 (19.2) 5 (20.0) 3 (12.5) 13 (17.3)
Neutral 0 (0.0) 6 (24.0) 1 (4.2) 7 (9.3)
Slightly 8 (30.8) 5 (20.0) 3 (12.5) 16 (21.3)
Very much 6 (23.1) 4 (16.0) 5 (20.8) 15 (20.0)
Missing 1 (3.8) 1 (4.0) 2 (8.3) 4 (5.3)
Activity is available
when I want
Not at all 0 (0.0) 1 (4.0) 2 (8.3) 3 (4.0)
Not really 3 (11.5) 1 (4.0) 2 (8.3) 6 (8.0)
Neutral 3 (11.5) 0 (0.0) 0 (0.0) 3 (4.0)
Slightly 4 (15.4) 7 (28.0) 6 (25.0) 17 (22.7)
Very much 16 (61.5) 15 (60.0) 12 (50.0) 43 (57.3)
Missing 0 (0.0) 1 (4.0) 2 (8.3) 3 (4.0)
Childcare available Not at all 21 (80.8s) 21 (84.0) 21 (87.5) 63 (84.0)
Neutral 2 (7.7) 1 (4.0) 0 (0.0) 3 (4.0)
Very much 0 (0.0) 1 (4.0) 1 (4.2) 2 (2.7)
Missing 3 (11.5) 2 (8.0) 2 (8.3) 7 (9.3)
Within walking distance
of home/work
Not at all 6 (23.1) 5 (20.0) 7 (29.2) 18 (24.0)
Not really 2 (7.7) 6 (24.0) 5 (20.8) 13 (17.3)
Neutral 3 (11.5) 3 (12.0) 2 (8.3) 8 (10.7)
Slightly 6 (23.1) 3 (12.0) 4 (16.7) 13 (17.3)
Very much 8 (30.8) 7 (28.0) 2 (8.3) 17 (22.7)
Missing 1 (3.8) 1 (4.0) 4 (16.7) 6 (8.0)
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TABLE 58 Responses to process evaluation closed questions (continued )
Survey question Scoring
Control
(n = 26),
n (%)
Mini
(n = 25),
n (%)
Full
(n = 24),
n (%)
Total
(n = 75),
n (%)
Within easy reach on
public transport
Not at all 7 (26.9) 9 (36.0) 6 (25.0) 22 (29.3)
Not really 2 (7.7) 6 (24.0) 5 (20.8) 13 (17.3)
Neutral 1 (3.8) 4 (16.0) 2 (8.3) 7 (9.3)
Slightly 9 (34.6) 2 (8.0) 5 (20.8) 16 (21.3)
Very much 5 (19.2) 3 (12.0) 2 (8.3) 10 (13.3)
Missing 2 (7.7) 1 (4.0) 4 (16.7) 7 (9.3)
If I feel I’m getting
something out of it
Not at all 2 (7.7) 0 (0.0) 0 (0.0) 2 (2.7)
Not really 1 (3.8) 1 (4.0) 1 (4.2) 3 (4.0)
Neutral 1 (3.8) 1 (4.0) 1 (4.2) 3 (4.0)
Slightly 7 (26.9) 6 (24.0) 6 (25.0) 19 (25.3)
Very much 15 (57.7) 16 (64.0) 13 (54.2) 44 (58.7)
Missing 0 (0.0) 1 (4.0) 3 (12.5) 4 (5.3)
Whether there is
someone to do it with
Not at all 11 (42.3) 8 (32.0) 10 (41.7) 29 (38.7)
Not really 6 (23.1) 7 (28.0) 1 (4.2) 14 (18.7)
Neutral 3 (11.5) 4 (16.0) 3 (12.5) 10 (13.3)
Slightly 4 (15.4) 4 (16.0) 6 (25.0) 14 (18.7)
Very much 1 (3.8) 1 (4.0) 0 (0.0) 2 (2.7)
Missing 1 (3.8) 1 (4.0) 4 (16.7) 6 (8.0)
It’s a habit Not at all 3 (11.5) 7 (28.0) 8 (33.3) 18 (24.0)
Not really 5 (19.2) 3 (12.0) 3 (12.5) 11 (14.7)
Neutral 3 (11.5) 8 (32.0) 6 (25.0) 17 (22.7)
Slightly 9 (34.6) 4 (16.0) 1 (4.2) 14 (18.7)
Very much 6 (23.1) 2 (8.0) 2 (8.3) 10 (13.3)
Missing 0 (0.0) 1 (4.0) 4 (16.0) 5 (6.6)
Whether I can make
time to do it
Not at all 1 (3.8) 5 (20.0) 3 (12.5) 9 (12.0)
Not really 4 (15.4) 4 (16.0) 1 (4.2) 9 (12.0)
Neutral 4 (15.4) 1 (4.0) 4 (16.7) 9 (12.0)
Slightly 12 (46.2) 7 (28.0) 7 (29.2) 26 (34.7)
Very much 4 (15.4) 7 (28.0) 5 (20.8) 16 (21.3)
Missing 1 (3.8) 1 (4.0) 4 (16.7) 6 (8.0)
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TABLE 58 Responses to process evaluation closed questions (continued )
Survey question Scoring
Control
(n = 26),
n (%)
Mini
(n = 25),
n (%)
Full
(n = 24),
n (%)
Total
(n = 75),
n (%)
My own health Not at all 1 (3.8) 1 (4.0) 0 (0.0) 2 (2.7)
Not really 1 (3.8) 1 (4.0) 0 (0.0) 2 (2.7)
Neutral 2 (7.7) 1 (4.0) 0 (0.0) 3 (4.0)
Slightly 2 (7.7) 2 (8.0) 4 (16.7) 8 (10.7)
Very much 18 (69.2) 19 (76.0) 18 (75.0) 55 (73.3)
Missing 2 (7.7) 1 (4.0) 2 (8.3) 5 (6.7)
Other inﬂuences Not at all 0 (0.0) 1 (4.0) 1 (4.2) 2 (2.7)
Very much 0 (0.0) 0 (0.0) 1 (4.2) 1 (1.3)
Missing 26 (100.0) 24 (96.0) 22 (91.7) 72 (96.0)
Q5: Do you do physical activity with anyone else?
No 17 (65.4) 14 (56.0) 8 (33.3) 39 (52.0)
Yes 9 (34.6) 10 (40.0) 14 (58.3) 33 (44.0)
Q6: If you answered ‘yes’ to Q5, who do you usually do physical activity with?
Spouse/partner Not ticked 4 (15.4) 5 (20.0) 8 (33.3) 17 (22.7)
Ticked 5 (19.2) 6 (24.0) 8 (33.3) 19 (25.3)
Not applicable 17 (65.4) 14 (56.0) 8 (33.3) 39 (52.0)
Other family member(s) Not ticked 6 (23.1) 8 (32.0) 12 (50.0) 26 (34.7)
Ticked 3 (11.5) 3 (12.0) 4 (16.7) 10 (13.3)
Not applicable 17 (65.4) 14 (56.0) 8 (33.3) 39 (52.0)
Friend(s) Not ticked 7 (26.9) 7 (28.0) 8 (33.3) 22 (29.3)
Ticked 2 (7.7) 4 (16.0) 8 (33.3) 14 (18.7)
Not applicable 17 (65.4) 14 (56.0) 8 (33.3) 39 (52.0)
Other adult(s) Not ticked 7 (26.9) 9 (36.0) 12 (50.0) 28 (37.3)
Ticked 2 (7.7) 2 (8.0) 4 (16.7) 8 (10.7)
Not applicable 17 (65.4) 14 (56.0) 8 (33.3) 39 (52.0)
Child or children under
16 years
Not ticked 7 (26.9) 7 (28.0) 14 (58.3) 28 (37.3)
Ticked 2 (7.7) 4 (16.0) 2 (8.3) 8 (10.7)
Not applicable 17 (65.4) 14 (56.0) 8 (33.3) 39 (52.0)
As part of a group/class
(including walking group)
Not ticked 6 (23.1) 9 (36.0) 13 (54.2) 28 (37.3)
Ticked 3 (11.5) 2 (8.0) 3 (12.5) 8 (10.7)
Not applicable 17 (65.4) 14 (56.0) 8 (33.3) 39 (52.0)
Other Not ticked 9 (34.6) 11 (44.0) 15 (62.5) 35 (46.7)
Ticked 0 (0.0) 0 (0.0) 1 (4.2) 1 (1.3)
Not applicable 17 (65.4) 14 (56.0) 8 (33.3) 39 (52.0)
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TABLE 58 Responses to process evaluation closed questions (continued )
Survey question Scoring
Control
(n = 26),
n (%)
Mini
(n = 25),
n (%)
Full
(n = 24),
n (%)
Total
(n = 75),
n (%)
Q7: If you answered ‘yes’ to Q5, how useful do you ﬁnd this support in helping you stay active?
Not applicable 1 (3.8) 0 (0.0) 0 (0.0) 1 (1.3)
Very useful 3 (11.5) 1 (4.0) 9 (37.5) 13 (17.3)
Fairly useful 3 (11.5) 8 (32.0) 4 (16.7) 15 (20.0)
Neither useful nor useless 1 (3.8) 1 (4.0) 1 (4.2) 3 (4.0)
Very useless 1 (3.8) 0 (0.0) 0 (0.0) 1 (1.3)
Doesn’t do activity
(‘no’ on Q5)
17 (65.4) 14 (56.0) 8 (33.3) 39 (52.0)
Missing 0 (0.0) 1 (4.0) 2 (8.3) 3 (4.0)
(n = 25) (n = 25) (n = 50)
Q8: If you were to receive further activity ‘booster’ counselling/advice in the future, how would you prefer it to
be delivered?
Over the telephone Not ticked NA 13 (52.0) 23 (95.8) 36 (73.5)
Ticked NA 12 (48.0) 1 (4.2) 13 (26.5)
In person (face to face) Not ticked NA 16 (64.0) 5 (20.8) 21 (42.9)
Ticked NA 9 (36.0) 19 (79.2) 28 (57.1)
Written advice Not ticked NA 17 (68.0) 20 (83.3) 37 (75.5)
Ticked NA 8 (32.0) 4 (16.7) 12 (24.5)
Q9: Did the ‘booster’ physical activity counselling/advice meet the expectations you described above?
No NA 2 (8.0) 0 (0.0) 2 (4.1)
Yes NA 19 (76.0) 23 (95.8) 42 (85.7)
Missing NA 4 (16.0) 1 (4.2) 5 (10.2)
Q10: The ‘booster’ counselling/advice sessions ﬁtted easily into my daily schedule
Strongly disagree NA 2 (8.0) 2 (8.3) 4 (8.2)
Disagree NA 0 (0.0) 1 (4.2) 1 (2.0)
Neutral NA 1 (4.0) 2 (8.3) 3 (6.1)
Agree NA 12 (48.0) 10 (41.7) 22 (44.9)
Strongly agree NA 7 (28.0) 8 (33.3) 15 (30.6)
Missing NA 3 (12.0) 1 (4.2) 4 (8.2)
Q11: The ‘booster’ counselling/advice sessions were conducted at a convenient location
Strongly disagree NA 0 (0.0) 1 (4.2) 1 (2.0)
Neutral NA 0 (0.0) 1 (4.2) 1 (2.0)
Agree NA 0 (0.0) 10 (41.7) 10 (20.4)
Strongly agree NA 0 (0.0) 10 (41.7) 10 (20.4)
Missing NA 25 (100.0) 2 (8.3) 27 (55.1)
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TABLE 58 Responses to process evaluation closed questions (continued )
Survey question Scoring
Control
(n = 26),
n (%)
Mini
(n = 25),
n (%)
Full
(n = 24),
n (%)
Total
(n = 75),
n (%)
Q12: Throughout the ‘booster’ counselling/advice sessions I feel I wasn't being judged by the project worker
Strongly disagree NA 1 (4.0) 2 (8.3) 3 (6.1)
Disagree NA 1 (4.0) 1 (4.2) 2 (4.1)
Agree NA 7 (28.0) 5 (20.8) 12 (24.5)
Strongly agree NA 13 (52.0) 15 (62.5) 28 (57.1)
Missing NA 3 (12.0) 1 (4.2) 4 (8.2)
Q13: The ‘booster’ counselling/advice sessions were non-confrontational in nature
Strongly disagree NA 1 (4.0) 2 (8.3) 3 (6.1)
Disagree NA 0 (0.0) 1 (4.2) 1 (2.0)
Neutral NA 1 (4.0) 0 (0.0) 1 (2.0)
Agree NA 6 (24.0) 5 (20.8) 11 (22.4)
Strongly agree NA 13 (52.0) 14 (58.3) 27 (55.1)
Missing NA 4 (16.0) 2 (8.3) 6 (12.2)
Q14: Throughout the ‘booster’ counselling/advice sessions I thought the project worker understood what I was saying
Strongly disagree NA 1 (4.0) 1 (4.2) 2 (4.1)
Agree NA 9 (36.0) 9 (37.5) 18 (36.7)
Strongly agree NA 12 (48.0) 13 (54.2) 25 (51.0)
Missing NA 3 (12.0) 1 (4.2) 4 (8.2)
Q15: How Involved did you feel in the ‘booster’ counselling advice sessions?
I spoke more than
the project worker
NA 15 (60.0) 7 (29.2) 22 (44.9)
I spoke less than
the project worker
NA 3 (12.0) 0 (0.0) 3 (6.1)
I spoke roughly the
same amount as the
project worker
NA 4 (16.0) 16 (66.7) 20 (40.8)
Missing 3 (12.0) 1 (4.2) 4 (8.2)
Q16: How do you feel about the amount of contact time that occurred between you and the project worker
About right NA 22 (88.0) 22 (91.7) 44 (89.8)
Slightly too short NA 0 (0.0) 1 (4.2) 1 (2.0)
Missing NA 3 (12.0) 1 (4.2) 4 (8.2)
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TABLE 58 Responses to process evaluation closed questions (continued )
Survey question Scoring
Control
(n = 26),
n (%)
Mini
(n = 25),
n (%)
Full
(n = 24),
n (%)
Total
(n = 75),
n (%)
Q17: During the ‘booster’ counselling advice sessions I was encouraged to set my own goals for physical activity
Not discussed NA 1 (4.0) 0 (0.0) 1 (2.0)
Neutral NA 2 (8.0) 1 (4.2) 3 (6.1)
Agree NA 13 (52.0) 12 (50.0) 25 (51.0)
Strongly agree NA 6 (24.0) 10 (41.7) 16 (32.7)
Missing NA 3 (12.0) 1 (4.%) 4 (8.2)
Q18: As a result of the ‘booster’ counselling/advice sessions I feel I have been able to resolve my barriers towards
physical activity
Disagree NA 1 (4.0) 0 (0.0) 1 (2.0)
Neutral NA 8 (32.0) 5 (20.8) 13 (26.5)
Agree NA 10 (40.0) 12 (50.0) 22 (44.9)
Strongly agree NA 3 (12.0) 6 (25.0) 9 (18.4)
Missing NA 3 (12.0) 1 (4.0) 4 (8.0)
Q19: As a result of the ‘booster’ counselling/advice sessions I now know more about the beneﬁts of physical activity
Neutral NA 8 (32.0) 5 (20.8) 13 (26.5)
Agree NA 11 (44.0) 11 (45.8) 22 (44.9)
Strongly agree NA 3 (12.0) 7 (29.2) 10 (20.4)
Missing NA 3 (12.0) 1 (4.2) 4 (8.2)
Q20: As a result of the ‘booster’ counselling/advice sessions I now know more about the risks associated with living an
inactive lifestyle
Not discussed NA 1 (4.0) 0 (0.0) 1 (2.0)
Disagree NA 1 (4.0) 0 (0.0) 1 (2.0)
Neutral NA 7 (28.0) 4 (16.7) 11 (22.4)
Agree NA 9 (36.0) 13 (54.2) 22 (44.9)
Strongly agree NA 4 (16.0) 6 (25.0) 10 (20.4)
Missing NA 3 (12.0) 1 (4.2) 4 (8.2)
Q21: As a result of the ‘booster’ counselling/advice sessions I am now more aware of available physical activity facilities
and opportunities
Not discussed NA 1 (4.0) 0 (0.0) 1 (2.0)
Neutral NA 7 (28.0) 5 (20.8) 12 (24.5)
Agree NA 9 (36.0) 13 (54.2) 22 (44.9)
Strongly agree NA 4 (16.0) 5 (20.8) 9 (18.4)
Missing NA 4 (16.0) 1 (4.2) 5 (10.2)
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TABLE 58 Responses to process evaluation closed questions (continued )
Survey question Scoring
Control
(n = 26),
n (%)
Mini
(n = 25),
n (%)
Full
(n = 24),
n (%)
Total
(n = 75),
n (%)
Q22: As a result of the ‘booster’ counselling/advice sessions my conﬁdence to stay active has increased
Neutral NA 5 (20.0) 0 (0.0) 5 (10.2)
Agree NA 12 (48.0) 13 (54.2) 25 (51.0)
Strongly agree NA 5 (20.0) 10 (41.7) 15 (30.6)
Missing NA 3 (12.0) 1 (4.2) 4 (8.2)
Finally, would you be happy to discuss some of the things mentioned in this questionnaire further in an interview with
a different person from the person you have been in contact with about this study so far, either face to face or over
the telephone?
No 1 (3.8) 1 (4.0) 2 (8.3) 4 (5.3)
Yes 25 (96.2) 21 (84.0) 21 (87.5) 67 (89.3)
Missing 0 (0.0) 3 (12.0) 1 (4.2) 4 (5.3)
Interview method:
face to face
No 6 (23.1) 11 (44.0) 7 (29.2) 24 (32.0)
Yes 20 (76.9) 14 (56.0) 17 (70.8) 51 (68.0)
Interview method:
over the telephone
No 12 (46.2) 11 (44.0) 14 (58.3) 37 (49.3)
Yes 14 (53.8) 14 (56.0) 10 (41.7) 38 (50.7)
NA, not applicable.
TABLE 59 Interview population baseline characteristics
Variable
Not interviewed
(n = 256)
Interviewed
Total
(n = 282)All (n = 26)
Mini booster
(n = 13)
Full booster
(n = 13)
Gender, n (%)
Male 116 (45) 14 (54) 7 (54) 7 (54) 130 (46)
Female 140 (55) 12 (46) 6 (46) 6 (46) 152 (54)
Employment status, n (%)
Part-time 44 (17) 8 (31) 5 (38) 3 (23) 52 (18)
Full-time 89 (35) 4 (15) 2 (15) 2 (15) 93 (33)
Not employed 121 (47) 13 (50) 5 (38) 8 (62) 134 (48)
Missing 2 (1) 1 (4) 1 (8) 0 (0) 3 (1)
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TABLE 59 Interview population baseline characteristics (continued )
Variable
Not interviewed
(n = 256)
Interviewed
Total
(n = 282)All (n = 26)
Mini booster
(n = 13)
Full booster
(n = 13)
Ethnicity, n (%)
White British 222 (87) 24 (92) 13 (100) 11 (85) 246 (87)
Any other 31 (12) 2 (8) 0 (0) 1 (8) 33 (12)
Missing 3 (1) 0 (0) 0 (0) 1 (8) 3 (1)
Marital status, n (%)
Single 40 (16) 5 (19) 4 (31) 1 (8) 45 (16)
Married 138 (54) 13 (50) 5 (38) 8 (62) 151 (54)
Co-habiting 18 (7) 2 (8) 1 (8) 1 (8) 20 (7)
Divorced/
separated
51 (20) 4 (15) 2 (15) 2 (15) 55 (20)
Widowed 9 (4) 2 (8) 1 (8) 1 (8) 11 (4)
Stage of change, n (%)
Contemplation 12 (4.7) 0 (0.0) 0 (0.0) 0 (0.0) 12 (4.3)
Preparation 114 (44.5) 11 (42.3) 7 (53.8) 4 (30.8) 125 (44.3)
Action 84 (32.8) 7 (26.9) 3 (23.1) 4 (30.8) 91 (32.3)
Maintenance 43 (16.8) 7 (26.9) 3 (23.1) 4 (30.8) 50 (17.7)
Missing 3 (1.2) 1 (3.8) 0 (0.0) 1 (7.7) 4 (1.4)
Age (years)
n (%) 256 (100) 26 (100) 13 (100) 13 (100) 282 (100)
Mean (SD) 54.3 (7.4) 57.6 (6.1) 57.0 (5.6) 58.2 (6.6) 54.6 (7.3)
Median (IQR) 54.5 (48.3
to 61.0)
58.1 (53.2
to 63.5)
56.7 (53.2
to 61.8)
61.1 (54.3
to 63.9)
55.3 (48.8
to 61.4)
Min. to max. 40.4 to 65.5 45.5 to 65.1 47.9 to 65.1 45.5 to 64.9 40.4 to 65.5
Height (m)
n (%) 255 (100) 26 (100) 13 (100) 13 (100) 281 (100)
Mean (SD) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1)
Median (IQR) 1.7 (1.6 to 1.7) 1.7 (1.6 to 1.8) 1.7 (1.6 to 1.8) 1.7 (1.6
to 1.8)
1.7 (1.6
to 1.8)
Min. to max. 1.5 to 1.9 1.6 to 1.9 1.6 to 1.8 1.6 to 1.9 1.5 to 1.9
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TABLE 59 Interview population baseline characteristics (continued )
Variable
Not interviewed
(n = 256)
Interviewed
Total
(n = 282)All (n = 26)
Mini booster
(n = 13)
Full booster
(n = 13)
Weight (kg)
n (%) 256 (100) 26 (100) 13 (100) 13 (100) 282 (100)
Mean (SD) 85.2 (19.1) 84.5 (13.9) 80.3 (13.1) 88.7 (13.9) 85.2 (18.7)
Median (IQR) 83.0 (72.3
to 96.5)
80.8 (74.5
to 96.6)
78.0 (73.5
to 89.3)
88.0 (79.0
to 97.0)
82.9 (72.5
to 96.6)
Min. to max. 46.9 to 160.0 57.0 to 114.0 57.0 to 101.9 70.5 to 114.0 46.9 to 160.0
BMI (kg/m2)
n (%) 255 (100) 26 (100) 13 (100) 13 (100) 281 (100)
Mean (SD) 30.4 (6.1) 29.6 (3.9) 27.9 (2.8) 31.3 (4.3) 30.3 (5.9)
Median (IQR) 29.8 (26.0
to 33.2)
29.5 (26.9
to 31.5)
27.7 (26.7
to 30.4)
29.9 (29.0
to 35.1)
29.8 (26.3
to 33.0)
Min. to max. 17.1 to 53.4 22.5 to 39.3 22.5 to 32.0 25.0 to 39.3 17.1 to 53.4
SPAQ change (3 months post randomisation)
n (%) 256 (100) 26 (100) 13 (100) 13 (100) 282 (100)
Mean (SD) 223.1 (382.3) 81.1 (178.6) 48.1 (187.3) 114.1 (170.4) 210.0 (370.4)
Median (IQR) 120.0 (60.0
to 257.5)
65.0 (0.0
to 200.0)
60.0 (0.0
to 150.0)
75.0 (40.0
to 200.0)
120.0 (60.0
to 255.0)
Min. to max. –1840.0
to 3360.0
–480.0
to 540.0
–480.0
to 270.0
–150.0
to 540.0
–1840.0
to 3360.0
BREQ-2 (RAI)
n (%) 248 (97) 26 (100) 13 (100) 13 (100) 274 (97)
Mean (SD) 5.2 (3.7) 5.7 (4.2) 3.8 (4.8) 7.6 (2.5) 5.3 (3.7)
Median (IQR) 5.8 (3.2
to 7.9)
7.2 (4.2
to 8.7)
5.8 (0.3
to 7.5)
8.3 (6.3
to 9.7)
6.0 (3.3
to 8.0)
Min. to max. –9.1 to 12.0 –4.7 to 11.0 –4.7 to 9.0 2.9 to 11.0 –9.1 to 12.0
max., maximum; min., minimum.
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TABLE 60 Objective physical activity levels in the interview population
Participant
Days meeting guidance/
accelerometry days
Median (range) moderate/
vigorous activity (minutes)
1064 0/3 0 (0 to 0)
1087 0/7 0 (0 to 9)
1094 0/7 0 (0 to 3)
1096 0/7 0 (0 to 5)
1152 3/3 576 (280 to 583)
1217 NA NA
1230 2/7 3 (1 to 91)
1231 1/7 7 (3 to 53)
1232 1/7 15 (4 to 43)
1235 NA NA
1237 NA NA
1238 2/7 2 (0 to 47)
1240 0/7 0 (0 to 0)
1243 0/7 0 (0 to 26)
1245 NA NA
1252 0/7 2 (0 to 23)
1253 NA NA
1257 1/7 1 (0 to 41)
1258 3/7 28 (2 to 54)
1265 0/7 5 (0 to 14)
1267 0/7 13 (0 to 26)
1272 0/7 3 (0 to 6)
1279 0/7 0 (0 to 0)
1280 NA NA
1281 0/7 2 (0 to 12)
1282 0/4 0.5 (0 to 3)
NA, not applicable.
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TABLE 61 Motivational Interviewing Treatment Integrity interventionist ratings (treatment ﬁdelity)
Name
Evocation (/5) Collaboration (/5)
Autonomy/support
(/5) Direction (/5) Empathy (/5)
First Second Mean First Second Mean First Second Mean First Second Mean First Second Mean
RA1 4 3 3.5 3 4 3.5 4 3 3.5 4 4 4 5 4 4.5
RA2 2 3 2.5 3 4 3.5 3 3 3 5 5 5 3 3 3
RA3 4 4 4 3 4 3.5 3 3 3 5 5 5 3 3 3
RA4 3 3 3 3 4 3.5 4 3 3.5 5 4 4.5 4 3 3.5
RA5 4 – 4 3 – 3 4 – 4 4 – 4 4 – 4
RA6 3 – 3 3 – 3 3 – 3 2 – 2 4 – 4
Note: proﬁciency = 3.5; competency = 4.0.
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Average global rating
(/5)
% Complex
reﬂections (%CR)
% Open questions
(%OQ)
Reﬂection to
question ratio (R : Q)
% MI adherent
(%MIA)
First Second Mean First Second Mean First Second Mean First Second Mean First Second Mean
3.6 3.3 3.5 67 23 45 27 53 40 2.5 2.6 2.6 100 75 88
2.6 3.3 3 24 11 18 36 36 36 0.6 1.8 1.2 0 100 50
3.3 3.6 3.5 20 16 18 38 51 45 1.1 1.2 1.2 100 100 100
3.6 3.3 3.5 45 22 34 28 54 41 0.7 1.6 1.2 100 100 100
3.6 – 3.6 38 – 38 30 – 30 1.8 – 1.8 100 – –
3 – 3 40 – 40 33 – 33 1.6 – 1.6 100 – –
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TABLE 62 Assumptions and derivations used to produce estimates of the intervention cost
Code Parameter Value Assumptions/source/derivation
A Sessions per completer 2 Booster trial
B Average number of completer sessions per RA 35.67 214 completers, six RAs
C Completers at 3 months in mini booster arm 55 Booster trial
D Completers at 3 months in full booster arm 52 Booster trial
E Completers at 9 months in mini booster arm 27 Booster trial
F Completers at 9 months in full booster arm 35 Booster trial
G Participants in mini booster 92 Booster trial
H Participants in full booster 94 Booster trial
I Fixed costs per RA, high estimate £1800 Upper estimate of training/monitoring
costs from booster MI expert
J Fixed costs per RA, low estimate £1000 Lower estimate of training/monitoring
costs from booster MI expert
K Hourly wage per RA £15.76 Assuming wage of £26,000/year and
1650 hours/year
L Additional cost per hour, full booster £10 RA estimate of room hire costs per
session
M Additional cost per hour, mini booster £4.80 Assuming telephone call costs
of 8p/minute
N Session duration, mini booster 20
minutes
RA estimate
O Session duration, full booster 30
minutes
RA estimate
P Participants per completer 1.87 200 participants/107 completers
Q Variable cost per session, mini booster £6.85 N × (M + K)
R Variable cost per session, full booster £12.88 O × (L + K)
S Effective sessions per completer, 3 months,
mini booster
3.35 A × (G/C)
T Effective sessions per completer, 3 months,
full booster
3.62 A × (H/D)
U Effective sessions per completer, 9 months,
mini booster
6.81 A × (G/E)
V Effective sessions per completer, 9 months,
full booster
5.37 A × (H/F)
W Variable cost per completer, 3 months, mini booster £22.92 Q × S
X Variable cost per completer, 3 months, full booster £46.56 R × T
Y Variable cost per completer, 9 months, mini booster £46.70 Q × U
Z Variable cost per completer, 9 months, full booster £49.18 R × V
AA Fixed cost per completer, 3 months, mini booster,
assuming I
£168.84 (I/C) × S
AB Fixed cost per completer, 3 months, full booster,
assuming I
£182.46 (I/C) × T
AC Fixed cost per completer, 9 months, mini booster,
assuming I
£343.93 (I/C) × U
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TABLE 62 Assumptions and derivations used to produce estimates of the intervention cost (continued )
Code Parameter Value Assumptions/source/derivation
AD Fixed cost per completer, 9 months, full booster,
assuming J
£271.08 (I/C) × V
AE Fixed cost per completer, 3 months, mini booster,
assuming J
£93.80 (J/C) × S
AF Fixed cost per completer, 3 months, full booster,
assuming J
£101.37 (J/C) × T
AG Fixed cost per completer, 9 months, mini booster,
assuming J
£191.07 (J/C) × U
AH Fixed cost per completer, 9 months, full booster,
assuming J
£150.60 (J/C) × V
AI Total cost per completer, 3 months, mini booster,
assuming I
£191.76 W+AA
AJ Total cost per completer, 3 months, full booster,
assuming I
£229.02 X + AB
AK Total cost per completer, 9 months, mini booster,
assuming I
£390.62 Y + AC
AL Total cost per completer, 9 months, full booster,
assuming I
£340.26 Z + AD
AM Total cost per completer, 3 months, mini booster,
assuming J
£116.72 W+AE
AN Total cost per completer, 3 months, full booster,
assuming J
£147.93 X + AF
AO Total cost per completer, 9 months, mini booster,
assuming J
£237.77 Y + AG
AP Total cost per completer, 9 months, full booster,
assuming J
£219.78 Z + AH
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